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American Association for the Advancement of Science.  Currently, he is the associate director of 
the Ohio Agricultural Research and Development Center, The Ohio State University and a 
professor in the Food Animal Health Research Program in the College of Veterinary Medicine.  
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Kansas City Marriott Downtown 
200 West 12th Street 
Kansas City, Missouri, USA 
Phone:  1-816-421-6800 
 
Meeting Rooms Map 
 
  
Posters 
Presentations Registration 
Joint Meetings:
2012 International PRRS Symposium (IPRRSS) and
National Swine Improvement Federation (NSIF) Conference
November 29 - 30, 2012 - Marriott KC Downtown, Kansas City, Missouri
Thursday, November 29
7:00 am  - IPRRSS and NSIF Registration Opens and Poster Set-up - (Marriott Tower, 2nd Level Foyer)
8:00 am - 5:00 pm NSIF - Pig Genetics and Breeding Conference
   (Marriott Tower, 2nd Level - Basie C)
   Session 1:  Utilizing Genetic Improvement to Capture System Protability 
     Moderator: Dr. Mark Knauer, North Carolina State University
   8:00 - 8:45 Key Economic Drivers of an Integrated Pork Production System
     Dr. Noel Williams, Iowa Select Farms
   8:45 - 9:30  It’s About Dam Time
     Dr. Chad Hastad, New Fashion Pork
   Session 2:  Genomics - From Obstacles for Implementation to Realized Genetic Progress
     Moderator: Dr. Justin Fix, National Swine Registry
   9:30 - 10:00 Technical Challenges to Implementation of Genomic Selection
     Dr. Christian Maltecca, North Carolina State University
   10:00 - 10:30 BREAK
   10:30 - 11:00 Economics of Genomic Selection in Swine
     Dr. Ken Stalder and/or Caitlyn Abell, Iowa State University
   11:00 - 11:30 Accuracy of Imputation and Potential Benets
     Dr. Juan Pedro Steibel, Michigan State University
   11:30 - 12:00 Genomic Selection - Dairy Cattle Challenges and Successes
     Dr. John Cole - AIPL
   
   
12:00 - 12:30 Genomic Selection - Swine Challenges and Successes
  Dr. Matt Culbertson, PIC
   12:30 - 2:00 Awards Luncheon
   1:30 - 2:00 Awards
   2:00 - 2:30 Graduate Student Presentation
   
   Session 3: Selecting for Pig Robustness 
     Moderator: Dr. David Casey, PIC
   2:30 - 3:00 Selecting for Robustness in Pigs
     Dr. Pramod Mathur, TOPIGS
   3:00 - 3:30 Selecting for Robustness in Broilers
     Dr. Danny Lubritz, Cobb-Vantress
   3:30 - 4:00 BREAK
3:00 pm - 7:00 pm  - IPRRSS and NSIF Registration Opens - (Marriott Tower, 2nd Level Foyer)
Wednesday, November 28
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Thursday, November 29
8:00 am - 5:00 pm NSIF - Pig Genetics and Breeding Conference
   (Marriott Tower, 2nd Level - Basie C)
   Session 4: Selecting for Sow Robustness
     Moderator: Dr. David Casey, PIC
   4:00 - 4:30 Sow Robustness: What it is and its Importance to the Bottom Line
     Dr. Benny Mote, Fast Genetics
   4:30 - 5:00 Selecting for Robustness in Dairy Cattle
     Dr. Bradley Heins, University of Minnesota
   
8:00 am - 12:00 pm PRRS CAP Vaccine Workshop: PRRS Vaccines - Past, Present, and Future
   (Marriott Tower, 2nd Level - Basie A/B)
   8:00   The Role of Host Genetics in Bringing the Pig Closer to the Vaccine
     Bob Rowland, Kansas State University
   8:30   Scaling and Sustaining in Eective Large-Scale PRRS Control: It Takes a (Committed)
     Village, and a (Full) Toolbox
     Dale Polson, Boehringer Ingelheim Vetmedica, Inc.
   9:10  Alphavirus Replicon-Based PRRSV Vaccine Development
     Mark Mogler, Harrisvaccines
   9:50  BREAK
   10:10  Molecular Breeding of PRRSV for Novel Vaccine Development
     X.J. Meng, Virginia Tech
   10:50  PRRS - Progress Against a Challenging Disease
     Jay Calvert, Pzer Animal Health, Fostera
   11:30  Roundtable Discussion on the Future of PRRS Vaccines
   12 Noon LUNCH - provided by NSIF, IPRRSS and BIVI
1:00 pm - 5:00 pm Boehringer Ingelheim Vetmdica, Inc. PRRS ARC & E Seminar
   (Marriott Tower, 2nd Level - Basie A/B)
   1:00 - 1:30 Sucient Surveillance for ARC&E: Getting the Big-Picture Without Missing
     the Important Stu
     Dr. Dale Polson, Boehringer Ingelheim Vetmedica, Inc
   1:30 - 2:00  Disease Bioportal: Visualization and Analytic Tools for PRRS Epidemiology
     Dr. Andres Perez, University of California, Davis
   2:00 - 2:30 Application of Disease Bioportal for Decision Making in a Production System
     Dr. Jean-Paul Cano, Boehringer Ingelheim Vetmedica, Inc
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Thursday, November 29
1:00 pm - 5:00 pm Boehringer Ingelheim Vetmdica, Inc. PRRS ARC & E Seminar
   (Marriott Tower, 2nd Level - Basie A/B)
   2:30 - 3:30 Area Regional PRRS Control Projects Breakout Session 
 Corner 1 Corner 2 Corner 3 Corner 4 
2:30-2:40 Project_W1 Project_E1 Project_E4 Posters 
2:40-2:50 Project_W2 Project_E2 Project_W4 Posters 
2:50-3:00 Project_W3 Project_E3 MN N212 Posters 
3:00-3:10 Project_W1 Project_E1 Project_E4 Posters 
3:10-3:20 Project_W2 Project_E2 Project_W4 Posters 
3:20-3:30 Project_W3 Project_E3 MN N212 Posters 
-All presenters will hand out 1-page summaries
   3:30 - 4:00 Update on Tools for PRRS Control: Filtration, Biosecurity, Vaccination
     Dr. Scott Dee, Pipestone Veterinary Clinic
   4:00 - 4:30 Emergency Measures for Disease Control Programs
     Dr. Jean-Pierre Vaillancourt, University of Montreal
   4:30 - 5:00 Applying Epidemiology to Animal Disease Control: A Review on Personal Experience
     Dr. Preben Willeberg, University of California, Davis
 
5:00 pm - 7:00 pm Reception and Poster Session (cash bar)
   (Marriott Tower, 2nd Level  Foyer)
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Friday, November 30
7:00 am  -   IPRRSS and NSIF Registration Opens - (Marriott Tower, 2nd Level Foyer)
7:00 am - 8:00 am Breakfast Provided by IPRRSS and NSIF - (Marriott Tower, 2nd Level Foyer)
8:00 am - 12:00 pm NSIF - IPRRSS Sponsored Talks on the Host Response to PRRSV Infection
   (Marriott Tower, 2nd Level - Basie A/B)
   8:00   Progress of the PRRS Host Genetics Consortium: Variation in Gene and Protein
     Expression in Response to PRRSV Infection
     Joan Lunney, USDA ARS - Beltsville
   8:30   Phenotypic Variability to PRRS in the Reproductive Model: A Potential Opportunity
     John Harding, University of Saskatchewan
   9:00  Genetic Basis of Host Response to PRRSV Infection
     Nick Boddicker, Iowa State University
   9:30  Perspectives on Eorts in the EU and Beyond
     Stephen Bishop, The Roslin Institute, University of Edinburgh
   10:00  BREAK
   10:30  Genomic Analysis of the Dierential Response in Experimental Infection with 
     Porcine Circovirus 2
     Daniel Ciobanu, University of Nebraska
   11:00  Genetic Engineering of Pigs for PRRSV Resistance
     Randy Prather, University of Missouri
   11:30  Roundtable Discussion
     Graham Plastow, University of Alberta
   12 Noon LUNCH - provided by IPRRSS
1:00 pm - 5:00 pm Ten Years of PRRS CAP and National Pork Board Research Progress in PRRS Control
   (Marriott Tower, 2nd Level - Basie A/B)
   1:00   Ten Years of Advancements in PRRSV Immunity
     Michael Murtaugh, University of Minnesota
   1:45  10 Years of Research in PRRSV Epidemiology/Ecology - An Overview
     Je Zimmerman
   2:30  PRRSV Vaccine and Diagnostic Assay Development:
     From Basic to Applied Sciences
     Ying Fang, South Dakota State University
   3:15  BREAK - POSTER REMOVAL
   3:30  Ten Years of Research in Structure and Function of PRRSV Proteins
     Dongwan Yoo, University of Illinois
   4:15  Progress in PRRS Area Regional Control and Elimination
     Robert Morrison, University of Minnesota
   5:00  ADJOURN
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Stephen Bishop. University of Edinburgh, Midlothian, United Kingdom. 
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2 Genetic basis of host response to PRRSV infection. 
Nick Boddicker. Iowa State University, Ames, Iowa, USA. 
p. 20 
3 Fostera™ PRRS –progress against a challenging disease. 
Jay Calvert. Pfizer Animal Health, Kalamazoo, Michigan, USA. 
p. 21 
4 Genomic analysis of the differential response in experimental infection with Porcine 
Circovirus 2. 
Daniel Ciobanu.  University of Nebraska, Lincoln, Nebraska, USA. 
p. 22 
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Ying Fang. South Dakota State University, Brookings, South Dakota, USA. 
p. 23 
6 Phenotypic variability in response to the PRRS virus in the reproductive model: a 
potential opportunity. 
John Harding.  University of Saskatchewan, Saskatoon, Canada. 
p. 24 
7 Progress of the PRRS Host Genetics Consortium: variation in gene and protein 
expression in response to PRRSV Infection. 
Joan K. Lunney.  USDA-ARS-BARC, Beltsville, Maryland, USA. 
p. 25 
8 Molecular breeding of PRRSV for novel vaccine development. 
XJ Meng. Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA. 
p. 26 
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Mark Mogler. Harris Vaccines, Ames, Iowa, USA. 
p. 27 
10 Regional PRRS elimination. 
Bob Morrison.  University of Minnesota, St. Paul, Minnesota, USA. 
p. 28 
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Michael Murtaugh. University of Minnesota, St. Paul, Minnesota, USA. 
p. 29 
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village, and a (full) toolbox. 
Dale Polson. Boehringer Ingelheim Vetmedica, Inc., St. Joseph, Missouri, USA. 
p. 30 
13 Disrupting sialoadhesin and CD163 to create pigs resistant to PRRSV infectivity. 
Randy Prather. University of Missouri, Columbia, Missouri, USA. 
p. 31 
14 The role of host genetics in bringing the pig closer to the vaccine. 
Bob Rowland. Kansas State University, Manhattan, Kansas, USA. 
p. 32 
15 Ten years of research in structural function of PRRSV proteins. 
Dongwan Yoo. University of Illinois at Urbana-Champaign, Urbana, Illinois, USA. 
p. 33 
16 Basics of PRRSV epidemiology - I. transmission. 
Jeff Zimmerman. Iowa State University, Ames, Iowa, USA. 
p. 34 
   
 POSTER ABSTRACTS  
 PRRS Epidemiology, Heterogeneity, and Evolution  
   
17 Summary of the PRRS control measures utilized by breeding herds in North 
America participating in the PADRAP database (2006-2011).  
N. DeBuse1, S. Rutten-Ramos2, S. Rao3, D. Holtkamp4, 1Minnesota Swine Reproduction Center, 
Northfield, MN, 2Farwell, MN, 3Animal Population Health Institute, Department of Clinical Sciences, 
Colorado State University, 4Iowa State University, Ames, Iowa. 
p. 36 
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18 An evaluation of the long-term effect of air filtration on the occurrence of new 
PRRSV infections in large breeding herds in swine-dense regions.  
S. Dee*1,5, J.P. Cano2, G. Spronk1, D. Reicks3, P. Ruen4, A. Pitkin4 and D. Polson2, 1Pipestone 
Veterinary Clinic, Pipestone, MN, 2Boehringer-Ingelheim, St Joseph, MO, 3Swine Vet Center, St. 
Peter, MN, 4Fairmont Veterinary Clinic, Fairmont, MN, 5University of Minnesota College of 
Veterinary Medicine, St. Paul, MN. 
p. 37 
19 Pen-side molecular diagnosis of porcine reproductive and respiratory syndrome 
virus (PRRSV) and porcine circovirus 2 (PCV2) – a pilot project in Alberta, Canada.  
M. Eschbaumer1*, S. Campbell2, R. Waeckerlin1, R. Dardari1, F. Marshall3,  
J. Acker2, M. Czub1, 1Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada, 
2Aquila Diagnostic Systems Inc., Edmonton, AB, Canada, 3Marshall Swine Health Services, 
Camrose, AB, Canada. 
p. 38 
20 Sequence diversity of PRRS virus in the Czech Republic. 
J. Janková1*, V. Celer1,2, 1University of Veterinary and Pharmaceutical Sciences Brno, Palackého tř. 
1/3, 612 42 Brno, Czech Republic, 2CEITEC, University of Veterinary and Pharmaceutical Sciences 
Brno, Czech Republic. 
p. 39 
21 Detection of PRRSV antibody in oral fluid specimens from individual boars using a 
commercial PRRSV serum antibody ELISA. 
A. Kittawornrat1*, M. Engle3, J. Johnson1, J. Prickett1, C. Olsen1, T. Schwartz1,D. Whitney1,  
K. Schwartz1, A. Rice4, A. Ballagi4, S. Lizano4, C. Wang1,2,J. Zimmerman1,1Department of Veterinary 
Diagnostic and Production Animal Medicine, Iowa State University, Ames, IA, 2Department of 
Statistics, Iowa State University, Ames, IA, 3PIC North America, Hendersonville, TN, 4IDEXX 
Laboratories, Westbrook, ME. 
p. 40 
22 Ring test evaluation for the detection of PRRSV antibody in oral fluid specimens 
using a commercial PRRSV serum antibody ELISA. 
A. Kittawornrat1*, C. Wang1, G. Anderson2, A. Ballagi3, A. Broes4, S. Carman5, K. Doolittle6,  
J. Galeota7, J. Johnson1, S. Lizano3, E. Nelson8, D. Patnayak9, R. Pogranichniy10, A. Rice3,  
G. Scherba11, J. Zimmerman1,1Iowa State University, 2Kansas State University, 3IDEXX 
Laboratories,Inc.,4Biovet Inc., 5University of Guelph, 6Boehringer Ingelheim Vetmedica Inc., 
7University of Nebraska, 8South Dakota State University, 9University of Minnesota, 10Purdue 
University, 11University of Illinois. 
p. 41 
23 Developing a work plan and toolbox for regional control and elimination of PRRS 
virus.  
Trevor Lank DVM1*, Leigh Rosengren DVM2, Manon St. Hilaire DVM2, 1Canadian Swine Health 
Board Provincial Biosecurity Coordinator (New Brunswick), 2CASV PRRS ARC-E Project co-
coordinator. 
p. 42  
24 Deep sequencing of PRRSV isolates: rapid and large-scale characterization of viral 
genomes. 
Manreetpal Singh Brar, Mang Shi, and Frederick C.C. Leung*, School of Biological Sciences, 
University of Hong Kong, HKSAR, China. 
p. 43  
 
25 Deletion polymorphism of NSP2 protein of HP-PRRSVs in China. 
Fei Liu1.2, Tong-Qing An1, Chun-Guo Liu1, Bi-Jun Zhou2, Jin-Mei Peng1, Guang-Zhi Tong1,  
Zhi-Jun Tian1* , Kai-Gong Wang2, 1State Key Laboratory of Veterinary Biotechnology, Harbin 
Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China, 2College of 
Animal Science, Guizhou University, Guiyang, China. 
p. 44  
26 Development of a new IDEXX ELISA for the detection of PRRS antibodies in 
swine oral fluids.   
Sergio Lizano and Sheri Koller, IDEXX Laboratories, Inc., Westbrook, ME, USA. 
p. 45 
27 The current situation and some researches of PRRS in Vietnam. 
N.T. Lan1, N.B. Hien1, N.H.Nam1, R.Yamaguchi2, 1Faculty of Veterinary Medicine, Hanoi University 
of Agriculture, Hanoi, Vietnam, 2Department of Veterinary Pathology, Faculty of Agriculture, 
University of Miyazaki, Miyazaki, Japan. 
p. 46 
2012 International PRRS Symposium/NSIF Conference 
12 
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Hein Min Tun1#*, Wenhui Lu2#, Jingyun Ma, Frederick Chi-Ching Leung, 1School of Biological 
Sciences, The University of Hong Kong, Hong Kong SAR, PR China, 2College of Animal Science, 
South China Agricultural University, PR China. # These authors contributed equally. 
p. 50 
32 Seroprevalence of porcine reproductive and respiratory syndrome virus (PRRSV), 
swine influenza (SIV), and porcine circovirus 2 (PCV2) in feral Hawaiian swine. 
Y. Wang*, R.J. Stephenson, M.A. Kerrigan, R.R.R. Rowland, Department of Diagnostic Medicine and 
Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS. 
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College of Veterinary Medicine, Kansas State University, Manhattan, KS. 
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R(D)SVS, University of Edinburgh, Edinburgh, UK. 
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The Norwegian University of Life Sciences, PO Box 5003, 1432 Ås, Norway. 
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p. 55 
   
2012 International PRRS Symposium/NSIF Conference 
13 
 
   
38 Developed RT-PCR technique for the diagnosis of porcine reproductive and 
respiratory syndrome virus (PRRSV), in Mexico.  
Sotomayor González*,  M. E. Trujillo Ortega, J. I. Sánchez Betancourt, Departamento de Medicina y 
Zootecnia de Cerdos, FMVZ–UNAM, Avenida Universidad No. 3000, Colonia Copilco-CU, 
Delegación Coyoacán, México City, 04510, D. F., México. 
p. 56 
39ǂ Whole genome association study for lactation feed efficiency in Yorkshire sows 
selected for residual feed intake during finishing. 
D. M. Thekkoot, J. M. Young, Z. Du, S. Onteru, M. F. Rothschild and J. C. M. Dekkers,  
Department of Animal Science, Iowa State University, Ames, IA. 
p. 57 
40 Dissection of cis-acting elements in 5′ untranslated region of porcine reproductive 
and respiratory syndrome virus. 
Fei Gao, Jiaqi Lu, Zuzhang Wei, Guangzhi Tong*, Shishan Yuan, Department of Swine Infectious 
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 PRRS Vaccines and Immunity  
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Perspectives on PRRS research in Europe 
 
S.C. Bishop1*, T. Ait-Ali1, A.B. Doeschl-Wilson1, C.M. Orrett1, Z. U. Islam1,  
D.G. McLaren2, N. Deeb3 and A.L. Archibald1 
1The Roslin Institute & R(D)SVS, University of Edinburgh, Midlothian, UK, 2Genus PIC,  
De Forest, WI, USA, 3Genus PIC, Hendersonville, TN, USA 
 
Europe has a large and active PRRS research community, reflecting the importance of the disease to the 
European pig industry, which mirrors many of the activities underway in the US and Canada. A 
framework for coordinating these activities and communicating the outcomes of the research is given by 
EuroPRRSnet (www.europrrs.net), an EU-funded network.  This initiative aims to develop more effective 
multidisciplinary collaborative PRRS research in Europe centred on PRRSV epidemiology, 
immunopathology, vaccine development and diagnostics tools. Major research topics currently include 
extensive efforts in the field of vaccine development, with a focus on exploring the potential for 
protection across PRRSV strains. Allied to this, much effort focusses on the definition and diagnosis of 
PRRSV subtypes, their pathogenicity and strain-specific immune responses. The EU-Asia project 
PoRRScon (www.porrscon.ugent.be/index.html) coordinates much of this research. Further, resources are 
put into devising sustainable methods of control, particularly developing combined control approaches 
including biosecurity and attempts at eradication. 
 
Several groups within Europe are also actively involved in various aspects of host genetics work, 
exploring options for exploiting genetic differences in host responses to infection to assist in disease 
control. This research involves the elucidation of breed differences in resistance to PRRSV infections, as 
well as genome scans for PRRS resistance in commercial pigs, in both the growing pig and the pregnant 
sow. In particular, The Roslin Institute has a cohesive and wide-ranging research program in PRRS 
resistance, much of which involves close collaboration with academic and industrial partners in North 
America. These studies range from elucidation of host functional responses to infection, through efforts to 
genetically improve resistance through natural variation and engineered resistance, to population-level 
studies and the development of mathematical models to describe the impacts of infection within hosts and 
the transmission of infection between hosts. 
 
A major focus of research on host genetic resistance has been the comparison of host resistance in the 
pregnant sow and the growing pig. Roslin-led research, in collaboration with Genus, has involved detailed 
interrogation of field data from a Chinese herd with 60k SNP chip data available. The dataset has revealed 
differential impacts of PRRS on reproductive outcomes, dependent on when during pregnancy the sow 
faced infection, and has given indications of a locus on SSC4 associated with reproductive losses. 
Currently we are assessing this result in independent commercial populations and determining whether 
this QTL is consistent with the SSC4 QTL, identified by the PHGC, which affects viremia in growing 
pigs. Using Bayesian inference techniques we are also obtaining detailed interpretations of the viremia 
profiles seen in the pigs challenged with PRRSV by the PHGC. Further, we are using in vitro techniques 
to determine mechanisms of host cell permissiveness to PRRSV. The analysis of experimental data is 
complemented by the development of mathematical host-pathogen interaction models to explore 
alternative hypotheses underlying infection dynamics. Our ambition is to use such models to help design 
and explore alternative disease control strategies.   
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Genetic basis of host response to PRRSV infection 
 
N. J. Boddicker1, J. K. Lunney2, R. R. R. Rowland3, D. J. Garrick1,  
J. M. Reecy1, and J. C. M. Dekkers1 
1Department of Animal Science, Iowa State University, 2USDA, ARS, BARC, 3College of 
Veterinary Medicine, Kansas State University 
 
Improvement of animal health, specifically for the economically important disease of PRRS, has 
been facilitated by improvements in biosecurity, vaccines and, most recently, the potential to use 
host genetics to select for more PRRS resilient pigs. The objective of this study was to discover 
the genetic basis of host response to PRRS virus infection using data from the PRRS Host 
Genetics Consortium PRRS-CAP project by conducting a genome-wide association analysis and 
estimating genetic parameters. Eight groups of ~200 commercial crossbred pigs were infected 
between 18 and 28 days of age with virus isolate NVSL 97-7985. Breeds represented in the 
crosses included Large White, Landrace, Yorkshire, Duroc, and Pietrain. Blood samples and 
body weights were collected up to 42 days post infection (dpi). Experimental pigs and their 
parents were genotyped with the Illumina Porcine 60k Beadchip that includes over 60,000 Single 
Nucleotide Polymorphisms (SNPs) across the genome. Whole genome analyses focused on viral 
load (VL = area under the curve for log-transformed RT-PCR based serum virus from 0-21 dpi) 
and weight gain (WG = gain from 0-42 dpi). Viral load data was only available for the first 7 
trials. Across trials, VL and WG heritabilities that were estimated using pedigree information 
were 0.41 and 0.29, respectively. Single nucleotide polymorphisms that were associated with VL 
and WG were identified using Bayes-B of GenSel software. A 38-SNP (~ 1 Mb) region on 
chromosome 4 explained 14.6% and 9.1% of the genetic variance for VL and WG, respectively. 
The effect of this region acted in a dominant manner, with the favorable allele at a tag SNP that 
captured most of the effect of the 1 Mb region estimated to decrease VL by 4 units (0.53 
phenotypic sd) and increase WG by 2 kg (0.49 phenotypic sd). The effect of this region was in 
the same direction and of similar magnitude within each trial. Furthermore, the favorable allele at 
the tag SNP was present at low frequency (0.04 to 0.34 %) in all breeds involved in the crosses 
and had an effect on phenotype regardless of breed or parental origin. Across all trials, the 
genotyped SNPs in the 1 Mb region were present in 77 unique haplotypes, of which 11 carried 
the favorable allele at the tag SNP. Furthermore, all haplotypes that carried the favorable allele 
were associated with improved viral clearance. In conclusion, the 1 Mb region on chromosome 4 
explained a substantial proportion of genetic variation in response to experimental challenge with 
a specific strain of the PRRS virus. Estimates of heritability were substantial and, with a minor 
allele frequency of 0.15 across all trials, there is room for genetic improvement in PRRSV 
clearance. The SNPs in this region are in high linkage disequilibrium, which makes further fine 
mapping difficult. This work was supported by PRRS CAP, USDA NIFA Award 2008-55620-
19132, NRSP-8 Swine Genome and Bioinformatics projects, the National Pork Board and 
breeding companies of the PRRS Host Genetics Consortium. 
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Fostera™ PRRS –progress against a challenging disease 
 
J.G. Calvert 
Pfizer Animal Health, Kalamazoo, MI 
 
More than 20 years have passed since Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) 
appeared in the swine industry and it still remains one of the major health challenges in pig production 
worldwide. Using a novel cell line Pfizer Animal Health recently introduced a new genotype 2 (North 
American genotype) modified-live virus (MLV) vaccine to the US and Canadian markets. Fostera™ 
PRRS contains a novel strain, and differs from the monkey-cell attenuated vaccines currently available. 
As with other genetically variable viruses, the extent to which immunity against one strain will also 
protect against others is a key question. Natural infection yields solid immunity against the homologous 
strain but only partial protection against heterologous strains. The level of protection of a vaccine will 
depend on both the overall immune response and the antigenic relatedness of the infecting strain. 
Unfortunately, however, the latter is difficult to predict. The ever-increasing genetic diversity amongst 
PRRS isolates takes the form of a continuous spectrum that persists over time, rather than a series of 
discrete steps in which new types emerge and quickly replace older types.  Although it is possible to 
measure genetic homology, this may not fully correlate with the degree of cross-protection. In addition to 
its ability to mutate, the PRRS virus encodes a number of immune system evasion mechanisms that 
reduce the ability of infected pigs to mount an effective immune response. Despite the challenges 
mentioned above, both killed and modified-live vaccines against PRRS have been developed and are 
widely used. It is generally believed that the latter have proved much more efficacious, but the use of a 
modified-live virus for vaccination introduces possible complications. The vaccine virus may shed and 
spread from animal to animal, raising the question of reversion to virulence. Certain populations, for 
example naive pregnant sows, may be susceptible to pathogenic effects, such as abortion, from some 
otherwise well attenuated strains. These potential risks are intrinsic to modified-live virus vaccines and if 
necessary can be managed, but they are a complication and may pose some restrictions on how such 
vaccines can be used. Pfizer Animal Health’s PRRSV research team has achieved scientific advances in 
our understanding of the genetic makeup of the virus and the importance of its structural proteins. From a 
practical perspective, however, the most significant breakthrough was the identification and isolation of 
the CD163 PRRS receptor and consequent development of novel cell lines to support virus growth. 
CD163 is normally expressed exclusively in macrophages, such as PAMs. Although other proteins have 
also been shown to be involved in the propagation of the PRRS virus by PAM cells, we have shown that 
transfection with the CD163 gene alone is sufficient to render a variety of non-permissive cell lines fully 
permissive to PRRSV, with production of progeny virus. The development of a new, non-simian cell line 
opened the way for Pfizer Animal Health to work in previously restricted areas, but it has scientific as 
well as commercial significance. The development of MLV vaccines involves attenuation by multiple 
passages through cell culture. During this process the virus gradually accumulates mutations that allow it 
to grow better in its new host cell, simultaneously losing properties that helped its survival and caused 
virulence in the pig. There is an element of randomness such that no two MLV vaccines are ever likely to 
be identical. Using different cell lines, however, greatly increases the likelihood of major differences in 
the mutations accumulated, as selective pressures will be different.  Thus, the introduction of Fostera™ 
PRRS in the US and Canada offers pork producers a new and innovative tool for the control of PRRS. 
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Genomic analysis of the differential response in experimental 
infection with Porcine Circovirus 2 
 
E.E. Jobman1, A.M. McKnite1, T.W. Moural2, J.K. Tart1, J.W. Bundy1,  
T.P. Bohnert1, S.Y. Barnes1, C.A. Kreikemeier1, T.B. Engle1, E.H. Davis1,  
J.K. Qiu1, J.A. Galeota2, S.P. Harris2, M.F. Rothschild3, T.E. Burkey1,  
R.K. Johnson1, S.D. Kachman4, D.C. Ciobanu1* 
1Animal Science Department, University of Nebraska, Lincoln, NE, 2Veterinary Diagnostic 
Center, School of Veterinary Medicine and Biological Sciences, University of Nebraska, 
Lincoln, NE, 3Department of Animal Science, Iowa State University, Ames, IA, 4Department of 
Statistics, University of Nebraska, Lincoln, NE 
 
  
Porcine Circovirus 2 (PCV2) is the etiological agent of several associated diseases that impact 
health, efficiency and could lead to mortality. Disease progression is influenced by several 
factors of which host genetics and co-infection play important roles. Using various crossbred 
lines of pigs experimentally infected with PCV2b, we explored the genetic variation of the main 
indicators of disease progression and immune response. Growth, viral load and specific antibody 
response were profiled weekly during the 28 day challenge period. The initial results provide 
evidence of host variation in magnitude and time of immune response to PCV2b. A higher viral 
load was correlated with slower growth (r = - 0.29) and higher level of PCV2 - specific 
antibodies, IgM (r = 0.32 to 0.43) and IgG (r = 0.30 to 0.43). Tumor necrosis factor-alpha, 
haptoglobin and total antioxidant capacity were increased in pigs that expressed high viral load 
and low growth. A genome wide association study that included the genotypes of 56,433 SNPs 
uncovered genomic regions that influence the variation of disease phenotypes. Major clusters of 
SNPs that impacted viral load were found on SSC6 (36.2 Mb), SSC7 (30.4 - 30.8 Mb, 134.1 - 
134.4 Mb) and SSC12 (18.2 - 18.6 Mb). The same region located on SSC7 had also an effect on 
growth during challenge. The cluster of genes from the Swine Leukocyte Antigen class II, is 
located in this region and could explain the observed phenotypic variation. These results 
represent the initial efforts to establish an extensive set of phenotypes and samples that will be 
used to uncover genes and genetic variants associated with PCVAD susceptibility. Application 
of DNA markers associated with disease susceptibility in selection programs has the potential to 
improve animal health, welfare and reduce production costs. 
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PRRSV vaccine and diagnostic assay development:  
from basic to applied sciences  
 
Ying Fang 
Department of Veterinary and Biomedical Sciences, Department of Biology/Microbiology, 
South Dakota State University, Brookings, South Dakota, USA 
 
PRRS is still the most economically devastating swine disease worldwide. The challenge in 
developing a broadly effective PRRS vaccine is mainly due to natural characteristics shared with 
all RNA viruses: PRRSV undergoes rapid evolution, which creates genetically and antigenically 
heterogeneous populations. This is also reflected on our inadequate knowledge of mechanisms 
employed by the virus in evading host innate and adaptive immune responses. In an effort to 
overcome these major obstacles, our studies have been directed to identify the virulence 
determinants and develop strategies to enhance the viral specific immunity. With the 
development of PRRSV reverse genetic system and advanced knowledge on the structure and 
function of nonstructural proteins, the rationale design of genetically engineered PRRS vaccine 
has been explored. On the other hand, with the absence of a completely effective vaccine, one of 
the key approaches to achieve PRRS control and elimination is to timely identify PRRSV 
infection and prevent the spreading of viruses to large animal populations. Thus, the availability 
of rapid, highly sensitive and specific diagnostic assays is essential. Currently available PRRSV 
diagnostic assays provide good sensitivity and specificity in controlled settings. However, the 
field experience with PRRSV outbreaks suggests that substantial improvement is needed in 
almost all of the areas. The PRRSV nonstructural proteins have been tested as potential new 
antigens for the development of diagnostic assays. To assist field epidemiological surveillance, 
oral fluid-based diagnostic assays are being developed as an alternative to serum-based assays. In 
addition, high throughput, multiplexing Luminex technology is being adapted for PRRSV 
antigen and antibody detection. In parallel with PRRS marker vaccine development, differential 
diagnostic assays have been explored for the ability to differentiate the vaccinated animals from 
the naturally infected animals. These studies represent our initial effort to develop a new 
generation of PRRS vaccines and diagnostic assays. Future advancements in our understanding 
of PRRSV biology and host immunity will provide a basis for additional and improved 
approaches to the development of vaccines and diagnostic assays for PRRS control and 
elimination. 
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6 
Phenotypic variability in response to the PRRS virus in the 
reproductive model: a potential opportunity 
 
J. Harding1*, C. Ashley1, A. Ladinig1, K. Clarke1, Z. Ye1, T. Chang1, S. Detmer1,  
P. Novakovic1, D. Wilson2, S. Walker2, S. Napper2, J. Wilkinson3, R. Yates4,  
N. McKenna4, J. Lunney5, J. Dekkers6, R. Rowland7, R. Kemp8, G. Plastow3 
1Western College of Veterinary Medicine, Univ. of Saskatchewan, Saskatoon, SK, 2Vaccine and 
Infectious Disease Organization, Univ. of Saskatchewan, Saskatoon, SK, 3Dept. Agricultural, 
Food and Nutritional Science, Univ. of Alberta, Edmonton, AB, 4Faculty of Veterinary 
Medicine, University of Calgary, Calgary, AB, 5USDA, ARS, BARC, APDL, Beltsville, MD, 
6Dept. Animal Science, Iowa State Univ., Ames, IA, 7Dept. Diagnostic Medicine and 
Pathobiology, Kansas State Univ., Manhattan, KS, 8PigGen Canada, Guelph, ON 
 
A large scale, multi-institutional project investigating genomic and phenotypic predictors of PRRSV 
resistance/susceptibility in pregnant gilts is underway at the University of Saskatchewan. This project 
links to the PRRS Host Genetics Consortium (PHGC) initiative by testing if the results obtained in the 
nursery pig model apply to reproductive PRRS. 
 
Phenotypic data associated with multiple aspects of host immune response in pregnant gilts and foetuses 
will be analysed.  Purebred Landrace gilts, synchronized and bred homospermically to York boars, are 
infected with type 2 PRRSV (NVSL 97-7895) at gestation day 85 (n=113) or are sham-inoculated 
(CTRL; n=19). Clinical signs are monitored daily. Blood, collected on 0, 2, 6, 19 days post inoculation 
(dpi), provides samples for measurement of PRRSV RNA concentration using a strain-specific in-house 
qPCR, white blood cell counts, and lymphocyte subset typing (T-helper, CTL, B-cells, gamma-delta cells, 
NK cells, myeloid cells) using flow cytometry. Gene networks regulating the in vitro responsiveness of 
peripheral blood mononuclear cells (PBMC) to homologous PRRSV and phorbol myristate 
acetate/ionomycin (PMA/I) will be assessed. Sera and the supernatants of PRRSV and PMA/I stimulated 
PBMCs will be tested for innate, T helper 1 (Th1) and Th2 cytokine levels by fluorescent microsphere 
immunoassay (FMIA).  
Following humane euthanasia at 21 dpi, gilts and foetuses are dissected. The position, preservation status 
and body weight of each foetus is recorded. Serum and multiple tissues are collected enabling 
measurement of PRRSV RNA concentration in gilt tissues (uterus, lung, tonsil, tracheobroncheal and 
reproductive LN), amniotic fluid, fetal sera and thymus. Alveolar macrophages harvested from gilt 
bronchoalveolar lavage fluid are tested to determine variability in functional responses and kinase 
activities associated with PRRSV infection (kinases have central roles in virtually all cellular behaviour, 
including immune defence). Pertinent tissues will be examined histopathologically to assess mechanisms 
of fetal death and variability in host pathologic responses. Gilts, sires and foetuses will be genotyped with 
the Illumina Porcine SNP60 BeadChip, enabling genome wide association studies. Bayesian genomic 
selection models will be developed to evaluate associations among phenotypic and genotypic data using 
imputed or measured 60K data from gilts and foetuses (n=1400).  
Funding for this project is provided by Genome Canada and Genome Prairie. We wish to thank the many 
people assisting with this project, including barn, animal care and necropsy staff, students, and 
administrative personnel. 
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Progress of the PRRS Host Genetics Consortium: variation in gene 
and protein expression in response to PRRSV infection 
 
J.K. Lunney1*, I. Choi1, C.J. Souza1, K.P.C. Araujo1, S.M. Abrams1, J.P. Steibel2,3, 
M. Arceo2, C.W. Ernst2, J.M. Reecy4, E. Fritz4, J.C.M. Dekkers4, N.J. Boddicker4, 
E.H. Waide4, X. Zhao4, M.F. Rothschild4, G.S. Plastow5, L. Guan5, P Stothard5, 
R.A. Kemp6, J.C.S. Harding7, M. Kerrigan8, B. Trible8, R.R.R. Rowland8 
1USDA, ARS, BARC, APDL, Beltsville, MD, USA, 2Dept. Animal Science, Michigan State 
Univ., East Lansing, MI, USA, 3Dept. Fisheries and Wildlife, Michigan State Univ., East 
Lansing, MI, USA, 4Dept. Animal Science, Iowa State Univ., Ames, IA, USA, 5Dept. 
Agricultural, Food and Nutritional Science, Univ. of Alberta, Edmonton, AB, Canada, 6PigGen 
Canada, Guelph, ON, Canada, 7Western College of Veterinary Medicine, Univ. of 
Saskatchewan, Saskatoon, SK, Canada, 8Dept. Diagnostic Medicine and Pathobiology, Kansas 
State Univ., Manhattan, KS, USA 
 
Porcine reproductive and respiratory syndrome virus (PRRSV) is the most important infectious 
disease threatening pig production worldwide. The PRRS Host Genetics Consortium (PHGC) 
was established to probe the role of host genetics in resistance to PRRSV infection and related 
growth effects. The PHGC uses a nursery pig model; to date, 13 groups of 200 commercial 
crossbred pigs have been infected with PRRSV and followed for 42 days post infection (dpi). A 
major goal of the PHGC is to collect extensive samples for deep phenotypic analyses; to that end 
blood serum and Tempus (RNA) samples were collected at 9 timepoints, body weights recorded 
weekly, and tonsils stored for viral persistence studies. Genomic DNA was genotyped with the 
PorcineSNP60 chip for genome wide association studies (see Boddicker abstract). Results 
affirmed that all pigs become PRRSV infected with peak viremia from 4-21 dpi. Bivariate 
statistical analyses of viral load and weight data have identified PHGC pigs in different high/low 
virus/weight categories. Sera and RNA from pigs in selected high/low categories are now being 
analyzed for immune and genetic factors involved in viral replication and recovery from 
infection. Data will be presented on speed and levels of gene expression based on Pigoligoarray, 
RNA-seq and quantitative PCR analyses and of immune proteins using fluorescent multiplex 
immunoassays. Combined with the genetic data these analyses should identify biomarkers that 
distinguish PRRS resistant/maximal growth pigs from PRRS susceptible/reduced growth pigs. 
PHGC funding: US National Pork Board, USDA ARS and NIFA, NRSP8 Swine Genome and 
Bioinformatics Coordinators, Genome Alberta/ALMA, Genome Canada, and private companies. 
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Molecular breeding of PRRSV for novel vaccine development 
 
Yan-Yan Ni1, Lei Zhou1, Tanja Opriessnig2, and X.J. Meng1 
1College of Veterinary Medicine, Virginia Polytechnic Institute and State University, 
Blacksburg, VA, 2College of Veterinary Medicine, Iowa State University, Ames, IA 
 
Molecular breeding via DNA shuffling can direct the evolution of viruses with desired traits. We 
demonstrated rapid attenuation of PRRSV by DNA shuffling of the viral envelope genes from 
multiple strains. The GP5 and the GP5-M genes of different PRRSV strains were molecularly 
bred by DNA shuffling, and cloned into the backbone of a DNA-launched PRRSV VR2385 
infectious clone. Two representative chimeric viruses, DS722 with shuffled GP5 genes and 
DS5M3 with shuffled GP5-M genes, were rescued. The two chimeric viruses replicated at lower 
levels and formed smaller plaques in vitro, and have significant reductions in viral RNA loads in 
sera and lungs, and in gross and microscopic lung lesions in pigs. Pigs vaccinated with the 
chimeric virus DS722 still induced protection against PRRSV challenge at a level similar to that 
of its parental VR2385 virus. Additionally, we also bred the PRRSV GP3 genes of genetically 
different PRRSV strains in an attempt to improve its heterologous cross-neutralizing ability. 
Eight GP3-shuffled chimeric viruses were recued and characterized.  The chimeras had similar 
levels of replication both in vitro and in vivo, compared to the backbone parental virus, 
indicating that the GP3 shuffling did not impair the replication capability of the chimeras. The 
chimera GP3TS22 induced a significantly higher level of cross-neutralizing antibodies in pigs 
against a heterologous strain PRRSV FL-12. The results indicated that DNA shuffling of PRRSV 
structural genes can attenuate the virus and produce a chimeric strain with improved cross-
neutralizing activity against a heterologous strain. Therefore, the findings have important 
implications future vaccine development.  
This project was supported by Agriculture and Food Research Initiative competitive grant 
no. 2011-67015-30165 from the USDA National Institute of Food and Agriculture and in part by 
a USDA PRRS CAP grant (2008-55620-19132). 
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Alphavirus replicon-based PRRSV vaccine development 
 
M.A. Mogler1,2,3*, D.L. Harris1,2,4, K.I. Kamrud1,2 
1Harrisvaccines, Ames, IA, Departments of 2Animal Science, 3Veterinary Microbiology and 
4Preventive Medicine, and Veterinary Diagnostic and Production Animal Medicine, Iowa State 
University, Ames, IA 
 
Alphavirus-derived replicon RNA particles (RP) are propagation-defective, single-cycle RNA 
vaccine vectors that are capable of eliciting potent humoral and cellular immunity to a variety of 
antigens.  In addition, RP induce robust systemic innate immune responses.  Recently, the RP 
platform system, derived from Venezuelan equine encephalitis virus (strain, TC-83), was granted 
USDA regulatory approval for use in veterinary vaccines.  This represents the first ever licensing 
of the RP technology, which has demonstrated efficacy and safety in a wide range of disease and 
animal models. 
 
The RP platform has been used to express various PRRSV proteins as vaccine antigens, and 
several candidate vaccines have been evaluated in challenge models.  The RP PRRS vaccines 
induced specific humoral and cellular immune responses, and significantly reduced viremia and 
viral load.  Additionally, pigs treated with an RP influenza vaccine 24 hours prior to PRRSV 
challenge had significantly reduced viremia and viral load.  The use of RP allows for 
differentiation of vaccinated from infected animals, which is an important consideration for 
future PRRSV control efforts. 
 
These results demonstrate that the RP platform is a potent tool for PRRSV research and vaccine 
development. 
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10 
Regional PRRS elimination 
 
Robert Morrison DVM, MBA, PhD 
University of Minnesota 
 
The first regional project in United States aimed at controlling PRRS virus spread started in 2002 
in eastern Rice Cy, Minnesota.  Some progress was made but in retrospect, the region did not 
have the ideal attributes to determine whether a voluntary, regional, coordinated, PRRS control 
& elimination program was feasible.  A second regional project started in 2004 in Stevens 
County in west central Minnesota and the project has been a resounding success.  Approximately 
90% of the producers in the county have participated and the prevalence of PRRS has decreased 
from approximately 50% of sites to less than 5% known sites having PRRS.  The project has 
expanded twice and now includes the northern half of Minnesota.  Today, we count 
approximately 20 regional projects around United States with the goal of controlling or 
eliminating PRRS virus.  This is a phenomenal expansion and Canada has also initiated several 
projects in Ontario, Quebec and Alberta as have regions in Mexico, Netherlands and Japan. 
 
The overarching goal of each project varies.  Most projects have the goal of regional control 
whereby “PRRS incidence, prevalence, morbidity or mortality is reduced to a locally acceptable 
level as a result of deliberate efforts.  Continued intervention measures are required to maintain 
the reduction.”  A regional control program will entail testing herds, surveillance, sharing 
information & acting accordingly.  A few projects have the goal of regional elimination 
whereby “PRRS is reduced to zero incidence in a defined geographical area as a result of 
deliberate efforts.  This requires continued measures to prevent re-establishment of virus 
transmission.”  
 
The projects vary in their progress and challenges.  Seven regional projects have participated in 
the USDA funded PRRS CAP project and as such, share reports on their progress (PRRS.Org).  
The AASV PRRS task force has been integrally involved in the progress and its first effort led 
by Drs. Derald Holtkamp, Dale Polson and Montse Torremorell was the sow herd classification 
guideline (2010 JSHAP).  Its second project was initiated at the 2010 committee meeting and is 
led by Dr. Jim Lowe.  This is the development of a standard operating protocol for managing 
sow herds in an effort to manage PRRS virus and potentially move herds from being positive and 
unstable to negative.  Additional challenges have been identified and working groups formed to 
address the following issues: (1) Develop a program to monitor prevalence and incidence of 
PRRS virus infection, (2) Develop guidelines for managing confidentiality and the risk of 
disclosure, (3) Develop guidelines for eliminating PRRS virus from farrow to finish farms, (4) 
Develop oral fluid sampling guidelines, (5) Developing guidelines for implementing common 
reports, including mapping Legends for Regions, (6) Uniform guidelines for risk based 
surveillance & geostatistical mapping, and (7) Develop guidelines for a certifying system for 
regions undergoing control / elimination projects.  Each of these working groups reports progress 
to the AASV PRRS task force and ultimately to the AASV membership. 
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Ten years of advancements in PRRSV immunity 
 
Michael Murtaugh 
University of Minnesota, USA 
 
Vaccination is the principal means used to control and treat porcine reproductive and respiratory 
syndrome virus (PRRSV) infection. An array of PRRS vaccine products is available in various 
regions of the world. However, despite extensive efforts, little progress has been made to 
improve efficacy since the first introduction of a live, attenuated vaccine in 1994 in the USA. 
Key limitations include (a) uncertainty about the viral targets of protective immunity that 
prevents a research focus on individual viral structures and proteins, and frustrates efforts to 
design novel vaccines; (b) inability to establish clear immunological correlates of protection that 
requires laborious in vivo challenge models for evaluation of protection against challenge; and 
(c) the great genetic diversity of PRRSV which requires that challenge experiments be 
interpreted cautiously since it is not possible to predict how immunological protection against 
one isolate will translate to broadly cross-protective immunity. Economically significant levels 
of cross-protection that are provided to a variety of field isolates still cannot assure that effective 
protection will be conferred to isolates that might emerge in the future. In addition to these 
substantial barriers to new PRRSV vaccine development, there are enormous gaps in our 
understanding of porcine immunological mechanisms and processes that provide immunity to 
PRRSV infection and memory responses for long-term protection. In the last 10 years, PRRS 
CAP and NPB funded a variety of PRRS immunology and vaccinology studies to address these 
issues. 
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Scaling and sustaining effective large-scale PRRS control– 
it takes a (committed) village, and a (full) toolbox 
 
Dale Polson 
Boehringer Ingelheim Vetmedica Inc., St. Joseph, MO 
 
This is not is a discussion about the past, present and future of PRRS vaccines.  Instead, it is a discussion 
about the past, present and future of PRRS control and, ultimately, elimination.  To be sure, vaccines 
should be considered an essential part of achieving the most effective and sustained PRRS control, just as 
is the case with other vaccines for contributing to the most effective control of other swine disease agents.  
 
Many institutions and companies continue working on PRRS vaccine advancements, as are we.  For two 
decades now, Boehringer Ingelheim Ventmedica Inc. (BIVI) has invested millions of dollars and tens-of-
thousands of hours, and has collaborated extensively with the best researchers and institutions in the 
world to research and evaluate the newest and best vaccine technologies.  BIVI continues to invest 
heavily and collaborate broadly with clear purpose: To develop and provide to the pork industry with new 
PRRS vaccines with significant advancements in performance and protection.   
 
Yet in spite of these major investments, research hours, collaborations and technologic advancements, 
it remains a reality that no one has yet developed anything that improves on the original modified-live 
vaccine that first became available in the United States back in 1994.  Since the introduction of the first 
MLV vaccine we have seen other modified live commercial and killed autogenous and commercial 
vaccines introduced – none of which have, by any scientific standard, proven to offer better performance.   
 
The perfect (DIVA) vaccine may be out there – we continue to believe it is, and believe that it is well 
worth pursuing.  But we also clearly understand that we cannot simply wait for its arrival as the “ultimate 
answer” for PRRS control.  The BIVI Swine Team continues to invest, collaborate and aggressively 
pursue major advancements in controlling and eliminating PRRS.  We’re committed to leveraging every 
available effective tool to its maximum, as well as collaborating with all others in the “committed village” 
who, like ourselves, are driven to control and eliminate PRRS across the pork production industry.   
 
Controlling (and, ultimately, eliminating) PRRS is clearly the consensus industry objective at every level 
– pig, pen, barn, site, flow, system, area, region and, yes, even globally.  Vaccine plays an important role 
in achieving that objective at every level.  However, in this discussion we are not going to focus on 
vaccine, but we are going to discuss vaccine in its relevant context – as one of several necessary, 
valuable and complimentary tools available today which, when used in concert, are highly effective for 
dealing with PRRS and achieving our consensus objective at every level.  Since 2003 the BIVI Swine 
Team has been actively developing capabilities and collaborations for industry-wide application of PRRS 
Area-Regional Control and Elimination (ARCE).  It is our belief that this approach offers the greatest 
opportunity for the effective and sustainable control (and eventual elimination) of PRRS in the USA and 
across North America.  
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13 
Disrupting sialoadhesin and CD163 to create pigs resistant to 
PRRSV infectivity 
 
R.S. Prather, K.M. Whitworth, T. Egen, J.M. Teson, K.D. Wells and, J.A. Green 
Division of Animal Sciences, University of Missouri, Columbia, MO, USA 
 
Porcine reproductive and respiratory syndrome virus (PRRSv) is thought to bind to 
sialoadhesin as the primary receptor on the surface of alveolar macrophages. This binding 
enables vesicular internalization of the virus.  After viral transit into endosomes, CD163 
facilitates viral disassembly and release of the viral genome into the cell. Since PRRSv has such 
a negative economic impact on the swine industry our goal was to genetically engineer pigs that 
would be resistant to PRRSv infection. These genetic modifications would be useful for more 
fully understanding the mode of infection and, if permitted to enter the food supply, could reduce 
the economic impact of PRRSv on the world’s pork supply. Our first modification created 
heterozygous SIGLEC1 knockout boars by disrupting part of exon 1 and all of exons 2 and 3 in 
fetal-derived fibroblast cells followed by somatic cell nuclear transfer. These founder boars were 
mated to wildtype gilts, and male and female F1 SIGLEC+/- were produced. Some of these F1 
females have been mated to the F1 males and are currently pregnant. If SIGLEC-/- animals are 
produced, our goal is to challenge them with PRRSv and determine if they show resistance to 
infection. Our second goal is to modify the N-terminal scavenger receptor cysteine-rich (SRCR) 
domain 5 of CD163. Previous reports have shown that disruption or replacement of SRCR 
domain 5 of CD163 in cultured cells results in loss of PRRSv infectivity.  For the CD163 
modification, exon 7, which encodes SRCR domain 5, is being modified to mimic human exon 
10 which encodes SRCR domain 8 of the CD163-like 1 (CD163L1) gene.  A targeting vector 
containing the mutated CD163 is being used to transfect fetal-derived fibroblast cells. Once 
candidate colonies are identified, then somatic cell nuclear transfer will be used to create the pigs 
with this modification. Once animals with the homozygous domain swap of CD163 are created, 
then a PRRSv challenge study will be conducted. It is anticipated that either mutation (CD163 or 
SIGLEC1) will restrict infectivity. If this is not the case, then the combination of both SIGLEC1 
disruption and the modification of pig SRCR domain 5 of CD163 will be tested. While 
researchers can use these pig models to characterize the mechanics of PRRSv infectivity, these 
genetic modifications may have a direct role in improving production agriculture. 
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The role of host genetics in bringing the pig closer to the vaccine 
 
Raymond R.R. Rowland 
Department of Diagnostic Medicine & Pathobiology, College of Veterinary Medicine, Kansas 
State University, Manhattan, KS 
 
PRRSV employs an array of host evasion strategies that subvert innate and adaptive immune 
responses. One important strategy involves the capacity of the virus to generate a high degree of 
genetic diversity.  The development of the next generation of PRRS vaccines is dependent on 
understanding its unique biology. A new tool for studying the immunological components of 
anti-PRRSV immunity is the availability of a pig that lacks B and T cells. The pig with severe 
combined immunodeficiency, or SCID pig, creates the opportunity to characterize the 
contributions of innate and adaptive immunity in the control of PRRSV replication (see Waide et 
al., abstract no. 59).  Previous work (Boddicker et al, J Anim Sci. 90:1733-1746) identified a 
marker in SSC 4 linked to decreased virus load and increased weight gain during PRRSV 
infection. The marker locates to a family of interferon inducible proteins linked to innate 
immunity. More recent work focuses on the analysis of markers in SSC 1 (Boddicker et al., 
abstract no. 63). Genomic markers related to adaptive immunity during PRRSV infection have 
not been characterized.  As a first step, Trible et al. (abstract no. 57) describe the PRRSV 
neutralizing antibody responses in several hundred experimentally infected pigs. Neutralization 
was performed using the homologous virus, as well as three viruses located on different branches 
of an ORF5 phylogenetic tree. The results show that pigs can be placed into distinct groups, 
including a small number of pigs that possess “broad” neutralizing activity.  As reported in 
another abstract (Hess et al., abstract no. 70), virus neutralizing activity possesses a heritable 
component. The presence of a broad neutralizing response suggests the existence of conserved 
neutralizing epitopes within the PRRSV proteome. The study of PRRS immunity within large 
populations will identify unique protective responses that can be incorporated into the design of 
the next generation of vaccines, a means to bring the vaccine closer to the pig. The results from 
genome-wide association studies and marker-assisted selection for innate and adaptive immune 
responses will bring the pig closer to the vaccine. 
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Ten years of research in structural function of PRRSV proteins 
 
D. Yoo*, M. Han, C.Y. Kim, Y. Sun 
Department of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, IL 
 
The PRRSV genome is a plus-sense RNA of 15 kb in size containing at least 11 open reading 
frames (ORFs). ORF1a and ORF1b are translated directly from the viral genome by the -1 
ribosomal frameshifting mechanism and two large polyproteins are made. These polyproteins are 
subsequently processed into 14 non-structural proteins. During replication, 6 different 
subgenomic RNA species are transcribed from the viral genome, and from these RNAs, 6 
structural proteins corresponding to ORF2 through ORF7 are translated. During the past decade, 
some of the ORFs have appeared to be bicistronic. ORF2b is a small internal ORF residing 
within ORF2, from which the small membrane (E) protein is translated. The E protein may 
function as an ion channel protein to facilitate the uncoating process during virus entry. A small 
ORF within ORF5, termed ORF5a, has also been identified and the ORF5a protein has been 
determined as a membrane-associated structural protein with an unknown function. Recently, an 
unusual -2 ribosomal frameshifting mechanism has been determined to utilize an alternative ORF 
that overlaps the nsp2-coding region of ORF1a in the +1 frame. This ORF is translated to make 
the transframe fusion (nsp2TF) protein of 883 amino acids. Extensive studies have been 
conducted to elucidate the function of nsps’ and it appears that some of the nsps’ function as 
viral antagonists to modulate host innate immunity. Nsp1a degrades the CREB-binding protein 
in the nucleus, while nsp1b blocks the nuclear translocation of ISGF3, thus both proteins 
resulting in the suppression of type I interferon (IFN) response. Nsp2 is a viral protease 
containing the ovarian tumor domain-containing deubiquitinase motif. Nsp2 deconjugates 
ubiquitine and ISG15 from cellular targets to evade innate immune responses. Nsp11 is a viral 
endoribonuclease and appears to degrade mRNA for the mitochondrially located adaptor protein 
MAVS, resulting in the suppression of IFN induction. The recent findings highlight that PRRSV 
has evolved to take the general plasticity of RNA virus genome and to codes for multiple 
proteins to take selective advantages to evade the rigorous host innate immune surveillance. 
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Basics of PRRSV epidemiology - I. Transmission 
 
Jeff Zimmerman, DVM PhD 
Iowa State University, Ames, Iowa 
 
The basics of PRRSV transmission are well-described: 
1. Infected animals shed virus in saliva (Wills et al. 1997a), nasal secretions (Christianson et al. 1993), 
urine (Wills et al. 1997a), semen (Christopher-Hennings et al., 1995), and feces (Christianson et al. 
1993). Pregnant susceptible females inoculated in late gestation shed virus in mammary secretions 
(Wagstrom et al. 2001).  
2. Pigs are susceptible to PRRSV by several routes of exposure, including intranasal, intramuscular, oral 
(Magar et al. 1995; Magar and Larochelle 2004), vaginal (Yaeger et al. 1993), and airborne 
(Kristensen et al. 2004).  Pigs are not equally susceptible to PRRSV by all routes of exposure and are 
most susceptible via intramuscular (Yoon et al., 1999) and (at least some isolates) aerosol exposure 
(Cutler et al., 2011). 
3 Indirect transmission of PRRSV to susceptible swine can occur by a number of routes (reviewed by 
Cho and Dee 2006), including contact with contaminated fomites and via the use of contaminated 
needles.  Once in the environment, PRRSV is relatively fragile and readily inactivated by heat and 
drying, but can remain infectious for an extended time under specific conditions of temperature, 
moisture (Linhares et al., 2012), and pH.   
4. PRRSV is transmitted from viremic dams transplacentally to fetuses, resulting in fetal death or in birth 
of infected pigs, some of which may appear clinically normal (Terpstra et al. 1991). 
5. PRRSV produces a chronic, persistent infection in pigs, i.e., virus replication occurs in clinically 
inapparent carrier animals for several months.  This is extremely well-documented (Allende et al. 
2000; Benfield et al. 2000; Horter et al. 2002; Wills et al. 1997b; Zimmerman et al. 1992).  Persistence 
is undoubtedly the single most significant epidemiological feature of PRRSV infection and the reason 
why PRRSV elimination is so difficult.   
6. Once infected, PRRSV tends to circulate within a herd indefinitely.  Endemicity is driven by a 
combination of persistent PRRSV infection in carrier animals and the continual availability of 
susceptible animals that enter the herd through birth, purchase, or loss of protective immunity.   
What is the limitation of the information given above?  The majority of the work was performed using a 
very small number of PRRSV isolates because of an underlying assumption that PRRSV kinetics would 
be relatively uniform.  Working against this assumption is the fact that PRRSV is increasingly recognized 
as remarkably genetically diverse (Stadejek et al., 2008).  From this perspective, is "uniformity in viral 
kinetics" a valid assumption?  This was most sharply drawn into question when Cutler et al. (2011) 
reported a median infectious dose (ID50) of <1 x 101 for isolate MN184 by aerosol exposure whereas 
Herman et al. (2005), working with the same aerosol equipment and laboratory procedures, estimated an 
aerosol exposure ID50 of 1 x 103.1 TCID50 for isolate VR-2332 (Herman et al., 2005).  This ~100-fold 
difference in infectivity is important.  Among other things, it implies that the behavior of PRRSV in 
populations could differ markedly among isolates.  In the field, it could explain why practitioners observe 
that some PRRSV isolates are easier to eliminate from herds than others.  Uniformity may be a safe 
assumption for some PRRSV characteristics, e.g., environmental stability, but clearly does not seem to be 
the case for others.  Which characteristics and how they vary among isolates has never been explored.   
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INTRODUCTION 
The Production Animal Disease Risk Assessment Program (PADRAP) database is a resource that enables 
identification and tracking of key attributes of swine breeding herds that relate to individual herd risk of 
experiencing PRRSV outbreaks.  The purpose of this investigation was to summarize the frequency with which 
several key health management practices were used among herds participating in PADRAP. A specific goal was to 
understand the prevalence of use of modified live-virus vaccine and methods for live virus exposure as part of herd 
level PRRS control programs. 
 
MATERIAL AND METHODS  
Data from the PADRAP database were obtained from PADRAP consisting of the initial or most recent herd survey 
as of the cutoff date of September 2011. A total of 1290 herds were included.  Data were analyzed to assess the 
relationship between herd demographics as well as seven key management practices. Demographic variables 
included location (i.e. country, limited to USA, Canada and Mexico), type of production (genetic vs. commercial), 
stages of production (farrow-to-wean, farrow-to-feeder and farrow-to-finish), and herd size.  Additionally, a 
distinction was made between PRRS virus status of farms, which was categorized within PADRAP as naïve, 
negative, positive, or unknown for the demographic summary.  The management practices evaluated included use of 
MLV, serum or other methods to immunize the herd or replacement females, use of naïve replacement females, use 
of naïve or negative semen and type of semen source. 
 
RESULTS 
From 1290 participating herds, 839 were from the USA, 292 from Canada and 150 from Mexico.  Commercial 
production herds accounted for 1,029 herds and genetic-related production accounted for 257 herds.  The majority of 
herds were positive (787 or 61%) for PRRSV infection, whereas 366 herds were naïve, 120 were negative and 16 
were of unknown status.  Herd size was categorized in increments of 500 sows, with 19.2% of herds < 500 sows, 
and 21.2% of herds at 501-1000 sows, 12.1% from 1001-1500 sows, 30.4% from 1501-3000, 9.7% from 3001-5000 
and 7.4% > 5001.  Modified live-virus vaccine was used in 36.7% of non-naïve herds reporting its use. Use of serum 
as method for herd exposure was identified in 22.5% of non-naïve herds. Use of “PRRS positive materials”, “live 
pigs” or “serum” in acclimation process was identified in 17.8%, 31.5% and 21.8% of non-naïve herds, respectively.  
Serum was used on a “routine basis” in only 4.6% of the non-naïve herds.  Other management practices included use 
of naïve or negative gilt replacements in 49.3% of non-naïve herds, use of naïve/negative semen in 74.8% of non-
naïve herds and use of semen from off-site, producer controlled boar studs in 39.5% of non-naïve herds. 
    
DISCUSSION and CONCLUSION 
Use of the PADRAP database and the extensive survey questions developed to determine herd risk levels can be a 
useful tool to demonstrate differences among herds.  Understanding the differences based on location, type of 
production and size, offers the industry ability to develop more thorough herd PRRSV control plans.  In many areas, 
herds of varying status and sizes co-exist and may impact each other in regional control programs. Furthermore, data 
from the PADRAP database can also be helpful in understanding trends over time on PRRSV control methods. 
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Airborne transmission of porcine reproductive and respiratory syndrome virus (PRRSV) is a risk 
factor for the infection of susceptible populations. Therefore, a long-term sustainability study of 
air filtration as a means to reduce this risk was conducted. Participating herds (n = 38) were 
organized into 4 independent cohorts and the effect of air filtration on the occurrence of new 
PRRSV infections was analyzed at 3 different levels from September 2008 to January 2012 
including the likelihood of infection in contemporary filtered and non-filtered herds, the 
likelihood of infection before and after implementation of filtration and the time to failure in 
filtered and non-filtered herds.  Results indicated that new PRRSV infections in filtered breeding 
herds were significantly lower than in contemporary non-filtered control herds (P < 0.01), the 
odds for a new PRRSV infection in breeding herds before filtration was 7.97 times higher than 
the odds after filtration was initiated (P < 0.01) and the median time to new PRRSV infections in 
filtered breeding herds of 30 months was significantly longer than the 11 months observed in 
non-filtered herds (P < 0.01). In conclusion, across all 3 levels of analysis, the long-term effect 
of air filtration on reducing the occurrence of new PRRSV infections in the study population was 
demonstrated. 
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Objective: The early and rapid detection of swine pathogens is critical for effective biosecurity and 
disease management. There is a pressing need to provide veterinarians with simple and sensitive assays 
that can be used in the field. Reliable testing with minimal turn-around times improves disease 
management within herds and can help to prevent the spread of disease between herds. 
Highly sensitive and specific molecular diagnostic assays such as quantitative real-time RT-PCR (qRT-
PCR) are available, but these require expensive and fragile equipment and are not suitable for on-farm 
use. Reverse transcription loop-mediated isothermal amplification (RT-LAMP) has been developed as a 
pen-side tool for PRRSV and PCV2 diagnosis, but it shows variable sensitivity and only limited 
repeatability. 
With the novel hydrogel post technology, which integrates easy sample processing and qRT-PCR 
capability in a small portable device, we will create robust PRRSV and PCV2 assays suitable for use 
under field conditions. 
Methods: The Domino diagnostic platform uses an array of colloidal hydrogel posts on a disposable 
plastic chip. Each post is a separate reaction vessel that contains all the reagents required for nucleic acid 
extraction, PCR and melting curve analysis, including enzymes and specific primers.  
Raw samples are loaded directly onto the chip; prior nucleic acid extraction is not required. The same 
chip can run multiple diagnostic tests in parallel using the same sample.  
The test is carried out in a portable detection device, which contains a heating element, a laser and a 
CCD-based detector for real-time PCR and melting curve analysis with maximum specificity. It has 
originally been developed for point-of-care molecular diagnostics in human medicine, where it is 
successfully used to detect polyomaviruses, herpesviruses and malaria in complex biological matrices 
including whole blood, urine and saliva. 
Outlook: We will create prototype Domino chips specific for PRRSV and PCV2. The chips will be 
validated using field samples whose disease status has been defined by an accredited veterinary diagnostic 
laboratory. 
This is a pilot project to test the technical feasibility of pen-side assays for PCV2 and PRRSV that can be 
used in local and regional control and eradication schemes. 
The project is funded by the Alberta Livestock and Meat Agency. 
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Genetic diversity among PRRS virus strains is of great importance for diagnostics of the 
disease and vaccine development. Higher genetic variability among European strains of PRRSV 
was observed than was originally expected. The aim of this work was to characterize the genetic 
diversity of Czech PRRSV strains by ORF 5 gene sequencing and compare it with heterogeneity 
of strains circulating in Europe. 
PRRS virus sequence heterogeneity was estimated on the collection of virus strains detected 
in conventional pig farms in the Czech Republic in the period from 2006 till 2012. Viral RNA 
was extracted from clinical field samples using a commercial kit and immediately used for RT-
PCR with specific primers. Seventeen virus strains were collected and their ORF 5 gene was 
sequenced. Obtained sequences were analyzed and compared with PRRS sequences from 
GenBank. 
All analyzed virus stains clustered into two major groups. One cluster showed similarity to 
strains originating from Denmark, Poland and Italy. The second cluster was highly similar to 
several strains isolated in Spain as well as to some vaccine strains. As vaccines originating from 
Spanish strains are widely used in the Czech Republic, the second group may likely represent 
detected vaccine strains. No North American strains were detected in the monitored period. 
Results of our survey show rather limited PRRS heterogeneity in ORF 5 gene, further 
analysis will be focused on ORF 7 and nonstructural genes of the virus. 
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Oral fluid specimens are used in human medicine for detection of a variety of infectious agents, 
hormones, and drugs.  Oral fluid samples are of interest in swine medicine because they are 
easily collected, yet highly efficacious for the surveillance of PRRSV and other pathogens using 
PCR-based assays (Kittawornrat et al., 2010; Ramirez et al., 2012).  Recent work showed that a 
commercial PRRSV serum antibody ELISA (IDEXX Laboratories, Inc., Westbrook, ME, USA) 
could be adapted to detect PRRSV antibody in oral fluid specimens (Kittawornrat et al., 2012).  
The object of this study was to describe the kinetics of the ELISA detectable anti-PRRSV IgG 
response in oral fluid collected from individually-housed boars.  The study was conducted in 72 
boars ranging from 6 months to 3.6 years in age.  Boars were under the ownership of PIC North 
America (Hendersonville, TN, USA) and housing, study procedures, and protocols were 
approved and supervised by the PIC USA Health Assurance and Welfare department.  Boars 
were assigned to three trials (I, II, III).  Boars (n = 24) in Trial I were intramuscularly (IM) 
inoculated with 2 ml of a modified live virus (MLV) vaccine (RespPRRS®, Boehringer 
Ingelheim Vetmedica, Inc., St. Joseph, MO, USA).  Boars (n = 24) in Trial II were IM inoculated 
with 2 ml of a Type 1 PRRSV field isolate.  Boars (n = 24) in Trial III were IM inoculated with 2 
ml of a PRRSV Type 2 isolate (MN-184).  Boars were monitored for 21 days post inoculation 
(DPI). Oral fluid samples were collected daily using 5/8" 3-strand 100% cotton rope. Serum 
samples were collected from all boars on DPI -7, 0, 7, 14, 21 and from 4 randomly selected boars 
on DPIs 3, 5, 10, and 17.  Thereafter, serum and oral fluid were assayed for PRRSV antibody 
using the ELISA protocol appropriate for each sample type (serum or oral fluid).  Individual boar 
oral fluid samples were ELISA positive from DPI 8 to DPI 21.  Overall, 96% of the results were 
in agreement, i.e., 145 oral fluid samples and 150 serum samples were ELISA positive.  These 
data support previous reports on the detection of anti-PRRSV antibody by ELISA in oral fluid 
and suggest that this approach could be used for disease surveillance in commercial breeding 
swine populations. 
Reference: 
1. Kittawornrat A, et al.  2010.  PRRSV in serum and oral fluid samples from individual boars.  
Virus Res 154:170-176. 
2. Kittawornrat A, et al.  2012.  Detection of PRRSV antibodies in oral fluid specimens using a 
commercial PRRSV serum antibody ELISA.  J Vet Diagn Invest 24 (2):328-32. 
3. Ramirez et al.  2012.  Efficient surveillance of pig populations using oral fluids.  Prev Vet 
Med 104 (3-4):292-300. 
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A commercial PRRS serum antibody ELISA (IDEXX Laboratories, Inc., Westbrook ME USA) 
was recently adapted to detect anti-PRRSV antibody in oral fluid specimens (Kittawornrat et al., 
2012).  Based on testing of field and experimental samples, diagnostic sensitivity and specificity 
was estimated at 94.7% (95% CI: 92.4, 96.5) and 100% (95% CI: 99.0, 100.0), respectively, at a 
sample-to-positive (S/P) cutoff of ≥ 0.40.  The purpose of this study was to evaluate the 
reproducibility and repeatability of the PRRS oral fluid ELISA in a ring test (check test) format.  
A total of 263 oral fluid samples were collected, completely randomized, and sent for testing in 
12 collaborating diagnostic laboratories.  In addition to the set of oral fluid samples, each 
laboratory received the materials required for conducting the test: ELISA plates (HerdChek® 
PRRS X3 ELISA, lot #40959-W721), reagents, positive and negative controls, pre-diluted 
conjugate antibody, and a copy of the standard operating procedure for the PRRS oral fluid IgG 
ELISA.  The laboratories tested the samples and returned the results for analysis.  Assay results 
were analyzed as S/P ratios, with S/P ratios ≥ 0.40 considered positive.  Variation in S/P results 
increased as the concentration of antibody in the sample increased. Overall, this had little impact 
on categorical results. That is, among the 263 samples tested by the 12 laboratories, 132 samples 
tested positive in all laboratories; 124 samples tested negative in all laboratories, and 7 samples 
had discordant results.  With the exception of sample #7, a discordant result was reported in each 
case by only one of the 12 laboratories.  Discordant results for sample #7 were reported at 3 
laboratories, but this may be explained by the fact that all results for sample #7 clustered close to 
the 0.40 cutoff.  The ring test results showed that the PRRS oral fluid IgG ELISA was highly 
reproducible across laboratories.  These results support the routine use of this test in laboratories 
providing diagnostic service to pig producers.  Thus, herd monitoring based on oral fluid 
sampling could be one part of a PRRSV control and/or elimination program.  Further, the 
successful adaptation of one assay to the oral fluid matrix suggests that this approach could 
provide the basis for monitoring specific health and welfare indicators in commercial swine 
herds using a "pig friendly" approach. 
 
Reference: 
1. Kittawornrat, A et al.: 2012. Detection of PRRSV antibodies in oral fluid specimens using a 
commercial PRRSV serum antibody ELISA. JVDI 24(2):262-269 
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PRRS Virus continues to cause major disease challenges and severe economic impact in the 
swine industry in North America.  In 2008, the USDA funded PRRS CAP in the United States to 
develop strategies for control and elimination of PRRS in the United States.   Despite regional 
success stories many regions in the U.S., even while involved in control and elimination projects, 
continue to have problems with regional spread and reinfection of herds that have eliminated the 
virus.   
 
Holtkamp et al. proposed guidelines for classification of herd status in 2011, with the intention to 
facilitate communication and aid with regional control and elimination.  As we move forward in 
our attempts to control and eliminate the virus from regions, a classification of the status of 
regions based on prevalence and incidence could also be useful in communicating within and 
between regions, and aid in control and elimination projects. 
 
In their paper, Lowe et al. outlined standard management strategies for the herd control and 
elimination of PRRS, using the above outlined classification system.  By looking at current 
scientific knowledge, along with effective management techniques, a standardized table of 
guidelines was established to allow herds to control and / or eliminate PRRS.   
 
This article is an attempt to do on a regional basis what the above authors have done at the herd 
level.  It will attempt to develop Regional PRRS Status categories into which regions can be 
classified, and develop regional biosecurity practices and control tools which can be used by the 
defined regions to control and eliminate PPRRS.  To accomplish this, the existing scientific 
knowledge on transmission and control of PRRS will be used.  After reviewing existing 
knowledge, a set of best management practices or management plans can be developed for each 
regional classification.  Through use of these management plans, regions will be better equipped 
to control and potentially eliminate PRRS.  Through this process, the authors hope to provide a 
“toolbox”, from which regional leaders can easily access information to undertake and be 
successful in regional control and elimination of the PRRS Virus. 
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Porcine reproductive and respiratory syndrome virus (PRRSV) is a single stranded, positive 
sense RNA virus with a genome size of approximately 15 kb. Much of the genetic 
characterization or viral genotyping of PRRSV isolates is limited to one or two viral genes only 
(ORF5 and/or ORF7) for a number of reasons, for example: (1) characterizing one or two ORFs 
is sufficient for diagnostics; (2) genome characterization is laborious because traditional (Sanger) 
sequencing yields only a single sequence of ~800-1000 bases per reaction; (3) large-scale 
genome characterization is time-consuming and costly. Collectively, this hinders the study of 
PRRSV genomic evolution at different levels (host, regional, and global). We demonstrate here 
the use of 454 technology to rapidly sequence PRRSV genomic nucleic acid from different 
sources (cell culture and swine tissue), genotypes (type 1 and type 2), and genome structure 
(non-deletion vs. deletion variants). Samples (n=16) were multiplexed to bring down cost per 
genome sequence. Assembly of sample specific reads resulted in a single contig in almost all 
instances (15 out of 16). Average genome coverage was 96.7% with reference to prototype 
isolates (Lelystad virus for type 1 and ATCC VR2332 for type 2). Average sequence depth was 
405 reads per nucleotide position. This high sequence depth allowed characterization of variants 
from quasispecies that occurred at frequencies even lower than 1%. In summary, next generation 
sequencing technology offers unparalleled opportunity to quickly and efficiently characterize 
near complete length PRRSV genomes in an economical manner. This allows experiments to be 
designed with considerations to viral genomic evolution rather than those with limited insights 
from select viral genes only. 
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Highly pathogenic PRRSV (HP-PRRSV) with 30-amino-acid discontinuous deletion (481 and 
534-562) in NSP2 protein was epidemic in China since 2006. Here, we investigated HP-PRRSV 
in the clinical samples from several provinces, and compared the NSP2 of PRRSV strains which 
were isolated in mainland China from 1996 to 2010. Besides of the 2 deletions (481, 534-562), 
other 6 different types of enlarged deletions in NSP2 was found in the present study. This report 
showed the NSP2 of HP-PRRSV were enlarged deletions with different polymorphism. The 
result will contribute to understand the evolution trend of HP-PRRSV in China.  
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Testing of swine oral provides a convenient and cost-effective tool for disease surveillance in 
commercial pig herds. Recently, Kittawornrat et al. (J Vet Diagn Invest. 2012 Mar;24(2):262-9.) 
described detection of antibodies to PRRS in oral fluids adapted using an overnight sample 
incubation format adaptation of the HerdChek® PRRS X3 ELISA, (IDEXX Laboratories, Inc.). 
In this study, we describe the new IDEXX PRRS oral fluids ELISA for same-day detection of 
PRRS antibodies in swine oral fluids. An S/P ≥ 0.4 is considered a positive result. A comparison 
between the new protocol and the standard overnight protocol (SOP) using a set of reference 
standards consisting of pooled oral fluids from vaccinated pigs indicated 100% agreement 
between the two tests, with average S/P values 1.4 to 1.5-fold higher than SOP. Moreover, 
analysis of a temporal series of paired oral fluids and serum collected from individual boars 
vaccinated or experimentally infected with type I or type II PRRSV for up to 21 days post-
infection (DPI), indicated little difference between the days to detection of anti-PRRSV 
antibodies in serum as in oral fluids, as well as a similar ability to detect both strains. the new 
IDEXX PRRS Oral Fluids ELISA had a percentage agreement of 98.7% with the PRRS X3 
results in paired serum. Finally, evaluation of pen-based oral fluid samples collected at various 
levels of prevalence (0%, 4%, 12%, 20%, and 36%) of antibody-positive vaccinated pigs 
introduced at 14 days post-vaccination into pens of PRRS-negative pigs indicated that the new 
test detects PRRS antibodies in ≥96% of all collection events in pens of at least 20% prevalence. 
Taken together, these results describe a new sensitive test for anti-PRRS antibody detection 
aimed to support the emerging use oral fluids for frequent surveillance of pig herds. 
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Porcine reproductive and respiratory syndrome (PRRS) caused by RNA PRRS virus, 
belong to family Arteriviridae. It caused serious economic loss for farmers in Vietnam. PRRS 
was first found in Vietnam in 1997 on pigs, which were imported from USA, with serum 
samples were tested. Until 2007, PRRS occured in many provices such as Hai Duong, Hung 
Yen, Bac Ninh, Bac Giang, Thai Binh.... and then PRRS outbreaks spreaded to Central and 
South provinces. The number of PRRS infected pigs died was 254.242. PRRS have been causing 
severe economic loss for the farmers since 2007 to now. In 2012, PRRS outbreaks happened 
quickly, has occured in 11 province of Vietnam and the first outbreak was in Lao Cai province. 
We collected samples from pigs showing typical clinical signs of PRRS infected pigs in Hoa 
Binh, Quang Ninh, Lao Cai, Bac Ninh provice....The clinical signs and gross findings were 
recorded during autopsy. RT-PCR and immunohistochemistry method were used to diagnose 
pigs infected with PRRS virus. The samples, which were positive with PRRSV, were selected for 
isolation of PRRSV by using Marc 145 cells. The biological and molecular characteristics of 
PRRS isolates were researched. PRRSV isolated in Vietnam were closed to each other and 
Chinese vaccine strains in phylogenetic trees. The homology of nucleotide sequence among 
Vietnamese isolates were from 93% to 98%. 
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Introduction     Pen-based oral fluid sampling allows for the collection of samples that represent 
a large number of animals.  For interpretation of results, however, performance of oral fluid 
assays (antibody- and nucleic acid-based) in populations of low disease prevalence must be 
established.  Therefore, the objective of this study was to determine the probability of detecting 
PRRSV infection in pen-based oral fluid samples from pens of known PRRSV prevalence. 
 
Materials and Methods     In one commercial swine barn, 25 pens were randomly assigned to 1 
of 5 levels of PRRSV prevalence (0%, 4%, 12%, 20%, or 36%).  PRRSV prevalence was 
established by placing a fixed number (0, 1, 3, 5 or 9) of pigs 14 days post-vaccination with a 
MLV PRRSV vaccine in pens such that the combination of negatives and positives in each pen 
totaled 25 pigs.  In total, 6 oral fluid samples were collected from each of the 25 pens (n = 150). 
 
To confirm individual pig PRRSV status, serum samples from the PRRSV-negative pigs (n = 
535) and the PRRSV vaccinated pigs (n = 90) were tested for PRRSV antibodies and PRRSV 
RNA.  The 150 pen-based oral fluid samples were assayed for PRRSV antibody and PRRSV 
RNA at 6 laboratories.   
 
Results and Conclusions     The overall mean (% positive) among all laboratories is as follows: 
 
Assay 
Prevalence 
0% 4% 8% 12% 20% 32% 36% 
 PRRSV RT-PCR 0.7% 15% 77% 80% 64% NA 90% 
 PRRSV ELISA 0.3% 15% 0% 63% 85% 93% 91% 
 
Overall, this data supports the use of pen-based oral fluid sampling and testing by either ELISA 
or PCR for PRRSV surveillance in commercial pig populations. 
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Introduction     Reports in human diagnostic medicine suggest that the material used to collect 
oral fluid samples can affect the detection of diagnostic targets, including hormones and 
antibody.1,5  The objective of the present study was to determine if the sampling material used 
to obtain pen-based swine oral fluid specimens affected the results of PRRSV antibody ELISA or 
RT-PCR testing. 
   
Materials and Methods     Oral fluid samples were collected from 104 pens on 2 commercial 
swine farms.  Three oral fluid samples2,3,4 were collected in succession from each pen using 
ropes made either of cotton (C), hemp (H) or nylon (N).  To account for the possible effect of 
collection order on assay results, samples were collected from pens in one of three sampling 
sequences: C-N-H, N-H-C, or H-C-N.  Thereafter, oral fluid samples were assayed for PRRSV 
antibody3 and PRRSV RT-PCR.  The effect of sampling material and collection order on the 
ELISA sample-to-positive (S/P) ratio was analyzed by ANOVA.  Qualitative (positive or 
negative) results of PRRSV RT-PCR testing were analyzed for differences in sampling material 
and collection order using logistic regression.  
  
Results and Conclusions     Analysis of the results found sampling material affected diagnostic 
results, but cotton rope provided the best overall diagnostic performance.  Therefore, oral fluid 
samples should be collected using cotton-based materials.   
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Introduction.  Porcine Reproductive and Respiratory Syndrome virus (PRRSv) continues to cost the 
United States swine industry $664 million annually.  In the fall and winter of 2011we began a 
collaborative effort between multiple swine production companies to describe the incidence and 
prevalence of PRRS infections in a sample of the US sow herd.   
 
Materials and Methods.  The database currently contains 285 sow farms, 10 systems, approximately 
971,000 sows (estimated 17% of the US sow herd) in 13 states.   Weekly PRRS status (AASV 
classification) for each farm is reported from July 2009.  Using July 1 as the start of the observation 
period for each year, an annual cumulative incidence and prevalence is calculated and reported at the 
aggregated and system specific level.  Cumulative incidence is also reported by beginning PRRSv status. 
An exponentially weighted moving average (EWMA) curve from July 2009 through the end of June 2012 
is calculated.  This method uses the number of weekly PRRS infections observed during the summer 
months as a means of defining an outbreak threshold.  Each week the observed number of PRRS 
infections is weighted for previous weeks and a EWMA ‘smoothed’ value is calculated.  An epidemic 
begins when this value exceeds the threshold and concludes when it falls below.  Using a subset of 161 
sow farms, we are beginning to identify locations of all pig sites within a three mile radius of each farm.  
Using the concept of spatial kernels and reproduction ratios we have developed a preliminary risk score 
for each site.   
 
Results.  New infections increase gradually in September, followed by a dramatic increase at the end of 
October, then plateau in late February.  The pattern is repeated over all three years of observation.  At the 
end of June 2012, 40% of the herds in the project reported a new infection.  Positive stable, vaccinated 
herds had the highest incidence, and the percentage of PRRS negative farms remained fairly stable over 
time.  The EWMA suggests the epidemic begins approximately mid-October and subsides approximately 
mid-March.  These data also suggest a mini epidemic in the spring lasting only a few weeks.   
 
Discussion.  This is the first effort to quantify the incidence of PRRS virus in a large sample of US sow 
herds.  Due to the voluntary nature of the study, this cohort may not be representative of the US sow 
industry.  That said, preliminary results are strikingly consistent across three years of data and among 
systems.  These data present several questions for investigation including understanding what factors lead 
to the high incidence every October and spring and why vaccinated herds have the highest incidence of 
new PRRSv infections. 
 
Acknowledgments.  The authors appreciate the willingness of the participating farms and veterinarians to 
share their data.  They would also like to acknowledge funding support from the National Pork Board, U 
of MN CVM, and the USDA PRRS Coordinated Agricultural Project. 
 
  
2012 International PRRS Symposium/NSIF Conference 
50 
 
31 
Circulating genotypes of porcine respiratory and reproductive 
syndrome viruses in southern China: re-emerging lineage 3 and 
genomic recombination with vaccine variants 
 
 Hein Min Tun1#*, Wenhui Lu2#, Jingyun Ma, Frederick Chi-Ching Leung  
1School of Biological Sciences, The University of Hong Kong, Hong Kong SAR, PR China 
2College of Animal Science, South China Agricultural University, PR China 
# These authors contributed equally. 
 
Porcine reproductive and respiratory syndrome virus (PRRSV) was first reported in 
China since the end of 1995 and several variants were further reported in subsequence years, 
causing huge economic losses to Chinese swine industry. In 2006, a country-wide outbreak of 
porcine high fever syndrome, caused by a highly pathogenic PRRSV (HP-PRRSV) emerged in 
China affecting more than 20 million pigs. To date, three lineages (lineage 3, lineage 5.1 and 
lineage 8.7) of PRRSV were reported in China based on our global genotyping for type 2 
PRRSV. Among these three lineages, only lineage 8.7 was the most significant variant where 
infected pigs showing severe clinical symptoms. Much investigation to this economically 
important lineage (lineage 8.7) caused lesser attention on other lineages in China during recent 
years. Based on our viral isolation in Guangdong Province of Southern China during 2009 and 
2011, the majority of isolates collected were grouped as HP-PRRSV cluster. Moreover, 
circulating vaccine-associated lineage (lineage 5.1) and re-emerging lineage 3 isolates were also 
found. Lineage 3 was previously reported in China, Hong Kong and Taiwan, but there were no 
reports for this lineage after 2005 in China.   Here, we present the re-emerging of this lineage 3 
viruses in southern China in 2010 and their evolutionary story. Additionally, we had identified 
inter-lineage genomic recombination between MLV vaccine strain and re-emerging lineage 3 
virus in a farm practicing MLV vaccination. Although modified live virus (MLV) vaccines 
provide solid protection against PRRSV infection, the safety of MLV vaccines has been 
questioned since the detection of vaccine revertants which caused productive problems similar to 
those of wild-type PRRSV. Based on our experimental study, no differences in virulence 
between the recombinant variant and wild-type lineage 3 were observed. However, further 
investigations on genomic recombination among PRRSV variants in China are needed. 
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Little is known about the prevalence of PRRSV, PCV2, and SIV in feral swine in the state of 
Hawaii. The overall goal of this project was to apply a multiplex serological test for the detection 
of IgG and IgM antibodies to PRRSV N protein (N), PCV2 capsid protein (CP), and SIV 
nucleoprotein (SIV NP). Serum samples were collected from 345 feral swine in the counties of 
Hawaii and Honolulu over a four year period (2007-2010). Target proteins were expressed in E. 
coli and coated onto Luminex beads, using standard protocols. Antibodies to the three antigens 
were present in the population. Overall, PCV2-specific antibody was most prevalent with 61% of 
the samples testing positive for PCV2-specific IgG.  SIV and PRRSV N IgG antibodies were 
detected at much lower rates of 7% and 3.5%, respectively. Approximately 3% of samples were 
positive for the presence of PCV2-specific IgM. Five of the PCV2 IgM-positive samples were 
further subjected to PCR amplification for the detection of genomic DNA. Products were 
obtained from three of the samples. Sequencing showed the presence of PCV2b-like viruses. The 
results illustrate the utility of multiplex serological assays for disease surveillance in feral 
populations. 
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Sources of genetic variation in PRRSV include substitutions, insertions-deletions and 
recombination. The goal of this research is to develop in-vitro models to study recombination. 
The first step is to determine if cells can be infected by two different PRRS viruses. MARC-145 
cells were co-infected with two identical viruses which contained GFP or RFP and confocal 
microscopy identified dual-fluorescent cells. Flow cytometry estimated a 17% rate of co-
infection. The model system developed to study recombination is a two-step process of co-
transfection of HEK cells followed by infection of MARC-145 cells. Two infectious clones were 
constructed. The first was a non-fluorescent virus containing a mutated EGFP gene (pP129-
EGFP-97C) and the other was a ‘defective virus’ (pP129-EGFP-d(2-6)) containing wild-type 
EGFP gene but lacking ORFs 2 to 6. Recombination events in the mutated EGFP region resulted 
in restoration of fluorescence. Emerging recombined viruses were detected as green fluorescent 
plaques in MARC-145 cells. The estimated recombination frequency was approximately 0.1%. 
This in-vitro system was used to determine if recombination events occur in sequences that lack 
significant homology. For this purpose another defective construct (pP129-GFP-d(2-6)) was used 
for co-transfection with P129-EGFP-97C. Recombination was not detected in this experiment 
implying the need for greater than 83% homology for recombination to occur. Further, the 
system was applied to determine if P129-EGFP-97C virus can recombine with mRNA derived 
from a separate plasmid instead of a virus genome. A stable HEK cell line that expressed wild-
type EGFP was created and transfected with pP129-EGFP-97C. MARC cells were productively 
infected but failed to detect a green recombined virus. This suggests that co-localization of 
infecting viruses within specialized replication complexes is critical for recombination to occur. 
The in-vitro system developed in this study is being applied to further investigate the molecular 
mechanism of recombination in PRRS virus as a model for other RNA viruses. 
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PRRSV infection studies have shown that the viraemia levels of infected pigs start to 
decline long before the onset of adaptive immune response processes. One of the suggested 
mechanisms responsible for this observed decline is that the permissiveness of porcine alveolar 
macrophages (PAMs), i.e. the primary target cells of PRRSV, may reduce over time. Given that 
the PAM receptors CD163 and CD169 have previously been established as a necessary condition 
for productive infection with PRRSV, it could be hypothesized that changes in PAM 
permissiveness are mirrored by structural changes of PAMs with respect to CD163 and CD169. 
An in-vitro infection study was carried out to assess (i) whether and how PAM 
permissiveness to PRRSV changes over (incubation) time, (ii) whether expression levels of 
CD163 and CD169 at the cell surface are reliable markers for (changes in)  PAM permissiveness 
to PRRSV. PAMs from naive pigs were pre-incubated for 0, 1, 2, 4, 6, 8 and 9 days prior to 
PRRSV (UK strain Humberside-2) infection. Eighteen hours post-infection, cells were either 
dually stained for viral antigen and CD163, or for CD169. The proportion of PRRSV permissive 
cells and / or cells expressing CD163 or CD169 on the cell surface was established via flow 
cytometry. PAM numbers and CD163 / CD169 -positive cells were compared with those of a 
mock control. The experiment was repeated three times, with each independent trial consisting of 
PAMs extracted from 3, 2 and 3 pigs, respectively. Statistical analysis was carried out using proc 
mixed in SAS with class (infected / control), trial, incubation time and their interactions as fixed 
effects and pig as random effect. 
PAM permissiveness to PRRSV changed significantly over time in all three trials, 
although the patterns of change differed significantly between the trials. The proportions of cells 
expressing CD163 or CD169 on the cell surface declined over time in all 3 trials, and there was 
no indication that infection decreased the number of viable cells or altered expression of either 
receptor (i.e. no significant class effect). The analysis revealed that the observed changes in 
PAM permissiveness to PRRSV could not be explained by changes in the proportions of cells 
classified as CD163 or CD169 positive. Surprisingly, a high proportion of PAMs (up to 65%) not 
expressing CD163 on the cell surface were found to be permissive, and this proportion of cells 
was found to increase over time. Thus, two alternative hypotheses emerged from this study: (i) 
Cells classified as CD163 negative in the flow cytometry may express CD163 in the early 
endosomes, where virus uncoating takes place, and (ii) an unknown alternative factor plays a 
vital role in PAM permissiveness to PRRSV. Both hypotheses are currently explored using a 
process-based mathematical model. The combined results of the described experiment and the 
mathematical model provide important insight about the factors involved in altering PAM 
permissiveness to PRRSV, which could be exploited for the development of vaccines or 
treatment. 
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Several studies have previously suggested that osteochondrosis (OC) is an important cause of lameness 
and leg weakness in pigs. OC is a disturbance in the process of enchondral ossification affecting 
individuals at early growth in several different species, and the disturbance is caused by ischemia. 
Necrosis of the epiphyseal growth cartilage is the first structural changes of OC and can cause 
abnormalities of cartilage and thereafter bone lesions. Formation of detached fragments [osteochondrosis 
dissecans (OCD)], fissures, or subchondral bone cysts can appear at predilection sites. OC has 
traditionally been assessed either by macroscopically scoring the cartilage or by means of sectioning the 
bone and scoring the slabs. The aim of this study was to evaluate if images from routine Computer 
Tomography (CT) of live boars could be utilized for assessment of OC. Annually, Norsvin CT-scans 
3500 purebred live boars. Feed intake and growth (FIRE) are also part of the phenotypic measures on the 
boars, and DNA is extracted for genotyping with the porcine 60K SNP chip (Illumina Inc, CA, USA). In 
this study, 1449 Norsvin Landrace boars were assessed for signs of OC. The distal ends of Humerus and 
Femur, both medial and lateral condyles were assessed, giving eight phenotypes for each animal. The 
scores (0 to 5) were assigned based on visible changes in the subchondral bone. In addition, the 
assessments were added up to a “total score” (OCT). The results reveal that most boars (~90 %) have 
changes in the subchondral bone tissue (OCT >0). However, the vast majority of boars (~99 %) have no 
signs of OCD (joint specific score 3 or less). Medial condyle of femur was most affected with only ~30 % 
being scored as normal (score 0). Lateral condyles of humerus were little affected with ~97 % of the 
animals being scored as normal. The variation of the heritabilities for OC between the anatomical 
locations was present, ranging from h2humerus right medial=0.21 to h
2
humerus left lateral=0.06. OCT gave the highest 
estimated heritability (h2=0.31). The genetic correlations between OC at the different scoring positions 
varied from rghumerus right medial, humerus left medial=0.96 to non-significant correlations between humerus left 
lateral and humerus left medial. The genetic correlations between the total score of OC and OC scores at 
all eight positions were high and favorable. We therefore conclude that the total score OC is the preferred 
trait for implementation in the breeding goal. Phenotypes from FIRE were used to calculate genetic 
correlations between growth in different periods and OCT. Results indicate that animals having 
genetically potential for high early growth are more susceptible for OC. As part of the project, the boars 
are in process of beeing genotyped with the porcine 60K SNP chip. Genome wide association studies will 
be performed in order to identify markers/genes affecting OC and other traits related to longevity. 
Genotypes of relevant markers/genes and implementation of genomic selection will be used in the 
breeding program to intensify the genetic improvement of traits related to longevity and robustness. 
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AIM: The aim of this study is to develop a next generation sequencing protocol to sequence the 
whole PRRS Virus genome in order to generate sequence information on multiple geographically 
diverse strains. Using Ion Torrent™ PGM sequencing technology, sequencing results can be 
generated in a relatively short period of time.  Using the latest bioinformatics techniques, the 
sequence information can be compared and contrasted to determine strain similarity based on 
different ORFs and potentially determine new regions of interest for robust assay development. 
 
METHODS: This study uses commercially available kits to isolate and purify PRRSV nucleic 
acid from animal sourced matrices. Techniques such as ribosomal RNA removal are then used to 
further enhance PRRSV RNA recovery and to remove endogenous porcine genome sequences. 
PRRSV genome libraries are then prepared and amplified to capture all representative portions 
of the genome. Finally, these libraries are attached to Ion Sphere Particles that are loaded onto a 
sequencing chip and placed on the Ion Torrent PGM for sequence generation.  Bioinformaticians 
then analyze the data based on the researchers needs.  
 
CONCLUSION: Although this is an ongoing project, initial results are promising.  Contigs 
obtained from de novo assembly of sequence reads span over 98% of the PRRSV genome based 
on comparison to a reference sequence. Less than 20% of the sequence information generated 
comes from endogenous porcine origin and that is likely to be reduced as more optimization is 
performed. We are collaborating with labs in the US and in Europe to obtain strains that are 
currently in circulation. The information generated by this study will increase robustness and 
effectiveness of future assay designs.  
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Objective 
The present study is based on the correct design of specific primers for the detection of American and 
European strains of PRRS virus in Mexico, specifically, the two commonly studied ORF’s (ORF5 and 
ORF7).  
Material and Methods 
The samples were obtained from fourteen states of Mexico, positive samples were determined through the 
RT-PCR test, using 4 pairs of specific primers designed for American lineage (ORF5, ORF7) and a 
nested PCR for ORF5 and ORF7 of European lineage. The samples used were: 40 lungs, 16 lung and 
lymph node, 9 nasal swabs, 2 lungs and trachea, 1 nasal turbinate, 1 semen. The primer designs were 
made with the program ClonManager 7.0 with the lineup of 200+GenBank sequences and then evaluated 
with the programs Primer and BLAST. RNA extraction was performed using the Gibco Life Tech., 1996 
technique. The PCR technique was conducted with the RT-PCR One Step Invitrogen ® kit. The 
temperatures used for amplification of the primers were: a cycle of 50°C for 30 min.; a cycle of 95°C/15 
min.; 40 cycles of 94°C/30 sec., 54°C/ 60 sec. (ORF 5) or 58°C/60 (ORF7), 72°C for 60 sec., and a cycle 
of 72°C/10 min. and the result was kept at 4°C indefinitely. The amplification products were obtained and 
analyzed with Kodak Gel Logic 100 imagining system program. 
Results 
From the total (69) samples, 47 (68.12%) were found positive. At least one positive sample was found 
from the 14 states sampled. With the primers targeting ORF7 more positive samples were detected 
(34/69) followed by the nested ORF5 (28/69), the ORF5 of American lineage detected only 5 positive 
samples. Regarding the presence of European virus in Mexico, our study has not detected any positive 
sample. From the 41 lung samples processed, 23 were positive to the PRRSv (57%), from macerated lung 
and lymphoid tissues 75% positive (12/15 samples), 100% of nasal swabs were positive (9/9) and 1 
sample of tracheal tissue was positive (1/2). The only sample of nasal turbinate and semen were both 
positive. 
Conclusions  
The RT-PCR targeting ORF7 gave more positive samples, followed by the nested RT-PCR, suggesting 
that the laboratory diagnosis of PRRS virus should be focused to the detection of ORF7 rather than 
ORF5. The use of RT-PCR technique allowed determining the positive samples to PRRS virus regardless 
of the type specimen. We conclude that the use of a single pair of primers would create false-negative 
results. The deepening of the analysis of the virus identified by sequencing is essential to know the sites 
of the genome with nucleotide variation. However, when we obtained amplicons of different sizes it 
shows the variation of this virus and suggests the presence of endemic strains in our country. 
Heterogeneity is considered to be a major obstacle for the effective prevention and control of PRRS. The 
high degree of genetic and antigenic diversity among field isolates underlines the complexity of the 
control and eradication of the disease and the development of future vaccines. 
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Over the past decades, genetic selection and management changes have resulted in sows with increased 
litter size and high milk production. These biological changes have resulted in higher energy requirements 
and greater mobilization of body reserves during lactation, leading to a prolonged negative energy 
balance. To counteract this, feed intake of sows during lactation must be increased. However, as a result 
of selection of leaner pigs with an improved feed conversion ratio during finishing, appetite and feed 
intake capacity of sows shows a declining trend. Thus, efforts are needed to increase feed efficiency 
during lactation, i.e. increase milk output per unit of energy obtained from feed intake and body reserves.  
Genetic improvement of sows for lactation efficiency is, however, hampered by the ability to collect 
accurate feed intake and body composition data during lactation. Thus, the objective of this study was to 
conduct a genome wide association study (GWAS) to identify SNPs / chromosomal regions associated 
with sow lactation efficiency. The Illumina porcine 60k SNP chip was used to genotype 512 purebred 
Yorkshire sows from the ISU Residual Feed Intake (RFI) lines, which were divergently selected for high 
and low RFI during finishing. After quality control, 48,521 SNPs were used for analysis. Traits included 
lactation feed intake (FI), RFI, estimated maintenance requirements (MR), energy balance (EB) and 
lactation efficiency (LE), along with sow body weight (BWW), fat mass (FMW), and protein mass 
(PMW) at the time of weaning. Lactation efficiency and energy utilization of sows and piglets was 
calculated based on on-farm measurements of sow body weight, back fat and loin muscle area before 
farrowing and at the time of weaning, sow feed intake during lactation, and piglets weights at birth, death 
and weaning. The GWAS was implemented separately for each trait using method Bayes B of GENSEL 
software, with genetic variances and proportions of SNPs with non-zero effects estimated using Bayes C. 
The fixed effects of line (high and low RFI), generation (7 levels), and parity (2 levels) were included in 
the model. The proportion of phenotypic variance explained by markers was 0.12 for LE, 0.28 for FI, 0.09 
for RFI and EB, 0.49 for MR, 0.57 for BWW, 0.51 for FMW and 0.43 for PMW. These estimates were 
comparable to pedigree-based estimates of heritability. Although there were no regions that explained a 
large proportion of variance for LE or RFI, several informative regions were identified for traits such as 
PMW that are components of LE. The proportion of variance explained by the most important regions 
varied widely by trait. E.g., for PMW, six 1 Mb windows (86 SNPs) together explained ~20% of genetic 
variance and for MR seven windows (166 SNPs) explained ~ 12%. Across the genome, for all traits 
analyzed, more than 80 1 Mb windows explained at least 1% of the genetic variance. Some regions on 
SSC 8 and SSC18 were associated with multiple traits. Nearly all important regions differed between 
parties but were little affected by removing line as a fixed effect. Overall, this GWAS revealed several 
genomic locations and markers associated with sow lactation feed efficiency and associated traits, which 
can provide a road map for future research and application. This research was funded by the Iowa Pork 
Producers Association. Partial funding for DMT was by Genome Alberta and Genesus Inc. 
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It is believed that the genomic 5′ untranslated region (UTR) of Arterivirus plays crucial 
roles in viral genomic replication, subgenomic mRNA transcription and protein translation, yet 
the structure and function still remain largely unknown. In this study, we conducted serial 
nucleotide truncation, ranging from 1 to 190 nucleotides, to the 5 UTR of the porcine 
reproductive and respiratory syndrome virus (PRRSV) infectious full-length cDNA clone 
pAPRRS. In vitro synthetic RNAs were transfected into MARC-145 cells for further genetic and 
virologic analysis. Our results demonstrated that the first three nucleotides of PRRSV 5 UTR 
were dispensable for virus viability, which however was repaired with foreign sequences. In 
order to assess if the primary sequence or structural element play more important regulatory 
roles, the CMV promoter-driven 5 UTR truncation mutant cDNA clones were directly 
transfected into the BHK-21 cell lines. We found that PRRSV tolerated the first 16 nucleotides 
sequence alteration of 5 UTR without losing virus viability. However, these revertant viruses 
contained a range of non-templated with unknown origin exogenous nucleotides in the repaired 
5 end. Further analyses revealed that the 5 proximal stem-loop 1 (SL1) in the highly structured 
5 UTR was invariably required for virus infectivity. Taken together, we conclude that authentic 
5- proximal primary sequence is nonessential, but the resultant structural elements are probably 
indispensable for PRRSV infectivity. 
The 5 untranslated region (UTR) is believed to be vital for the replication of porcine 
reproductive and respiratory syndrome virus (PRRSV), yet its functional mechanism remains 
largely unknown. In this study, to define the cis-acting elements for viral replication and 
infectivity, the 5 UTR of type 1 PRRSV was used to replace its counterpart in the type 2 
infectious full-length cDNA clone pAPRRS. The chimeric cDNA clone pTLV8 was constructed 
and used for further genetic and virologic analysis. The chimeric virus vTLV8 could be rescued, 
and it had similar virologic properties to vAPRRS, including plaque morphology, growth 
kinetics and subgenomic mRNA (sg mRNA) transcription. Taken together, the results present 
here demonstrate that the 5 UTR of type 1 PRRSV dose not affect the growth rate of type 2 
PRRSV in vitro. The 5 UTR of type 2 PRRSV can be functionally replaced by its counterpart 
from type 1. 
 This is the first report that the type 1 5′ UTR could play regulatory function in type 2 
genomic backbone and fully functional. In addition, we did the related research to explore the 
origin of 5 UTR 5 terminal exogenous sequences, results showed that the insertion sequences 
which used for repair was template independent. 
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porcine reproductive and respiratory virus HuN4 strain 
 
Yi-feng Jiang, Yan-jun Zhou, Ya-xin Wang, Jian-ping Zhu, Yan-zhao Xu, 
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To investigate the molecular mechanisms of the different virulence between highly pathogenic 
porcine reproductive and respiratory virus (HP-PRRSV) HuN4-F5 strain and its attenuated 
vaccine strain HuN4-F112, we generated six full length infectious cDNA clones with 
interchange of ORF1a, ORF1b, or ORF2-7 region, between the two viruses, named rHuN4-F5-
ORF1a, rHuN4-F5-ORF1b, rHuN4-F5-ORF2-7(genetic backbone of virulent HP-PRRSV, 
HuN4-F5 with ORF1a, ORF1b or ORF2-7 from attenuated HP-PRRSV, HuN4-F112) and 
rHuN4-F112-ORF1a, rHun4-F112-ORF1b, rHun4-F112-ORF2-7 (genetic backbone of HuN4-
F112 with ORF1a, ORF1b or ORF2-7 from HuN4-F5) , respectively. The piglets were infected 
with chimeric viruses rHuN4-F5 and rHuN4-F112, and the sera from each pig were collected. 
The virus titer in sera from pigs infected with the chimeric viruses was significantly lower than 
that from parental virus at 3, 5, 7 and14 dpi. But pigs infected with rHuN4-F5-ORF2-7 showed 
significantly lower titer than that of rHuN4-F5 at 7 and 14 dpi. There was no significantly 
difference among pigs infected with chimeric viruses except rHuN4-F112-ORF1a at 7 dpi. The 
level of IL-1 in response to rHuN4-F5 was significantly increased and all the chimeric viruses 
were not significantly changed. The levels of IL-6 in response to rHuN4-F5-ORF2-7 infection 
were significantly higher than that infected with the other chimeric viruses or rHuN4-F112 at 
both 3 and 5 dpi. At 3, 5, 7 and 14 dpi, higher levels of IL-10 were induced by the infection of  
rHuN4-F5-ORF2-7 or rHuN4-F5 than that induced by the other virus. And at 3, 5, 7 and 14 dpi 
the infection of rHuN4-F5-ORF1b triggered much higher amount of IL-10 than that infected by 
the other viruses except rHuN4-F5-ORF2-7 and rHuN4-F5. The rescued viruses with a common 
backbone of rHuN4-F5 stimulated higher amount of IL-10 than rescued viruses with a backbone 
of rHuN4-F112, except rHuN4-F5-ORF1a and rHuN4-F112-ORF1a. The infection of all the 
viruses also resulted in the secretion of IFN-γ with a moderate level. Taken together, in this study 
we concluded that: the regions encoding for Non-structure proteins were important for the virus 
infection, especially in the production of viremia and the induction of IL-6 and IL-10. ORF1a 
plays a very important role in viremia production, IL-6 and IL-10 induction. ORF1b was 
involved in the production of IL-6 and IL-10. Therefore, this study set up a foundation for further 
elucidation of the diversity between HP-PRRSV and avirulent PRRSV in genetic level. 
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Activation of type I interferon (IFN-alpha/beta) production is essential for cellular resistance to 
virus infection, but during infection with porcine reproductive and respiratory syndrome virus 
(PRRSV) only a low level of IFN is induced and the disease in pigs is often associated with viral 
persistence. Non-structural protein (nsp) 1 of the virus has been reported as an IFN antagonist, 
and in the present study the nsp1-beta subunit was examined for IFN modulation. Nsp1-beta was 
localized to both the cytoplasm and nucleus of the cell and inhibited IFN induction by targeting 
the IRF3- and NF-kB-dependent IFN production pathways. The nsp1-beta subunit-mediated IFN 
suppression was consistently weaker than that of nsp1, the non-cleaved precursor of nsp1-alpha 
and nsp1-beta The inhibitory activity was not limited to the IFN production pathway, but also 
observed in the IFN-induced Janus kinase (JAK)-signal transducers and activators of 
transcription (STAT) signaling pathway responsible for IFN-dependent ISRE expression.  
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Benchmarking is an ongoing process used by many industries seeking continuous improvement.  
Benchmark is a point of reference for a measurement and serves as a standard by which others may be 
measured or judged. In quality based science, benchmarking is the process of comparing the current 
project, methods or processes with the best practices and using this information to drive improvement of 
overall company performance. It focuses on how to improve any given business process by exploiting 
best practices rather than merely measuring the best performance. This abstract describes benchmarking 
implementation model in porcine reproductive and respiratory syndrome (PRRS) Area Regional Control 
an elimination (ARC&E) projects. Currently, there are several ARC projects lead by veterinarians, 
producers and researches all around the globe. Most of them follow a standard structure: I. Feasibility 
Study, II. Pig related site id. III. Region characterization, IV. Design control strategies, V. 
Execution & Monitoring.  Benchmarking among these ARC projects is possible by applying DIAMR 
model. (Determine current best practices; Identify best practices; Analyze best practices; Model best 
practices; Repeat the cycle). Benchmarking in PRRSv ARC represents an opportuntiy to boost current 
projects for improvement learning from best projects in class. 
 
Table 1. Model DIAMR to apply Benchmarking to PRRS ARC projects. 
D I A M R 
+Select what we 
want to improve 
within the 5 
phases  
+Identify 
critical success 
factors from 
several ARC  
successfully 
implemented  
+Select specific 
measurement of 
success 
according to the 
goals and 
expectations 
 
+Evaluate the 
measurement of 
success for the 
current project 
and get a baseline 
+Determine 1 or 2 
state of the art 
projects to 
benchmark with 
+Ask for 
interaction and a 
formal 
benchmarking to 
experts with 
profound 
knowledge on the 
selected projects. 
+ Collect critical 
information and 
data for success in 
ARC projects  
+Evaluate and 
compare current 
practices with the 
selected projects 
+Note potential 
improvements 
areas at each 
ARC phase 
considering 
current conditions 
 
+Drive 
improvement 
changes to advance 
performance levels 
+Communicate 
these initiatives and 
extend the 
measurement of 
success goals 
within the working 
group 
+Incorporate this 
information in 
ARC project’s  
newsletter 
+Share results with 
benchmarking 
partner(s) 
 
+Repeat the 
process until 
achieving  
desired goals 
+ As the need 
forimproveme
nt changes 
include new 
leading ARC 
projects 
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Pilot project to develop a novel methodology for the detection of 
airborne porcine reproductive and respiratory syndrome virus 
during a twenty-four hour period 
 
Brian Payne, DVM, Laura Batista, DVM, PhD* 
Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO, USA 
 
Porcine reproductive and respiratory syndrome virus (PRRSv) is known to be spread via aerosol. 
Aerosol collectors have been used for ≤30 minute periods and with saline solution (SS) as the 
sampling solution. The objectives of this pilot study where: 1. To determine if lactated Ringer’s 
solution (LRS) could be an alternative to SS, and 2. To confirm the aerosol collector could run 
for a 24 h period. On day 0, fifty milliliters (mL) of SS and LRS were placed in two 50mL sterile 
containers. Each solution was spiked with 0.5mL of Ingelvac® PRRS MLV vaccine (Boehringer 
Ingelheim Vetmedica, Inc. St. Joseph, MO). In order to detect the presence of PRRSv, a 12.0 mL 
aliquot was removed from each container at 1 and 30 minutes, and 6 and 24 hours post-spiking. 
Each 12.0mL aliquot was subdivided in three 4.0mL aliquots, placed into sterile tubes, and 
stored at three different temperatures: 19°, 3° and -18°C (frost-free freezer). In order to confirm 
if the aerosol collector (Midwest MicroTek, Brookings, SD, USA), could be used for a 24 hour 
period, the collector was left running for five (n=5) consecutive 24 hours periods at 4800 RPM. 
A 1000mL LRS intravenous (IV) fluid bag was placed next to the collector and an IV drip set 
(60 drops per ml) was installed, allowing the IV line to drip into one of the collector’s container 
holes. The IV line was allowed to drip at a rate of one drop every 4-5 seconds (12-15ml/hr). All 
samples were tested in triplicate for the presence of PRRSv nucleic acid by reverse transcriptase 
polymerase chain reaction (rt-PCR) and were reported in cycle threshold (Ct) values. As shown 
in table 1, there was no numerical difference in Ct values at the various sampling times and 
storage temperatures. Due to small sample size no statistical inference should be made. Aerosol 
collectors were able to run for 24 continuous hours with a LRS IV drip during 5 days with no 
effect on functionality or damage to the motor. The results of this study present a novel 
methodology for the detection of airborne PRRSv for ≥30 minutes. Implementation of this 
methodology would allow for practical and longer sampling periods to monitor the the presence 
of PRRSv in the air.  
 
Table 1. PRRSv RT PCR results (Ct) from PRRS MLV spiked saline solution (SS) and lactated 
Ringer’s solution (LRS) 
 Storage Temperature (0C) 
Sampling time 19° 3° -18° 
 SS LRS SS LRS SS LRS 
1 min 25.5 26.3 25.2 26.1 26.4 27.4 
30 min 25.4 26.4 25.4 26.1 25.8 26.8 
6 h 25.8 26.8 25.3 26.3 27.4 27.5 
24 h 25.5 26.6 25.4 26.4 27.3 27.2 
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1Food Animal Health Research Program (FAHRP), OARDC, Department of Veterinary 
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and Immunity, The Ohio State University, Columbus, OH 
 
 
Porcine reproductive and respiratory syndrome (PRRS) is an economically important disease of 
pigs, caused by PRRS virus (PRRSV), incurring estimated $664 million losses annually to the 
US pork industry. Routinely used modified live PRRSV vaccine is implicated in transmission of 
mutated vaccine virus to susceptible pigs. Unfortunately, currently available killed PRRSV 
vaccine elicits poor immunity. Therefore, our goal was to develop a safe and protective killed 
PRRSV vaccine. We adopted two strategies: firstly, entrapped the killed PRRSV vaccine in 
PLGA [poly(lactide co- glycolide)] nanoparticles (Nano-PRRSV vaccine); and secondly, co-
administered the vaccine with a potent adjuvant, Mycobacterium tuberculosis whole cell lysate 
(M. tb WCL) that we identified earlier. To analyze the cross-protective efficacy of the vaccine, 
pigs were co-administered with killed PRRSV vaccine (VR2332 strain) and M. tb WCL, in the 
form of entrapped (Nano-PRRSV vaccine) or unentrapped in nanoparticles, intranasally, and 
then challenged with a virulent heterologous PRRSV (MN 184 strain). Our results indicated that, 
Nano-PRRSV vaccine co-administered with unentrapped  M. tb WCL elicited cross-protective 
immunity, indicated by the following immune correlates detected at both the lungs and blood: (1) 
increased levels  of PRRSV specific IgG and IgA antibody titers with enhanced antibody avidity; 
(2) balanced Th1 and Th2 type responses; (3) upregulated heterologous and heterogenotypic 
PRRSV specific neutralizing antibody titers; (4) Increased secretion of Th1 cytokines (IL-12 and 
IFN-γ) with enhanced frequency of IFN-γ secreting cells in the lungs and reduced 
immunosuppressive cytokines (IL-10 and TGF-β); and (5) complete clearance of replicating 
virus from the lungs and blood. In conclusion, our study for the first time demonstrated that 
adjuvanted Nano-PRRSV vaccine elicits cross-protective immunity against PRRS in pigs. This 
project was supported by National Pork Board, USDA PRRSV CAP2, and OARDC OSU to 
RJG. 
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The annual loss associated with PRRS in the US swine industry has been recently estimated at 
USD-$664 million. The elimination of PRRS virus (PRRSv) from breeding herds through load, 
homogenize and close protocols is effective and repeatable; however, transmission between 
farms occurs all too often, making it very difficult to meet and maintain health and productivity 
expectations. An alternative is to implement cooperative and coordinated disease control efforts 
among producers and veterinarians working together with their neighbors and business partners 
in order to significantly reduce the risk of re-infection in those herds.  The objectives of this 
project are:  1) To reduce the incidence and prevalence of PRRS in the region. 2) To minimize 
the severity and duration of PRRS episodes, and 3) To establish a structure for disease 
surveillance and communication in the region. As part of this voluntary project, producers sign 
participation agreements to allow information sharing and minimize the concern of legal actions 
among neighbors. Participants are granted access to the project website by the project 
coordinator. Every other week, veterinarians communicate any change in PRRSv infection status 
during the previous 2 weeks to the coordinator. A prevalence summary table, a list of herds that 
changed status and the maps are updated in a bi-weekly bulletin that is sent to all participants. 
Quarterly meetings are held to discuss needs and actions as well as to evaluate the progress of 
the initiative considering change in prevalence, number of new cases, outbreaks identified by 
veterinarians and genetic diversity. The primary control area of this project is mostly occupying 
Washington County, located in Southeast Iowa. A peripheral control area includes parts of the 6 
surrounding counties and 3 more counties to the Northeast. Washington County is the sixth most 
hog dense county in the state of Iowa and twelfth in the US. A significant proportion of the pigs 
introduced to the region are from diverse pig sources. By September 2012, 27 breeding herds, 63 
nursery sites and 309 finishing sites have enrolled in the project. Most are family owned farms 
averaging 2700 pigs per site. About 21% of the herds have been reported as PRRSv stable or 
negative and the infection status of 1% of herds remains unknown. The regional control plan for 
this project is based on the use of modified-live virus vaccination in breeding and grow-finish 
herds, air filtration in specific sow farms and comprehensive biosecurity programs to 
systematically mitigate the impact of PRRSv and reduce transmission between herds. The 
monitoring/surveillance protocol allows for early detection of PRRSv infection (oral fluids, PCR, 
sequence analysis) and facilitates continuous proactive communication and  coordinated pig flow 
or transit modifications.  
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The present study aimed to determine the full-length nucleotide sequence of a Korean type 2 
PRRSV nsp2 deletion mutant, designated CA-2. The full-length genome of KNU-07 was found 
to be 15,018 nucleotides in length excluding the poly(A) tail, which was 393-nucleotide shorter 
than that of the type 2 NA prototype strain VR-2332 due to the notable large 393-bp (131-aa) 
deletion within the nonstructural protein 2 (nsp2) gene. The CA-2 genome consisted of a 189-
nucleotide 5' untranslated region (UTR), a 14,677-nucleotide protein-coding region, and a 151-
nucleotide 3' UTR. Full-length sequence analysis of the CA-2 genome with the 20 fully 
sequenced PRRSV genomes revealed sequence divergence ranging from 13.7% (the Korean CA-
1 strain) to 42.2% (the Lelystad strain). To evaluate the in vitro immunity of CA-2, we sought to 
explore alteration of inflammatory cytokine and chemokine expression in PAM-pCD163 cells 
infected with CA-2 by using quantitative real-time RT-PCR. Cytokine genes including 
interferons (IFN-β, γ, and λ), IL-7, IL-8, IL-15, and TNF-α, and chemokines such as AMCF-1 
and MCP-2 were found to be significantly elevated in CA-2 virus-infected PAM cells. In 
addition, antiviral genes including ISG-15 and ISG-54 were up-regulated in PAM cells upon CA-
2 infection. However, expression of the anti-inflammatory cytokine IL-10 was dramatically 
reduced during the course of CA-2 infection in PAM cells. Animal studies to determine 
pathogenicity of this nsp2 deletion mutant are currently in progress and results of in 
vivo assessment will be discussed. 
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RNA sequencing technology has created unprecedented possibilities for deciphering genetic 
mechanisms. Its application towards elucidating the transcriptome changes after viral infection 
will provide major insights to help improve pig health and disease resistance. The abundance of 
globin transcripts, however, impedes the ability to detect less abundant transcripts when whole 
blood samples are examined. Our preliminary studies determined that globin depletion methods 
effective for human whole blood do not work for pig blood samples. The objective of our study 
was to develop and evaluate a porcine specific globin reduction protocol using globin (HBA and 
HBB) oligonucleotides and RNA-seq. Total RNA was prepared from blood samples collected 
using PAXgene (n = 6) and Tempus (n = 17) tubes. RNA quality pre/post treatment was checked 
using Agilent Bioanalyzer. RNA-seq was performed using Illumina HiScan SQ system. On 
average, 46.9 and 35.6 million reads were generated and 36.1 and 27.7 million reads were 
uniquely mapped in pre versus post globin reduction treated samples, respectively. The uniquely 
mapped reads of HBA and HBB tags comprised up to 55 % of the pre-treatment reads; this was 
reduced to 0.1 - 2.5 % post globin RNA reduction. For validation, qPCR results confirmed that 
HBA and HBB mRNAs were efficiently depleted (97.2 % and 96 %, respectively). In addition, 
1030 genes on average were newly identified after globin reduction; these were involved in 
differential biological and toxicological functions, and canonical immune pathways. In summary, 
our porcine specific globin reduction protocol minimizes the number of reads of globin RNA and 
provides increased accuracy and reproducibility of transcriptome analysis. Based on these results 
we will now be able to unravel the complexities of host response to Porcine Reproductive and 
Respiratory Syndrome virus (PRRSV) infection. Plans are underway to use the Tempus tube 
blood samples from the PRRS Host Genetics Consortium to reveal immune pathways enhanced 
in pigs which are genetically more resistant to PRRSV infection. This work was supported by 
grants from Genome Alberta and Genome Canada. 
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For effective disease surveillance, rapid and sensitive assays are needed to detect antibodies 
developed in response to PRRS virus (PRRSV) infection.  In this study, we developed a 
multiplexed fluorescent microsphere immunoassay for detection of PRRSV specific antibodies in 
oral fluid and serum samples.  Recombinant nucleocapsid protein (N) and nonstructural protein 7 
(nsp7) from both PRRSV genotypes (Type I and Type II) were used as antigen and covalently 
coupled to Luminex fluorescent microspheres.  Based on an evaluation of 488 oral fluid samples 
with known serostatus, the oral fluid-based FMIAs achieved greater than 92% sensitivity and 
91% specificity.  In serum samples (n = 1639), the FMIAs reached greater than 98% sensitivity 
and 95% specificity.  The assay was further employed to investigate the kinetics of antibody 
response in infected pigs.  In oral fluid, N protein was more sensitive for the detection of early 
infection (7 and 14 dpi), but nsp7 detected higher level and longer duration of antibody response 
after 28 days post infection.  In serum, the antibodies specific to nsp7 and N proteins were 
detected as early as 7 days post infection, and the responses lasted more than 202 days.  This 
study provides a framework from which a more robust assay could be developed to profile the 
immune response to multiple PRRSV antigens in a single test.  The development of oral fluid-
based diagnostic tests will change the way we survey for diseases in swine herds and improve 
our ability to cheaply and efficiently track PRRSV infections in both population and individual 
animals.  
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The dipstick tests were developed based on the high binding capacity of a specific pathogen 
antigen to swine antibodies, and the conjugation of swine immunoglobulin with colloidal gold 
nanoparticles as a color probe. Using nucleocapsid proteins (SIV, PCV2) and nsp7 (PRRSV) as 
antigens, dipstick assays were developed based on testing standard positive and negative control 
sera as well as a panel of field serum samples, and the diagnostic specificity and sensitivity were 
compared to the classical enzyme-linked immunosorbent assay (ELISA) or hemagglutination 
inhibition (HI) test. Based on the evaluation of 456 serum samples of known serostatus from pigs 
experimentally infected with either type I or type II PRRSV, the PRRSV dipstick assay showed 
an overall sensitivity and specificity of 95% and 96% respectively, in comparison with the 
IDEXX HerdCheck X3 ELISA. The inter-rater agreement (kappa value) between dipstick test 
and ELSA was 0.965. The SIV dipstick test achieved a sensitivity of 96% and a specificity of 
99% using 177 field serum samples previously tested in HI assay, and the kappa value between 
dipstick and HI was 0.953. For PCV2 antibody detection, results from nucleocapsid protein-
based dipstick test and ELIA were compared using 135 samples from experimentally infected 
animals. The sensitivity and specificity of PCV2 dipstick test were 88% and 80%, respectively. 
These assays present advantages of simplicity, rapidity and cost-effectiveness, and the test is 
field deployable with a user-friendly format, which can be performed on-site in a swine farm by 
untrained personnel; therefore, it is very suitable for large-scale field application on porcine 
respiratory disease surveillance and epidemiology studies.  
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Adjuvants selection for an improved PRRSV Vaccine 
 
Benoît Levast, Jill van Kessel, Stacy Strom, Kate Szombathy, Volker Gerdts 
Vaccine and Infectious Disease Organization (VIDO), Department of Veterinary Microbiology, 
Western College of Veterinary Medicine, University of Saskatchewan, SK, Canada 
 
Current vaccines fail to provide complete protection against Porcine Respiratory and 
Reproductive Syndrome Virus (PRRSV) for several reasons, including the inability to overcome 
the suppression of the innate immune responses, and in particular the expression of interferon 
alpha (IFN-a). We hypothesize that adjuvants can overcome this suppression and help to 
stimulate the immune response to the vaccine. To achieve this goal we are using a recently 
developed adjuvant platform consisting of three individual components, namely innate defense 
regulator peptides (IDR), Toll-Like Receptor (TLR) ligands and polyphosphazenes (PCEP).   
 
The first step is to optimize of the adjuvant formulation in vitro and to identify synergy between 
the individual components and their interactions with antigen. To this end, adjuvants are tested in 
porcine dendritic cells (DCs) and Porcine Alveolar Macrophages (PAMs) alone or in 
combination for their ability to stimulate the expression of pro-inflammatory cytokines. The VR-
2385 North American strain was used to stimulate PAMs or DCs. 
 
Using RT-qPCR analysis we confirmed the mRNA expression of TNF, IL-8, CCL2 and IFN-b 
by Poly(I:C) stimulation on PAMs. We also found that IDR LL37 (human origin) and 1002 
(synthetic) have the capacity to decrease the Poly(I:C)-induced TNF and IL-8 mRNA expression 
but not CCL2 and IFNb. Thus, by acting synergistically these adjuvants may prevent excessive 
inflammation, boost IFN production, and possibly facilitate monocyte recruitment. As the virus 
itself inhibits expression of IFN-a, the adjuvant might help to overcome this deficiency. 
 
Using Flow cytometry, we demonstrated that LL37 inhibited apoptosis in PAMs and moDCs. 
IDR peptide 1002 displayed a similar effect but to a lesser extent. In addition, we were able to 
show that IDR LL37 was able to inhibit virus infection on PAMs. 
 
Thus, we were able to demonstrate that the described combination of adjuvants may help to 
overcome the immune suppression by the PRRSV virus and will help to stimulate an effective 
immune response. 
 
The next steps are to test the adjuvant formulation with a vaccination/challenge experiment in 
vivo and to analyze the immune cells like PAMs and pDC, their infection status and their 
capacity to stimulate an anti PRRSV immune response. Work with new strains and heterologous 
challenge will follow to validate our improved PRRSV vaccine. 
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Impact of the use of specific avian immunoglobulins 
(ImmunoPRRS®) to control PRRS in a multisite farm  
in Northern Mexico 
 
E. Lucio*, W.E. González, D.B. García, J. Munguía 
Investigación Aplicada SA de CV, Tehuacán, Puebla, México 
 
Introduction. Porcine Reproductive and Respiratory Syndrome (PRRS) is considered the most 
significant infectious disease in swine with the most economically significant effects worldwide. Previous 
studies have shown that the administration of specific immunoglobulins against PRRSv (ImmunoPRRS®) 
to gestating sows affords full protection against the agent, a phenomenon evidenced by the fact that no 
affected piglets were produced after treatment, suggesting egg derived immunoglobulins are capable of 
blocking the infection. 
Material and methods. The farm is located in  orthern Mexico at 27  04  51     and 109  26  43    W, with 
an altitude of 33 masl and 1000 sows in production. During 2010 an unstable behavior was observed 
along with abortions, thus an immunoglobulin based program against PRRS was established by 
administering a dose of 5mL of the product ImmunoPRRS® to the breeding herd  and repeating the dose 
15 days later. Afterwards, the same program was applied each 4 months to sows at the 10th and 12th weeks 
of gestation and also to the replacements 15 days prior to their introduction to the farm and on the day of 
introduction. 
Results. Comparative results of the serological analysis (ELISA), before and after the application of the 
product show how antibody levels against PRRS decrease after administering the egg derived 
immunoglobulins (ImmunoPRRS ®), reaching levels under the test cut point (Chart 1). 
 
DATE S/P (ELISA) 
06/JUL/2010 0.786 
29/OCT/2010 0.877 
14/JAN/2011 0.918 
21/APR/2011 0.341 
12/JUL/2011 0.317 
29/OCT/2011 0.007 
18/JAN/2012 0.265 
09/APR/2012 0.327 
30/JUL/2012 0.245 
 
 
 
Along with the decrease of S/P levels, the increasing birth rate shows a tendency to increase the numbers 
of live born piglets further (Chart 2). The sanitary control program favored the absence of viremic piglets, 
as corroborated by PCR results at the third week and also increased productivity of site 1 and 2 as 
compared to results from previous years. 
Discussion and conclusions. Productive parameters show a clear stability and improvement after 
beginning the egg derived immunoglobulins program (ImmunoPRRS®). This can be observed by the 
increase in farrowing rates, live born piglets (LBP) and birth averages, as well as weaned piglets (WP) 
with their corresponding rates and finally an important decrease in mortality at the maternity stage.   
  
PRODUCTIVITY SUMMARY 
  2009 2010 2011 2012* 
Births 2,011 2,054 2,174 2,391 
LBP 20,571 22,810 25,466 28,692 
Avg. Born 10.23 11.11 11.71 12.00 
Weaned 
Piglets 
16,929 18,932 22,002 26,683 
%Mat. 
mortality 
17.70% 17.00% 13.60% 7.0% 
Chart 1: Dynamic S/P levels 
Chart 2: Productive parameters 
 * Values projected with data up to August 
2012 
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A methodical approach to PRRS management, a success story of 
production improvements 
 
Arturo Oropeza-Munoz, MVZ, M Sc.*, John Kolb DVM, M Sc.ABVP 
Boehringer Ingelheim Vetmedica Incorporation Swine Division, St. Joseph, MO, USA 
 
Porcine Reproductive and Respiratory syndrome Virus (PRRSv) continues to be a major pathogen that 
impacts the swine industry. The PRRS virus is known to have a wide range of impact on breeding herd 
and growing pig performance. A 26,000 sow system had been affected by outbreaks of PRRSv infections 
throughout several years, and traditional strategies of gilt isolation, virus inoculations and herd closures 
achieved unacceptable levels of success for managing disease and production performance. The objective 
of this project was to improve the reproductive and growing pig performance, through strategic use of 
PRRS modified live vaccine (MLV), herd closure, and flow management. The duration of this project was 
from January 2009 through May of 2011 in two phases. The system had 26,000 sows housed in 12 sow 
farms, 70,000 pigs in two nursery flows, 64,000 finishing pigs in three finishers; 16,000 pigs in two wean 
to finish farms, gilt development and isolation. The rest of the pigs were finished at another location. In 
addition, these animals were positive to Mycoplasma, PRRS and SIV. Phase 1 occurred the first 18 
months post-vaccination and Phase 2 was the following 10 months.  The project protocols were: 1] Sow 
herd closure for approximately 170 days; 2] Whole herd vaccination with Ingelvac® PRRS MLV 
(Boehringer Ingelheim Vetmedica, Inc, St. Joseph, MO) 4 weeks after closures, and again 30 days later, 
followed by quarterly sow herd vaccinations; 3] Vaccination of suckling pigs at approximately 15 days of 
age followed by a second dose of vaccine three weeks later during the nursery stage; 4] Flow 
management: managing rooms all in/all out, and when possible entire barns emptied, washed and 
disinfected; 5] Cessation of intentional exposure to wild-type PRRS viruses. Production performance was 
monitored using Statistical Process Control methodology (SPC). Significant improvements were achieved 
in both reproductive and post-weaning performance. Results are described in Table 1 below. A significant 
improvement in reproductive and growing pig performance was achieved by a well defined process that 
included the strategic use of Ingelvac PRRS MLV. 
 
Table 1.  Performance before and after PRRS control process implimented 
Production Data Baseline Phase 1 Achieved 
difference 
Phase II Achieved 
difference 
Pigs weaned/sow farrowed 9.2 9.66 +0.44* 10.03 +0.83* 
Nursery ADG, lb/d 0.763 0.930 0.170* 0.988 0.225* 
Nursery mortality, % 5.62 3.39* -2.226* 2.124 -3.50* 
Finisher ADG, lb/d 1.64 1.70 +0.06* 1.74 +0.10* 
Finisher mortality, % 2.96 2.21 -0.75* 2.22 -0.74* 
*Significant change in process behaviour  
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Growth performance improvement and mortality reductions 
derived from a PRRS large-scale control project in the U.S. 
 
Jose Angulo, John Kolb, Reid Philips*, Jean Paul Cano 
Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO, USA 
 
PRRSv has demonstrated to have an economical impact per pig up to $ 28.3 U.S dollars in finisher phase. 
Modified-live virus vaccine represents a viable option to minimize the negative impact of PRRS in 
growing pigs. The objective of this project was to determine if strategic use of Ingelvac® PRRS MLV 
(Boehringer Ingelheim Vetmedica, Inc. St. Joseph MO) could improve growing pig performance and 
reduce mortality compared to the previous 24 months of production data in a large-scale pig production 
system. The project was performed in a 70,000 sow multisite production system. Breeding herds, 
nurseries and finishers were endemically infected with PRRSv type 1 (EU) and type 2 (NA). The primary 
interventions were herd closure (130 days) and systematic breeding herd mass vaccination with Ingelvac 
PRRS MLV (2 ml), followed by quarterly sow mass vaccination, and ongoing pig Ingelvac PRRS MLV 
vaccination (2 ml) at weaning.  Project duration was 15 months. In growing pigs, system-wide average 
daily gain (ADG) and mortality percentage were compared in a before-after analysis, running 2-sample t-
test for ADG and 2-sample proportion test for % mortality (MINITAB 16.1). In the nursery phase, a total 
of 703 closeout groups (3,656,862 pigs) were included in the before period, and 328 closeout groups 
(1,463,539 pigs) were included in the after period. In the finisher phase, 489 closeout groups (2,659,631 
pigs) were included in the before period and 188 closeout groups (1,006,072 pigs) were included in the 
after period.  Monthly diagnostic monitoring in piglets at each breeding herd as well as nursery and 
finisher pigs (hospital pens) was implemented to assess PRRSv circulation dynamics and system-wide 
wild type (WT) presences (using ORF-5 sequencing) proportion during the project. Before and after 
vaccination results are shown in Table 1.This large scale PRRS control project was successfully 
implemented for 15 months. A significant increase in ADG (P<0.01) and significant decrease in mortality 
(P<0.01) was detected in both nursery and finisher pigs when compared against the previous 24 months 
closeouts. In addition, a reduction of PRRS wild type virus proportion in the whole system was observed.  
PRRS MLV pig vaccination and modified herd closure were the primary tools utilized to achieve an 
improvement in ADG and reductions in mortality even in the presence of both PRRSv type 1 and type 2 
in the system.    
 
Table 1. Analysis of system-wide closeout gain and mortality before and after vaccination 
 Vaccination 
Parameter Before After 
Nursery   
ADG, lbs 0.905±0.12a 0.975±0.07b 
Mortality, % 3.19±0.008a 2.45±0.008b 
Finisher    
ADG, lbs 1.704±0.01a 1.825±0.06b 
Mortality, % 5.56±0.009a 3.65±0.003b 
System-wide WT-PRRS virus 100%a 49.6%b 
Rows with different superscripts differ at P<0.01 
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Development of a differentiable virus through a spontaneous 
deletion in nsp2 region associated with cell-adaptation of porcine 
reproductive and respiratory syndrome virus 
 
Xiaomin Wang, Lichang Sun, Yanhua Li, Tao Lin, Fei Gao,  
Guangzhi Tong*, Zuzhang Wei, Shishan Yuan 
Department of Swine Infectious Diseases, Shanghai Veterinary Research Institute,  
The Chinese Academy of Agricultural Sciences, Shanghai, PR China 
 
   Porcine reproductive and respiratory syndrome virus (PRRSV) is notorious for genetic, 
antigenic and pathogenic heterogeneity. As a consequence, high pathogenic PRRSV (HP-
PRRSV) has been emerging and resulting in tremendous economic loss of swine industry. In this 
study, a Chinese HP-PRRSV JX143 isolate was serially passaged in MARC-145 cells up to 100 
times. We found that the phenotypic changes involving the cell-adaptation process of PRRSV 
JX143 were characterized by higher titer, faster growth kinetics, and larger plaque size as the 
passage number increasing compared with parental virus. Piglets inoculated with JXM100 virus 
did not show high fever in body temperature and clinical signs throughout the experiment and 
the average body weight of piglets in JXM100 infected group were similar to that of the control 
groups, suggesting that the virulence of the JX143 isolate to piglets was decreased greatly at 
passage 100 (JXM100). The JXM100-infected group could resist the lethal challenge of JX143 
and did not show any changes in body temperature nor clinical signs and gained weight as well 
as that of control, suggesting that the JXM100 could protect piglets from lethal challenge and 
might be a candidate vaccine against the HP-PRRSV. Genome-wide analysis revealed that 
JXM100 strain contains a continuous 264 nucleotide (88 amino acids) deletion in the nsp2 region 
and 75 nucleotides mutation randomly across the genome. These nucleotide changes that arose 
during MARC-145 passage of the HP-PRRSV JX143 virus provide a potential molecular basis 
for the observed cell-adapted phenotype in MARC-145 cells and attenuated phenotype in vivo. 
The study also showed that pigs inoculated with JXM100 with 88 aa deletion (del88) in nsp2 
elicited a strong antibody response against the N protein but did not develop antibody against the 
del88, whereas a strong reactivity was observed in the sera obtained from piglets infected with 
JX143 using the same del88-based ELISA. It is suggested that del88 can use as the genetic 
marker to differentiate JXM100 serologically from JX143. Finally, we developed an infectious 
cDNA clone of JXM100, which provide platform for further dissection of molecular basis of HP-
PRRSV as well as rational design of DIVA vaccine. 
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Construction and identification of a recombinant PRRSV 
expressing immunodominant of VP1 gene of type O foot-and-mouth 
disease virus 
 
Wu Tong1,2, Yanzhao Xu1, Yanjun Zhou1, Yifeng Jiang1, Shanrui Zhang1,  
Shen Yang1, Lingxue Yu1, Jing Sun1, Huanchun Chen2, Guangzhi Tong1* 
1Shanghai Veterinary Research Institute, CAAS, Shanghai, 2College of Veterinary Medicine, 
Huazhong Agricultural University, Wuhan, China 
 
Porcine reproductive and respiratory syndrome (PRRS), caused by PRRS virus (PRRSV), is an 
acute transmissible disease of pigs characterized by reproductive disorders in sows, and 
respiratory distress and mortality in piglets. PRRSV consists of two genotypes, North American 
type and European type represented by VR2332 and LV, respectively. The disease can be spread 
horizontally and vertically in swine herds and causes great economic losses to swine industry. In 
2006, a “high fever disease” emerged in Chinese swine herds characterized by high morbidity 
and mortality in all age pigs, the causative agent of the disease was later identified as a variant of 
PRRSV (also called highly pathogenic PRRSV). At present, an attenuated vaccine against the 
highly pathogenic PRRSV has been developed in China, but when vaccination of pigs together 
with this vaccine and other vaccines (such as attenuated foot and mouth disease vaccine), it may 
cause immune failure of other vaccines as PRRSV could induce immunosuppression in pigs. To 
avoid the interference, developing of a combined vaccine by using PRRS vaccine virus as vector 
should be significantly practical. 
 
In the study, based on an infectious molecular clone of highly pathogenic PRRSV derived 
vaccine strain HuN4-F112, one infectious cDNA clones deletions in nsp2 region was constructed 
and named as rHuN4-F112-△508-532, respectively. Using rHuN4-F112- △508-532 as vector, a 
synthesized fragment representing 421-480nt（141-160aa）and 598-639nt（200-213aa）of 
VP1 gene of foot and mouth disease virus (FMDV) was inserted into the deleted site of nsp2 
region. The two discontinued sequences contain multiple neutralizing antigenic epitopes of 
FMDV. The recombinant cDNA was in vitro transcripted followed by trancfection of BHK-21 
cells, 36 h later, supernatant of the cell culture was transferred to monolayer of MARC-145 cells 
for recovery of the recombinant virus. CPE was developed visible after a couple of passages in 
MARC-145, and the rescued virus (designated as rPRRSV-F112-O/VP1ep) was identified by 
Mlu I digestion, sequence determination and immunofluorescence assay. At meanwhile, 
expression of inserted FMDV epitopes was detected by indirect immunofluorescence assay with 
polyclonal antibodies to VP1 protein of FMDV. The titer of the rescued recombinant PRRSV 
was similar to its direct parental virus rHuN4-F112-△508-532, but higher than rHuN4-F112.  
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Characterizing the Antibody Response Following Experimental 
PRRSV Infection in a Large Population of Pigs 
 
Benjamin R. Trible*, Luca N. Popescu, Yu Wang, Maureen A. Kerrigan,  
Raymond R.R. Rowland 
Department of Diagnostic Medicine & Pathobiology, College of Veterinary Medicine,  
Kansas State University, Manhattan, KS 
 
In general, the neutralizing antibody (nAb) response following PRRSV infection is weak and 
delayed. Furthermore, nAb is primarily directed against the homologous virus used for infection.  
The purpose of this study is to evaluate the total and nAb response in a large population of 
experimentally infected pigs. Based studies of immune response to HIV, we predicted that a 
subpopulation of pigs exists that are capable of producing broadly neutralizing antibody (bnAb). 
Serum samples from an ongoing study evaluating the role of host genetics in resistance-
susceptibility to PRRSV infection were used for this study. Samples were obtained from 689 
pigs challenged at about 4 weeks of age with NVSL 97-7895 (482 pigs) or a contemporary 
isolate, KS06 (207 pigs), which is still circulating in the field. Blood and other samples were 
collected regularly for phenotypic data. Virus neutralizing activity was measured at 42 days after 
infection. Neutralizing assays were performed using 4 viruses, KS-06, NVSL 97-7895, 2867, and 
VR-2332, which are well separated within a phylogenetic tree. Isolates had a difference ranging 
from 5-11% at the nucleotide level of ORF5. Based on the results of neutralization assays, 
samples were placed into the following categories: Group 1, no neutralizing activity (14.4%); 
Group 2), neutralizing activity against only the homologous virus (50.5%; homologous nAb); 
Group 3, neutralizing activity against the homologous virus and one or two additional isolates 
(29.6%; heterologous nAb); or 4) neutralizing activity against all four isolates (5.5%; broadly 
nAb). There was no apparent correlation between total anti-PRRSV antibody (measured against 
the N protein) and the amount of neutralizing activity. As reported in another abstract (Hess et 
al.), virus neutralizing activity has a heritable component. There is also an inverse relationship 
between virus load and homologous neutralizing titer, indicating a role for nAb in the control of 
virus replication. The identification of pigs that possesses a “broadly” neutralizing antibody 
response suggests the existence of conserved neutralizing epitopes. The genetic basis for a bnAb 
response creates the opportunity to develop pig lines that are tailored to respond optimally to 
current or future PRRS vaccines. 
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Antibody Immune Masking, a new platform to develop a broadly 
protective porcine reproductive and respiratory syndrome virus 
(PRRSV) vaccine 
 
Jessie Trujillo1, Khushboo Hemnani1, Tanja Opriessnig3, Robert Messe3,4,  
and Peter L. Nara1, 2, 5 
1Center for Advanced Host Defenses, Immunobiotics and Translational Comparative Medicine, 
College of Veterinary Medicine, Iowa State University, Ames, IA, 2Biomedical Science, College 
of Veterinary Medicine, Iowa State University, 3Veterinary Diagnostic and Production Animal 
Medicine, College of Veterinary Medicine, Iowa State University, 4Immunobiotics Iowa (IBI2), 
Ames, IA, 5Biological Mimetics Inc., Frederick, MD 
 
Porcine Reproductive and Respiratory syndrome virus (PRRSV) has become a major health issue 
for swine industry worldwide, with an estimate loss of $640 million/year in US alone. Current 
vaccines provide limited protection especially against minor and divergent strains (up to 40% 
variability). Major challenges in the development of a broadly protective vaccine besides high 
mutation rate are multiple host evading properties of the virus, amongst them is the property of 
certain epitopes and other domains on the pathogen to be immunodominant and non-protective 
by focusing the stimulation of antibodies, innate and cell-mediated responses on non-critical or 
strain-restricted targets on the virus.  This leads to a non-protective immune response, away from 
the recognition of conserved subdominant more broadly protective epitopes. We hypothesize that 
a proprietarily prepared autogenous PRRSV vaccine derived from the technology of Antibody 
immune Masking (AIM) can refocus the immune response from these immunodominant epitopes 
to broadly protective subdominant epitopes. Here we present the efficacy of two challenge 
models in reducing viremia, PRRSV associated pathology in primary organ of PRRSV 
replication and reduction of infection. In the preliminary study, pigs receiving the AIM vaccine 
and later challenged with a heterologous virus developed anti-virus antibody response, towards 
both the homologous and heterologous strains, a week earlier as compared to the control groups 
receiving the virus alone and also had greatly reduced lung lesions. The most recent trial 
demonstrated that AIM vaccination was 33% effective in prevention of infection from a 
heterologous PRRSV virus. AIM vaccinated pigs that were not protected from infection had 
significant reduction in peak viremia post challenge as compared to the autogenous vaccines 
(p=0.0034) and unvaccinated controls (p=0.0001). AIM vaccinated pigs also had a significant 
reduction in pulmonary viral loads as compared to unvaccinated controls (p=0.0126) that was 
reflective of reduced pulmonary pathology in vaccinated groups as compared to the non-
vaccinated controls. Future goals would be to translate the vaccine to field and elucidate the 
mechanism of vaccine protection.  
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Bone marrow allotransplantation rescues severe combined 
immunodeficiency phenotype in pigs 
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D.M. Thekkoot1, J.M. Young1, E. Snella1, C.-S. Ho2, R.R.R. Rowland3,  
C.R. Wyatt3, H. He3, J.C.M. Dekkers1 
1Department of Animal Science, Iowa State University, Ames, IA, 2Histocompatability 
Laboratory, Gift of Life Michigan, Ann Arbor, MI, 3College of Veterinary Medicine, Kansas 
State University, Manhattan, KS 
 
Severe combined immunodeficiency (SCID) is a primary immune deficiency that occurs 
naturally in humans, dogs, and horses, and has been introduced by transgenics into mice and 
recently into pigs. We recently identified the first natural occurrence of SCID in pigs. Routine 
necropsy of four piglets that died soon after weaning revealed underdeveloped lymph organs, 
few T- and B-cells, and low levels of antibodies. These piglets were from related parents of the 
ISU low residual feed intake selection line, which descends from commercial purebred 
Yorkshire pigs. Repeat matings of the two sires and four dams have produced 6 additional litters 
with confirmed SCID piglets in an approximately 20-25% frequency. Affected piglets appear 
healthy while on the sow but deteriorate quickly after weaning, succumbing to opportunistic 
infections. To identify the genomic region associated with this defect, 20 affected piglets, 50 
unaffected littermates, the 6 parents, and 96 normal ancestors were genotyped using the Illumina 
Porcine SNP60 Beadchip. The dfam option of PLINK was used to identify a 5.6 Mb region that 
is associated with the threshold disease trait (P = 2.7x10-7). Haplotype phasing analyses using 
Phase (2.1.1) identified two distinct haplotypes that are associated with the defect. Single SNP 
testing in the region confirmed the BeadChip data and co-segregation of this region and the 
SCID phenotype. The region contains a very strong candidate gene based on comparative 
information from other species. Sequencing is underway to identify the causative mutation. Pre-
suckling serum antibody levels, lymphocyte numbers from complete blood counts (CBC), and 
single SNP testing were used to rapidly identify nine affected piglets from four additional litters. 
Bone marrow transplantation was used to treat affected piglets, in order to obtain genetically 
affected pigs of reproductive age for more effective production of SCID piglets for biomedical 
research. A fully MHC matched bone marrow donor of the opposite sex bone marrow donor was 
identified for each affected recipient; marrow was harvested and transferred into each affected 
piglet through an ear vein. Blood was drawn biweekly post transfer to assess engraftment. CBC 
data showed an increase in lymphocyte and total white blood cell numbers over a two-month 
period. Flow cytometry showed increases in both B- and T-cell populations. Five of the nine 
bone marrow recipients developed graft versus host disease and were euthanized. Two pigs from 
the first two transplant litters are currently eight months of age and two pigs from the most recent 
two litters are four months of age. EHW is supported by USDA NIFA National Needs grant 
#2010-38420-20328; project is supported by funds from the ISU Research Foundation and from 
the Office of the Vice President for Research and Economic Development. 
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Lianghai Wang* and Wen-hai Feng 
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Immunology, College of Biological Science, China Agricultural University, Beijing, China 
 
In May 2006, highly pathogenic porcine reproductive and respiratory syndrome (HP-PRRS) 
attacked the swine industry of China, with the characteristics of high fever, high morbidity and 
mortality in pigs of all ages. Several conventional live attenuated HP-PRRS virus vaccines have 
been generated by continuous blind cell passages. However, this kind of vaccines has a 
disadvantage that they cannot be distinguished from naturally infected field virus strains by 
serological assays. Reverse genetics system provides a powerful tool to rationally develop 
vaccines with marker. Here, a recombinant HP-PRRSV expressing TRS6-drived GFP (RvHV-
GFP) was constructed by inserting a copy of the transcription regulatory sequence for ORF6 
(TRS6) between ORF1b and ORF2a. Intramolecular homologous RNA recombination was 
identified not only between the copy of TRS6 and the authentic TRS6 but also between the 
inserted GFP gene and ORF4/5. Thus, structural protein-encoding genes deleted non-viable 
viruses were continuously produced upon virus replication. The recombinant RvHV-GFP virus 
replicated slower than both wild-type HV and rescued HV (RvHV) virus and the different was 
significant. Moreover, RvHV-GFP also caused less cell death and milder cytopathic effect (CPE) 
in vitro. Most importantly, pigs infected with RvHV-GFP survived with none or mild syndromes 
such as lower rectal temperature, lower virus titers both in serum and tissues and scarcely 
pathologic changes, whereas all pigs infected with HV or RvHV (3 pigs per group) died before 
12 days post infection. Furthermore, vaccination with RvHV-GFP could fully protect pigs 
challenged with both homologous and heterologous HP-PRRSV strains. Our data implicates the 
possible development of novel live attenuated marker virus vaccines against arterivirus and 
coronavirus based on intramolecular homologous RNA recombination.  
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Development of a new vaccine based on a PRRSV replicon 
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Currently used modified live vaccines (MLV) for PRRSV are far from ideal. First, it 
provides full protection against PRRSV strains that are antigenically close to the vaccine virus, 
but only partially protective against heterologous PRRSV strains. Second, there is a risk of the 
reversion of the vaccine virus to virulence. Third, vaccinated pigs become viremic and shed the 
virus into the environment. Fourth, current modified live vaccine lack a DIVA potential 
(possibility to differentiate infected and vaccinated pigs). Therefore, a new better vaccine is 
urgently needed for the swine industry.  
In this study, we used a DNA-launched infectious clone of a highly virulent PRRSV 
strain VR2385. A propagation-defective viral genome was generated by deleting the ORF2 
region of the genome that encodes the GP2 and E proteins that are essential for virus spread. The 
self-replicating but propagation-defective PRRSV was generated by injection of the plasmid 
DNA containing the deletion mutant genomic clone into the pig muscle. To evaluate 
immunogenicity and protective efficacy of this vaccine candidate, PRRSV-negative 3 weeks-old 
piglets were divided into three groups comprising eight animals each. Group 1 pigs were 
vaccinated twice at a 3 week interval intramuscularly with the vaccine candidate (replicon); 
group 2, as a negative control, received pCI-neo DNA and group 3 had a commercial MLV. 
Three weeks after the second immunization, all pigs were intranasally challenged with PRRSV 
VR2385. Rectal temperatures were measured every other day after challenge. Blood samples 
were collected for virus and viral RNA isolation and serology. The pigs were euthanized on day 
14 post-challenge, and bronchoalveolar lavage fluids (BALF) were collected for virus isolation.  
Before PRRSV challenge, only pigs vaccinated with MLV developed antibody response 
measured by ELISA, and none of the pigs developed PRRSV neutralizing antibodies in serum. 
The MLV vaccinated pigs also showed high PRRSV-specific INF-γ response, whereas replicon-
vaccinated pigs showed low but detectable INF-γ response. After challenge, all pigs were 
positive for PRRSV-specific ELISA antibody, and replicon-vaccinated pigs elicited higher titers 
than control pigs. In addition, all pigs showed similar PRRSV-specific serum neutralizing titers 
on day 14 post challenge. Also, on day 14 post challenge, all MLV-vaccinated pigs were 
PRRSV-negative based on virus isolation from serum and BALF, whereas 25% sera and 50% 
BALF of replicon-vaccinated pigs were PRRSV-positive.  Control pigs showed virus in 50% 
serum and 85% BALF samples. To further evaluate quantitative levels of PRRSV replication in 
challenged pigs, RNA genome copy numbers in serum samples at 6 and 14 days post challenge 
were determined by real-time RT-PCR. The RNA copy numbers in sera from control group were 
significantly higher than from other groups. Rectal temperatures were significantly decreased in 
the MLV-vaccinated pigs on day 2, 6 and 10 post-challenge in comparison to other groups.   
Vaccination with the PRRSV replicon increased numbers of IFN-γ producing cells and 
decreased viremia in blood and BALF of the PRRSV-challenged pigs. Thus, the vaccine is 
partially protective and is a potential vaccine candidate for the future with further improvement.  
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The effectiveness of vaccines against porcine reproductive and respiratory syndrome virus 
(PRRSV) is hampered by the high error rate and genetic diversity of PRRSV, which are thought 
to play an important role in virus immune evasion. Neutralization escape is the proposed 
mechanism for the emergence of PRRS in vaccinated herds; however, it has been difficult to 
demonstrate a causative relationship between specific mutations and immune escape. In the 
present study, we examined genetic diversity in samples available through the PRRSV Host 
Genetics Consortium, in which over 1500 pigs experimentally infected with PRRSV were 
followed through 42 days post-infection (dpi).  In approximately 30% of the pigs, the virus was 
cleared by 21 dpi, but rebounded by 42 dpi, indicating potential escape from host immune 
control. Serum samples were obtained from seven pigs, including two that successfully cleared 
the virus (cleared), two that maintained high levels of viremia throughout the trial (persistent), 
and three that initially cleared the virus then rebounded by day 41 (rebound).  Viral RNA was 
isolated from the PRRSV NVSL97-7985 inoculum, from day 7 serum, and from late day sera 
from persistent and rebound pigs. cDNA was synthesized and ORF2-6, which codes for GP2-5 
and M, were amplified, cloned, and 10-30 clones were sequenced from each pig/day post 
infection. Viral populations within pigs and the inoculum were compared by multiple sequence 
alignment (ClustalW). Comparisons between the inoculum and day 7 virus populations identified 
six sites with a change in dominant amino acid in at least one pig.  Comparisons between day 7 
and late day populations from persistent and rebound pigs identified twelve sites with a change 
in predominant amino acid, with the number of dominant amino acid changes ranging from one 
to eight within individual pigs. The dominant amino acid changes were observed in GP2, GP3, 
GP4, GP5a and GP5, as well as in overlapping reading frames; however, only one of these 
changes occurred in an identified B-cell epitope. Phylogenetic analysis (RAxML) of the entire 
GP2-M region within single pigs revealed that late day virus populations often formed a distinct 
clade, especially in rebound pigs, indicating divergence of the late day virus from inoculum and 
day 7 virus populations. Simulations were used to check if the changes in allele frequencies were 
greater than predicted by genetic drift under a neutral model.  Assuming the effective population 
size never dropped below 100 during the course of infection, evidence of selection was found in 
six of seven pigs at day 7 and three of five pigs later in infection.  Selected sites tended to be 
shared among all pigs at day 7, but were unique for each pig later in infection. Together, these 
results suggest that some mutations in ORF2-6 of PRRSV arise from selective pressure, and may 
contribute to immune escape in vivo.  
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 Host genetics has been proven to be associated with resistance/susceptibility to Porcine 
Reproductive and Respiratory Syndrome virus (PRRSV) infection. Specifically, a region on Sus 
scrofa chromosome (SSC) 4 harbors a large quantitative trait locus (QTL) that is associated with 
decreased virus load and increased weight gain. The objective of the current study was to explore 
other genomic regions associated with resistance/susceptibility to PRRSV infection using data 
from the PRRS Host Genetics Consortium (PHGC) PRRS-CAP project by conducting a genome-
wide association analysis. Eight groups of ~200 commercial crossbred pigs from 5 breeding 
companies were experimentally infected between 18 and 28 days of age with virus isolate NVSL 
97-7985. The first 3 trials were from the same company and cross. Breeds represented in the 
crosses included Large White, Landrace, Yorkshire, Duroc, and Pietrain. Blood samples and 
body weights were collected up to 42 days post infection (dpi). Pigs were genotyped for over 
60,000 single nucleotide polymorphisms (S P s) across the genome with Illumina’s Porcine 60k 
Beadchip. Whole genome analyses focused on viral load (VL = area under the curve for log-
transformed RT-PCR based serum virus from 0-21 dpi) and weight gain (WG = gain from 0-42 
dpi). Viral load data was only available for the first 7 trials. A 1 Mb region that was associated 
with VL was identified on SSC1. This region explained only 0.24% of the genetic variance in 
trials 1-3 and 0.04% in trials 4-7. Jointly, this region explained 1.5% across trials 1-7. For WG, 
the SSC1 region explained less than 0.04% in trials 1-3 and 1-8. This region included 21 SNPs 
across trials. Two important candidate genes lie within 2 Mb of this region: DBC1 (deleted in 
bladder cancer 1) and TLR4 (toll-like receptor 4). Gene DBC1 has been reported as a tumor 
suppressor gene and may partially regulate apoptosis. Gene TLR4 is a cell receptor that 
recognizes pathogenic invasion in different cell types, including macrophages, which is where 
PRRSV replicates. Previous QTL mapping work has also identified a QTL Complement 3 
concentration (C3c) in this region. The C3c QTL is associated with assisting antibodies to clear 
pathogens from the host. Further haplotype and SNP analyses are underway. This work was 
supported by PRRS CAP, USDA NIFA Award 2008-55620-19132, NRSP-8 Swine Genome and 
Bioinformatics projects, the National Pork Board and breeding companies of the PRRS Host 
Genetics Consortium. 
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The appearance of highly-pathogenic porcine reproductive and respiratory syndrome virus 
(PRRSV) isolates in Asia necessitates investigation into the clinical repercussions of these 
viruses if the strains were to appear in the US. Epidemiologic data from Asian outbreaks suggest 
that disease severity was associated with both the PRRSV isolates from these cases and 
secondary bacterial infections. Previous reports have indicated that US isolates of PRRSV 
predispose to secondary bacterial infections as well, but outbreaks like the ones described in Asia 
have not been reported in the US. The objectives of this research were to compare the 
pathogenesis of Asian and US PRRSV isolates of varying virulence with regard to their ability to 
cause disease and predispose to secondary bacterial infections in swine. The experiment 
consisted of 10 groups of 9-10 pigs each. At 6 weeks of age, half the groups were inoculated 
with a bacterial cocktail of Streptococcus suis, Haemophilus parasuis, and Actinobacillus suis 
and 1 week later 4 bacterial colonized groups and 4 non-bacterial colonized groups were 
inoculated with 1 of 2 Asian HP-PRRSV strains (JXwn06 or SRV07) or 1 of 2 US PRRSV 
strains (SDSU73 or VR2332). The pigs infected with JXwn06 were clinically the most severely 
affected (based on clinical signs, febrile response, and weight gain) while the pigs infected with 
SRV07 and SDSU73 were moderately affected, and pigs infected with VR2332 showed minimal 
clinical signs. One pig coinfected with JXwn06 and bacteria became moribund and was 
euthanized. An increase in the levels of proinflammatory cytokines in the sera occurred, in 
general, around day 6-8 post viral infection with the magnitude of increase generally correlating 
with the severity of clinical disease. The highest viral titers were detected in pigs challenged with 
JXwn06. A. suis and/or H. parasuis was cultured from the lungs of 3/9 pigs from groups 
challenged with the bacteria alone, VR2332/bacteria, and SDSU73/bacteria, and from 6/9 pigs 
challenged with SVR07/bacteria and JXwn06/bacteria, respectively. These bacteria were not 
isolated from the non-challenged control pigs or pigs challenged with virus alone. Lesions 
consistent with bacterial pneumonia, including abscesses, were seen in the groups coinfected 
with PRRSV and bacteria. The levels of proinflammatory cytokines in the serum were often 
lower for pigs coinfected with virus and bacteria compared to pigs only infected with PRRSV. 
There was a range of virulence among the PRRSV isolates and differences in their ability to 
predispose to secondary bacterial infection. 
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Specific objective: Porcine reproductive and respiratory syndrome virus (PRRSV) and porcine 
circovirus type 2 (PCV2) are the main causes of porcine respiratory disease complex (PRDC) 
which is one of the most important disease in Taiwan pig farms. The Boehringer Ingelheim 
CircoFLEX ® was the only PCV2 vaccine marketed in Taiwan when this study was conducted a 
year ago. The purpose of this study was to evaluate its influence on lung lesions and distribution 
of PRRSV and PCV2 in sera and tissues after PCV2 vaccination in the field pigs.  
 
Methods:  Three hundred 4-week-old pigs were divided into vaccinated and control groups, with 
150 pigs each in three pens respectively in the same house. The pigs in the vaccinated group 
were intramuscularly injected with one dose of BI CircoFLEX® vaccine and the pigs in the 
control group with one ml of saline. Twenty pigs in each group were randomly selected and 
tagged. Among them, four pigs in each group were humanely euthanized at days 0, 7, 21, 35 and 
49 after vaccination. The lung lesions were macroscopically examined, scored and collected. The 
sera, lymph nodes and spleens were also collected at same time to quantify the amounts of 
PRRSV RNAs by reat-time PCR. ANOVA analysis was performed to compare significant 
difference between groups. 
 
Results and conclusions: The results showed that the scores of lung lesions in vaccinated pigs 
are clearly lower than those in the control pigs, with significant difference at day 21. It was also 
found that the pigs in the vaccinated group had lower quantities of PRRSV RNAs than those in 
control group, as significant difference seen in lung, lymph node and spleen at day 49 (p<0.05). 
Taken together, the usage of BI CircoFLEX® could reduce the lung lesions and tissues’ PRRSV 
RNAs in vaccinated pigs and so that could provide certain protection from PRRSV infection.  
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Genetic variation in both structural and non-structural genes is a key factor in the capacity of 
PRRSV to maintain persistence within an animal, and within a production system. However, the 
exact mechanisms of how genetic variation contributes to persistence remain unclear. As part of 
a study to understand the role of host genetics in disease resistance, we identified pigs that were 
still viremic at 42 days after PRRSV infection. We took advantage of this subpopulation to 
identify mutations that appeared in circulating viruses at 42 days after infection. The focus was 
on sequencing four regions of the genome that show sequence hypervariability.  Specific and 
universal primers were designed for four hypervariable regions within nsp1β, nsp2, ORF3 and 
ORF5. Total R A  was extracted from 100 μL sera using TRIzol and cD A generated by reverse 
transcription using random hexamer primers. The first round of PCR was performed using 
sequence-specific primers. A second amplification was performed using 454 adaptor multiplex 
identifier (MID) primers. For unidirectional sequencing, MID were included on only the forward 
primers.  PCR products were then subjected to 454 sequencing. Mutations were identified in all 
regions, including distinct differences between pigs and at different frequencies within virus 
populations. Frequencies ranged between 12.3% and 100%. The same D85E substitution 
(frequencies: 99.9-100%) in GP3 in all pigs was identified. In addition, we also found some 
mutations identical in at least in two pigs, for instance, a Q44R mutation (38.7-83.1%) in nsp1β, a 
L469S mutation (86.1-86.2%) in nsp2, a T30A mutation (28.3-98.9%) within a N-glycosylation 
site in GP3, a A27V mutation (40.3-70.6%) in GP5, and a N32S mutation (53.6-59.3%) in GP5. 
The N32S mutation created an additional N-glycosylation site. This study illustrates the 
usefulness of deep sequencing for the analysis of PRRSV qausispecies. Only one mutation, D85E, 
was common to all pigs. 
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Introduction: 
 
The porcine reproductive and respiratory syndrome virus (PRRSV) has a tropism for pulmonary 
alveolar macrophages (PAMs) and may also infect specific dendritic cell (DCs) subsets in pigs. 
Modulation of the innate and adaptive immune response by PRRSV results in the establishment 
of persistent infection in herds, making it the most economically significant disease in the swine 
industry today. PRRSV mechanisms of immunomodulation, which confer variable pathogenicity 
amongst strains, are highly unknown. 
 
Results: 
 
Infection by PRRSV is restricted to cells that express CD163, which is needed for viral entry into 
the cytoplasm. Because monocytes and PAMs constitutively express CD163, it is highly 
plausible the monocyte derived DCs (MODCs) express the molecule as well. Unfortunately, 
differentiated MODC populations are often contaminated with monocytes and macrophages. As 
a result, models demonstrating infection of MODCs aren’t entirely reliable. Other models for 
PRRSV infection of DCs include the blood DC (BDC) and bone marrow derived DC (BMDC) 
populations. Our lab has performed comparisons of PRRSV infection of the three different DC 
populations using flow cytometry, q-RT-PCR, and Northern blots. Results have shown that 
BMDCs are the most appropriate model to demonstrate DC infection. Furthermore, we have 
launched an investigation into the role that non-structural protein 2 (nsp2) of the virus plays in 
immunomodulation. A unique feature shared amongst highly pathogenic strains of PRRSV is a 
major deletion in the nsp2 gene. We have established a model using Adenovectors to express 
nsp2 from three different strains of PRRSV in order to efficiently transduce DCs and PAMs. We 
will determine the immunomodulatory capabilities of nsp2 in order to further understand viral 
pathogenicity. 
 
Conclusions: 
 
Dendritic cells are the professional antigen presenting cells of the immune system and provide a 
direct link between the innate and adaptive immune response. Establishing that BMDCs are the 
most appropriate model to demonstrate PRRSV infection of DCs has allowed us to launch an 
investigation into the immunomodulatory mechanisms of nsp2, which is responsible for 
increased virulence. 
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PRRS not only constitutes a major threat to pig health but also has detrimental impacts on 
growth and reproductive performance. Simultaneous improvement of disease resistance and 
reduction of the impact of PRRSV infection on performance would therefore constitute a 
desirable goal for genetic improvement programs. Accumulating evidence suggests that there 
may be substantial variation between pigs in their resistance and tolerance to PRRSV infection.  
However, defining and quantifying resistance and tolerance phenotypes for genetic analyses is 
not straightforward because the effects of these traits are usually confounded and their (co-) 
expression can vary drastically throughout the time course of infection.  
 
We propose a new quantitative framework for obtaining individual phenotypes that capture the 
dynamic interactive effects of host resistance and tolerance on health and performance. This 
framework is based on individual performance–health trajectories obtained from plotting 
pairwise individual measurements of performance and health traits (e.g. growth and virus load) 
taken at different stages of the infection. Like viraemia and growth profiles, these trajectories are 
a visual representation of the impact of PRRSV on the host over time. However, as outlined 
previously for human diseases, these trajectories reveal a wealth of additional information about 
a host’s response to infectious pathogens at different stages of the infection that cannot be 
detected from infection or growth profiles alone. This information can be exploited to devise 
treatment strategies. For example, inspection of these trajectories allows classification of hosts 
according to specific types of response or impact, and informs on which stages of the infection to 
focus on in future genetic, immunological or intervention studies. Future breeding goals may aim 
to achieve specific health-performance trajectories. In order to implement this information into 
genetic improvement programs, quantitative phenotypes that fully specify the individual 
trajectories will need to be derived using tools available from mathematical dynamical systems 
theory.  Current studies are underway to implement these concepts for genetic improvement of 
pigs’ responses to PRRSV infections.  
  
2012 International PRRS Symposium/NSIF Conference 
87 
 
69 
Different patterns of suppressed IFN- transcription and reduced 
IRF3 phosphorylation in poly(I:C)-treated MARC-145 cells infected 
with PRRSV 
 
H.X. Hu, X. Zhang, H.S. Zhang, G.L. Wen, X.L. Li, W.H. Fang 
Institute of Preventive Veterinary Medicine, Zhejiang University, Hangzhou, China 
 
 Porcine reproductive and respiratory syndrome virus (PRRSV) causes huge economic 
loss to the swine industry. The virus can escape innate immune surveillance probably by 
suppressing interferon signaling pathways. However, the definite mechanisms by which PRRSV 
inhibits production of IFN- are poorly understood and there are contradictory results regarding 
the role of PRRSV in suppressing IFN regulatory factor 3 (IRF3)-mediated responses. This study 
attempted to examine the time-course profiles of IFN- transcription, IFN-promoter activity and 
IRF3 phorphorylation in poly(I:C)ptreated and PRRSV-infected MARC-145 cells using 
quantitative PCR, luciferase reporter assay, Western-blotting and confocal imaging. 
 There was no stimulation of IFN- promoter activity during the course of PRRSV 
infection up to 60 hs even though PRRSV RNA increased exponentially from 8 to 24 hpi with a 
plateau reached thereafter. Similarly, there was virtually no significant IFN-β expression in virus 
infected cells throughout the infection period, which was in sharp contrast with marked increase 
of IFN- transcript in poly (I:C) stimulated cells. PRRSV infection suppressed poly(I:C)-induced 
IFN-β gene expression. Such inhibition was time-dependent with PRRSV infection, being 
significant at 12 hpi and more pronounced with the progression of viral infection up to 60 hs. 
The IFN promoter based luciferase activity was not significantly decreased until 48 hpi in 
PRRSV-infected and poly(I:C)-treated cells. There was apparent gap of at least 36 hs between 
suppressed IFN- transcription and reduced luciferase activity. IRF3 phosphorylation did not 
occur in cells infected with PRRSV only, but did occur in poly(I:C)-stimulated and PRRSV 
infected cells. PRRSV infection significantly suppressed poly(I:C)-induced IRF3 
phosphorylation between 48 and 60 hpi. The quantity of pIRF3 was less in poly(I:C)-stimulated 
and PRRSV-infected cell nuclei than that in poly(I:C) stimulated control. Confocal co-
localization also provided evidence that PRRSV partially abolished pIRF3 nuclear translocation.  
 In conclusion, the significant time gap between suppressed IFN- expression and IRF-3 
nuclear translocation/IFN- promoter activity suggests that IRF3 pathway does not appear to 
have a major role in PRRSV suppressed IFN- expression in poly(I:C)-activated MARC-145 
cells in the early period of infection. PRRSV seems to deploy a yet to be identified mechanism to 
disarm the type I IFN responses in the cell line used in early infection. 
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Porcine reproductive and respiratory syndrome (PRRS) is a devastating disease that has plagued the pork 
industry for nearly three decades.  The influence that this disease has on the industry has prompted much 
research on the interaction between the PRRS virus (PRRSv) and the host’s immune system. The aim of 
the PRRS Host Genetics Consortium is to identify genomic markers and pathways associated with host 
response to PRRSv infection. A marked characteristic of PRRS is a delayed and unusually weak 
neutralizing antibody (NAb) response to PRRSv; however, studies have shown that the level and breadth 
of the NAb response contributes to the host’s ability to fight infection. Thus, strategies to control PRRS 
should include methods to enhance the NAb response to infection. The aim of the research reported 
herein was to examine host genetic differences in NAb response and elucidate the factors that influence 
NAb response.  Samples and data collected on 464 Large White-Landrace piglets, all infected with 
PRRSv strain NVSL 97-7895, were used. Viremia, evaluated by quantitative PCR, increased and peaked 
for all pigs at 7-14 days post infection (dpi) and thereafter declined. Viral load was defined as area under 
the curve of log viremia from 0-21 dpi.  In about 30% of pigs, virus rebound was observed, defined as at 
least a one Log increase in viremia after the virus had started to clear.  Serum samples collected at 42 dpi 
were assayed for NAb to the homologous NVSL 97-7895 using the following assay:  200 TCID50 of the 
virus was incubated with 1:2 dilutions of serum then transferred to tissue culture plates containing 
confluent MARC-145 cells; PRRSv cytopathic effects were assayed 4 days later.  The inverse of the 
highest serum dilution without cytopathic effects was recorded as the NAb titer and ranged from <8 to 
>1024.  For statistical analyses, titers were converted to an adjusted Log2 scale ranging from 0 (<8) to 8 
(>1024).   Analyses were performed using an animal model in ASReml in order to utilize pedigree 
information to establish the presence of a heritable component to NAb response.  The NAb response to 
NVSL 97-7895 was found to be a lowly heritable trait (h2=5.7± 9.7%).  Systematic and environmental 
factors influenced NAb response (plate explained 12.1±4.2% of variance, pen 1.1±2.1%, and dam 
2.1±5.9%).  Other variables were fitted as fixed effects in the model.  A one standard deviation increase in 
viral load was associated with a 0.34+0.09 decrease in log2 NAb titer (p      ).  Virus rebound was 
associated with a 0.81+0.19 increase in log2 NAb titer (p<0.001).  Viral load and virus rebound were 
uncorrelated (p=0.3)   Interestingly, the genotype of a SNP on chromosome 4 (WUR10000125) that was 
previously found to be associated with viral load in these data was not correlated with NAb response 
(p      . These data demonstrate the presence of a possible heritable genetic component to NAb 
response to PRRSv that independently either influences or is influenced by both level of viremia 
immediately following infection and virus rebound following initial clearance.  This work was supported 
by PRRS CAP, USDA NIFA Award 2008-55620-19132, NRSP-8 Swine Genome and Bioinformatics 
projects, the National Pork Board and breeding companies of the PRRS Host Genetics Consortium.       
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 Viremia profiles of PRRSV challenged pigs reflect disease progression and severity in the host, 
and impact on the subsequent control measures required. Inspection of serum viremia profiles of 964 pigs 
experimentally infected with PRRSV revealed that there were three broad categories of PRRS viral 
profile: clearance, persistence and reactivation [data provided by the PRRS Host Genetics Consortium 
(PHGC)]. The first category of viral profile is when the virus is cleared within 4-6 weeks post infection 
(pi), the second category is when the virus persists at a high level after 6 weeks pi and the third category 
is when the virus is initially cleared but there is a rebound in viremia levels after 4 weeks pi. Virus 
reactivation profiles consist of two distinct phases: the initial phase from 0-21days pi and a secondary 
phase containing the rebound from 21days pi onwards. These viraemia profiles further indicate that there 
may be large variation between hosts in their response to a PRRSV challenge. 
 The primary objective of the current study was to provide a suitable quantitative description that 
captured the full range of PRRS viremia profiles. For this purpose a method by which profiles could be 
classified was defined and thresholds for reactivation and persistence were calibrated to the PHGC data 
used. Initial visual inspection of PRRS viremia profiles indicated that the non-reactivated viral profiles 
and the primary phase of reactivated profiles could be captured by both the rapid increase to an 
asymptotic peak and the gradual exponential decline of the Woods curve: a gamma-type function often 
used to empirically describe lactation curves in dairy cattle. Further, in order to capture the biphasic 
reactivation profiles, the Woods function was extended to result in a bimodal function. The uni-modal 
profiles were analysed using a mixed models framework applied to a linearised Woods function, thus 
allowing the investigation of random subject-specific effects that represent the natural heterogeneity of 
the population and various fixed effects. However, to improve the bimodal reactivation profiles a 
Bayesian framework was adopted: we used an adaptive population-based Markov chain Monte Carlo 
method to fit the bi-phasic model to the viral profiles of the individual pigs in this study. Model fits were 
compared using the Akaike information criterion (AIC) and inspection of the standardised residuals. 
 The threshold of reactivation calibrated to this dataset on the log10 scale was z=1.5 for the 
secondary phase of the profile (i.e. viremia increased by 1.5 units), and persistence was defined as 
log10(viremia) ≥1 at 40-42 days pi. It was observed that 31% (n=300) of the pigs in this study experienced 
virus reactivation and 6% (n=38) of the non-reactivation profiles were classed as persistent. Under a 
mixed models framework the best fitting model was one in which individual variation was expressed in 
all three model parameters. There were no significant systematic differences between trials. Reactivation 
could not be predicted from the parameters derived from the primary phase. Bayesian inference 
confirmed that the uni-modal and bimodal Woods functions provided an adequate fit to all types of 
profile, but suggested that the exponential decline of the Woods function was too fast. This is the first 
study to quantitatively address the viral reactivation process. Parameter estimates derived from this study 
can be integrated into subsequent quantitative genetic and genomic analyses, and they can be used to 
validate process based dynamic mathematical models of PRRS viremia. 
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Objective 
A large scale project investigating the genomic and phenotypic predictors of PRRS resistance in pregnant gilts 
is underway at the University of Saskatchewan. One of the objectives of this project is to evaluate the 
susceptibility of gilts by assessing fetal preservation and viral levels in late term fetuses. Since the experiment 
is still ongoing, preliminary results from 6 out of 12 groups are presented.  
Materials and Methods 
Fifty-six PRRS-naïve high-health purebred Landrace gilts were synchronized and bred to Yorkshire boars. At 
gestation day 85 ±1, 49 gilts were inoculated with a Type 2 PRRSV, 50% IM and 50% IN (105 TCID50 total 
dose). Seven gilts were similarly sham inoculated (control). All gilts were monitored daily. On 21 dpi, dams 
and their litters were humanely euthanized and fetal preservation scored (Table 1). PRRSV RNA levels in fetal 
thymus were quantified by in-house RT-PCR and categorized as: 0=not detected, 1=positive not quantifiable, 
2=quantifiable, below mean, and 3=quantifiable, above mean. Mummified fetuses, considered dead prior to 
inoculation, were excluded from analysis. 
Table 1: Criteria for scoring fetal preservation in PRRS infected gilts 21 dpi (gestation day ~105) 
Preservation status Appearance external surfaces  Appearance internal organs 
Viable (VIA) Normal, white with visible hair Normal 
Meconium stained (MEC) Alive at termination but covered with inspissated, 
brownish amniotic fluid 
Normal 
Decomposed (DEC) Dead, generally white, < 50% of surface discolored Liquefied, friable, adhered 
Autolysed (AUT) Dead, > 50% of surface discolored Liquefied, friable, adhered 
Mummified (MUM) Small, dehydrated, inspissated remains: less than 20 cm crown rump length 
Results and discussion 
One infected gilt died (11 dpi) and one aborted (20 dpi); results from these gilts are not included. Apart from a 
reduced feed intake and rise in rectal temperature in some individual gilts, no other clinical signs were noted. 
No PRRSV RNA was detected in fetal thymus of control gilts. About half of the fetuses were VIA at 
termination (Table 2). MEC fetuses were observed only in infected gilts suggesting a PRRS-related pathologic 
process. Fetal preservation status was positively related to thymic viral loads (P<0.001; GLLAMM 
proportional odds model). Given a 1 unit increase in thymic viral load (scored 0.3), a fetus was 1.6 times more 
likely to be elevated to the next preservation category. Fetal preservation and PRRS virus levels in fetal 
thymus were highly variable among litters suggesting differences in susceptibility exist.  
Table 2: Fetal preservation and viral load in fetal thymus of infected gilts 
BY FETUS BY LITTER 
Fetal preservation % VIA % MEC % DEC % AUT Live/dead status % live % dead 
 Control (n=84) 98.8 0 0 1.2  Control (n=7) 98.70 1.30 
 Infected (n=624) 50.3 8.5 8.3 32.9  Infected (n=47) 59.92 40.08 
Viral load (infected) VIA MEC DEC AUT Fetal viral load (n=624) live dead 
 % negative 47.8 5.7 3.9 7.8  % negative 41.69 7.03 
 % PNQ 15.9 5.7 0.0 15.2  % PNQ 14.44 12.11 
 % positive 36.3 88.7 96.2 77.0  % positive 43.87 80.86 
Mean (SD) of positive 
log10 copies/mg 
5.9 (1.8) 6.9 (1.1) 5.7 (1.1) 4.3 (1.0) 
Mean (SD) of positive 
log10 copies/mg 
6.2 (1.7) 4.7 (1.2) 
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Objective 
A large scale project investigating the genomic and phenotypic predictors of PRRS resistance in pregnant 
gilts is underway at the University of Saskatchewan. One of the objectives of this project is to evaluate 
temporal relationships in white blood cells (WBC), PBMC subsets and PRRS RNA levels in serum 
following infection. Since the experiment is still ongoing, preliminary results from 6 out of 12 groups are 
presented.  
Materials and Methods 
Fifty-six PRRS-naïve high-health purebred Landrace gilts were synchronized and bred to Yorkshire 
boars. At gestation day 85 (±1), 49 gilts were inoculated with a Type 2 PRRSV strain, 50% IM and 50% 
IN (105 TCID50 total dose). Seven gilts were similarly sham inoculated (control). All gilts were monitored 
daily. Blood was collected on 0, 2, 6 and 19 dpi into plain and heparinized tubes. PRRS RNA was 
quantified in sera using an in-house RT-qPCR. Automated WBC counts (Cell-Dyn 3500, Abbott 
Diagnostics) and manual differential counts were performed (300 cells total) on heparinized blood. 
PBMC isolated from whole blood were stained with fluorochrome-conjugated, monoclonal antibodies to 
define cell subsets using flow cytometry.  
Results 
One PRRS-infected gilt aborted (20 dpi) and 1 gilt died (11 dpi). All cell subsets decreased by 2 dpi in 
PRRS infected gilts (Table 1). All except B-lymphocytes began to recover by 6 dpi. PRRS RNA 
concentration in serum peaked at 6 dpi (D2 = 2.9 ±0.6, D6 = 4.2 ±0.8 log10 copies/µl). At 21dpi, 17% 
(8/48) of animals had no detectable PRRS RNA in serum, 42% (20/48) had detectable but non-
quantifiable levels, and 42% (20/48) had quantifiable levels (mean 1.34 ±0.33 log10 copies/µl).  
Table 1. Mean (SD) cell counts in 49 gilts inoculated with type 2 PRRS virus at 85 days of 
gestation 
Cells 
(x109/L)   Group 
0 dpi 2 dpi 6 dpi 19 dpi 
mean SD mean SD % chg mean SD % chg mean SD % chg 
WBC  control 9.5 1.5 11.2 3.0 119 10.5 2.5 111 9.6 2.2 102 
 
PRRS 11.2 1.9 6.2 1.8 55 8.5 1.7 75 11.2 3.0 99 
T-lymphocyte  control 4.8 1.1 5.4 1.2 112 4.9 1.2 101 5.0 1.2 103 
(CD3+) PRRS 5.4 1.2 2.3 0.9 42 4.5 1.2 84 4.7 1.4 87 
B-lymphocyte  control 1.1 0.2 1.1 0.3 109 1.1 0.3 100 1.1 0.4 105 
(CD79a+) PRRS 1.3 0.5 0.7 0.3 57 0.6 0.3 49 1.0 0.4 81 
NK cells       control 0.1 0.1 0.1 0.05 99 0.1 0.1 130 0.1 0.1 136 
(CD3-CD8a+) PRRS 0.2 0.1 0.05 0.04 23 0.1 0.1 62 0.2 0.1 93 
Myeloid cells  control 0.8 0.2 0.8 0.3 104 0.7 0.2 85 0.7 0.2 82 
(CD172a+) PRRS 0.8 0.2 0.5 0.2 64 0.6 0.2 84 0.8 0.4 106 
Legend: % change (%chg) = no. cells at D2, 6 or 19 divided by no. cells at D0  
Conclusions and Discussion  
PRRS infection in pregnant gilts results in an acute profound transient pan-lymphopenia associated with a 
prominent viremia. The leukocyte responses however, varied considerably between individual gilts. Virus 
levels in serum peaked within 1 week; some animals are able to clear the virus by 21 dpi, while others are 
still viremic. Understanding how these changes correlate with clinical signs is underway. 
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Introduction:  Porcine high fever disease (PHFD) was first described in China as an acute onset of 
high morbidity and mortality in growing pigs.  Although a number of bacterial and viral pathogens were 
isolated from these cases, porcine reproductive and respiratory syndrome virus (PRRSV) was consistently 
detected leading to the assumption that PRRSV was the cause.  PHFD was reproduced with virus derived 
from an infectious clone of the PHFD JX143 PRRSV isolate resulting in this lineage of virus being called 
highly pathogenic PRRSV (HP-PRRSV).  In previous studies, virus rescued from a full-length clone of a 
2006 Chinese HP-PRRSV (JXwn06) induced severe disease in conventionally-raised pigs leading to 
100% mortality in 4-week-old pigs.  In contrast, pigs given VR-2332 challenge virus were much less 
affected with a mild fever and no mortality.  A variety of respiratory bacterial pathogens and opportunists 
were isolated from the HP-PRRSV infected group.  Based on clinical signs, lesions, and bacterial loads in 
previous studies, we hypothesized HP-PRRSV has a potent immunomodulating capacity that negatively 
affects the pig’s homeostasis allowing the onset of secondary bacterial disease which contributes 
significantly to the clinical disease.  A study using germ-free pigs housed in sterile isolators was 
conducted to evaluate the pathogenic potential of HP-PRRSV in the absence of bacteria. 
Methods:  Germ-free pigs were surgically derived and housed in sterile isolators.  At 15 days-of-
age 12 pigs were inoculated with about 1000 CCID50 virus derived from the JXwn06 HP-PRRSV isolate, 
and 5 pigs were left as controls.  Pigs were scheduled to be bled on 0, 4, 7, 11, and 14 days-post-challenge 
(dpc).  Periodic rectal swabs collected from the pigs were used to monitor bacterial-free status.  At 
necropsy, tissues were collected for histopathology.  Virus load was determined by testing ante-mortem 
plasma samples and the bronchoalveolar lavage collected at necropsy for virus titer.   
Results:  Control pigs remained normal throughout the study.  Most virus-challenged pigs began 
developing anorexia, fever, and listlessness 2 dpc; the clinical signs were variable and intermittent for the 
next 2-3 days as the pigs became more affected.  By 6 dpc some pigs were severely affected and a seizure 
was observed in 2 pigs.  Several pigs had developed a dark stool and one pig passed frank blood.  A pig 
was euthanized the evening of 6 dpc and within 24 hours 7 more pigs were either found dead or were 
euthanized.  The remaining 4 pigs had succumbed by 12 dpc.  Gross lesions in most pigs consisted of a 
mild pneumonia and petechial hemorrhages to varying degrees in the cortex of the kidney.  In addition, 
about half of the pigs had a hemorrhagic enteritis and swollen kidneys.  Cutaneous petechial hemorrhages 
were noted in two pigs.  Histopathology results are pending.  One isolator containing 4 pigs became 
contaminated with bacteria, although the GI tract became colonized in each pig, no sepsis was found 
(bacterial identification pending).  Virus loads were similar to previous conventional pig studies. 
Conclusion:  The objective of this pig study was to evaluate the pathogenicity of the JXwn06 HP-
PRRSV in the absence of bacteria.  The virus induced a fatal disease in the gnotobiotic pig model 
beginning about 6 dpc.  Interestingly, this is about the time when the onset of mortality is observed in the 
conventional pig model.  Moreover, the clinical disease in the one contaminated isolator was similar to 
what was seen in the other 2 isolators suggesting the bacterial infection did not potentiate the disease.  
Additional studies will be necessary to understand the putative synergy between HP-PRRSV and bacteria.   
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A recombinant porcine reproductive and respiratory syndrome 
virus expressing Gaussia luciferase gene 
 
Yanhua Li1*, Zhenhai Chen1, Zhi Sun1, Ying Fang1,2 
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South Dakota State University, Brookings, SD, USA 
We generated a recombinant porcine reproductive and respiratory syndrome virus (PRRSV) that 
expresses the Gaussia luciferase, designated as vSD-Gluc. The Gaussia luciferase gene was 
inserted into the nsp1beta and nsp2 junction of the viral genome, with its N- and C-terminus 
flanking a protein auto-cleavage cassette encoding the oligopeptides of foot-and-mouth disease 
virus (FMDV) 2A motif and PRRSV nsp11/12 cleavage site. The in vitro growth 
characterization demonstrated that vSD-Gluc remains the similar growth properties of the wild-
type virus.  Stability of the recombinant virus was followed for 10 serial passages in MARC-145 
cells. Sequence analysis on the passage 10 of the vSD-Gluc showed that the Gaussia luciferase 
gene and auto-cleavage cassette coding region remained intact in the virus genome. The potential 
application of the vSD-Gluc in the screening of anti-viral inhibitors was explored. When tested 
using IFN-α, the luciferase expression was highly corrected with virus titer reduction. 
Furthermore, ribavirin was identified as PRRSV replication inhibitor at a low millimolar 
concentration (0.2 mM). The information obtained in this study will be valuable for the 
development of anti-viral inhibitors. The luciferase reporter gene could also be effectively used 
to follow virus replication and gene expression in both cell culture system and in vivo animal 
studies.  
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Yuhai Bi1, Wenjun Liu1,2,* 
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Sciences, Beijing, China 
 
Porcine reproductive and respiratory syndrome (PRRS) has caused large economic losses in 
swine industry in recent years. However, current antiviral strategy could not effectively prevent 
and control this disease. Consequently, there is a need to develop a new antiviral strategy. 
MicroRNAs play critical roles in intricate host-pathogen interaction networks, but the 
involvement of miRNAs during PRRS virus (PRRSV) infection is unknown. In this research, 
eleven microRNAs were expressed by the psiSTRIKETM vectors and the inhibition against 
PRRSV was determined in MARC-145 cell. It was found that pretreatment with miR-26a could 
significantly inhibit the viral replication up to 120 hours post infection in a dose-dependent 
manner with evidence of alleviating CPE, reducing viral titer in supernatant, inhibiting viral 
RNA and protein synthesis in Marc-145 cells infected either with PRRSV VR2332 strains or 
with the highly pathogenic PRRSV 7-1 strain. Additionally, the expression of miR-26a by instant 
transfected plasmid at 8 hours post PRRSV infection could still efficacious inhibits PRRSV 
replication. Our study is the first attempt to suppress PRRSV replication in MARC-145 cells 
through vector based cellular miR-26a, which indicated that cellular miR-26a might be applied to 
be a new promising anti-PRRSV strategy.  
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following infection with strains of North American or Highly 
Pathogenic PRRSV 
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K. Faaberg2, T. Nicholson1 
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Recently, a highly pathogenic (HP) PRRSV strain has emerged in Asia, which causes severe 
clinical disease and mortality. Since its emergence, work has focused on characterizing the virus 
and host response following infection to determine the mechanism of enhanced virulence. 
PRRSV infection has been shown to cause a decrease in circulating T cell populations, 
lymphadenopathy and thymic atrophy; however, the relationship between these features in 
relation to HP-PRRSV has not been evaluated. Groups of pigs were challenged with one of two 
different North American isolates (VR-2332 or SDSU73) or one of two different HP-PRRSV 
isolates (SRV07 or JXwn06) for this study. Circulating T cell populations were enumerated on 1-
4, 6, 8 and 10 days post-infection (dpi) using a newly developed flow cytometric based assay 
with whole blood. T cell populations in the thymus and lymph node were evaluated on dpi 4 and 
10. Regardless of the challenge strain, there was a significant decrease in the number of 
circulating CD3+ T-cells, including CD4+ and CD8+ subsets, following infection. The sharpest 
decline occurred between dpi 1 to 2 in VR-2332, SDSU73 and JXwn06 groups and between dpi 
2 to 4 for SRV07 group. There was not a significant difference in the lowest number of 
circulating T cells between the SDSU73, SRV07 or JXwn06 groups. VR2332, SDSU73 and 
JXwn06 groups were viremic by dpi 1 while pigs challenged with SRV07 displayed a gradual 
increase in serum virus titers. The JXwn06 group had the greatest amount of virus in the sera 
beyond dpi 2; however, the number of circulating T cells was similar between SDSU73 and 
JXwn06 groups. Thus, serum virus titers alone do not explain the decrease in circulating T-cells. 
There was a significant increase in the number of dead T cells (CD4, CD8 and CD4/CD8 double-
positive) in the thymus of all PRRSV infected pigs, though SDSU73 and JXwn06 pigs were the 
most affected. There was not a significant increase in serum cortisol levels in any of the pigs. 
Taken together, there is a rapid decrease in the number of circulating T-cells following PRRSV 
infection, but, this effect does not appear to correlate to virulence, serum virus titers nor serum 
cortisol levels. 
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Porcine reproductive and respiratory syndrome virus (PRRSV) is a major pathogen of swine 
worldwide. Emergence in 2006 of a novel highly pathogenic PRRSV (HP-PRRSV) isolate in 
China warranted a comparative investigation into the host transcriptome response in 
tracheobronchial lymph nodes (TBLN) 14 days post-infection with HP-PRRSV rJXwn06, strain 
VR-2332 or sham inocula. RNA from each was prepared for next-generation sequencing. 
Amplified library constructs were directly sequenced and a list of sequence transcripts and 
counts was generated using an RNAseq analysis pipeline to determine differential gene 
expression. Transcripts were annotated and relative abundance was calculated based upon the 
number of times a given transcript was represented in the library. Major changes in transcript 
abundance occurred in response to infection with both PRRSV strains, each with over 630 
differentially expressed transcripts. The largest increase in transcript level for either virus versus 
sham-inoculated controls were three serum amyloid A2 acute-phase isoforms. However, the 
degree of up or down-regulation of transcripts following infection with HP-PRRSV rJXwn06 
was greater than transcript changes observed with US PRRSV VR-2332. Also, of 632 
significantly altered transcripts within the HP-PRRSV rJXwn06 library 55 were upregulated and 
69 were downregulated more than 3 fold, whilst in the US PRRSV VR2332 library only 4 
transcripts were upregulated and 116 were downregulated more than 3 fold. The magnitude of 
differentially expressed gene profiles detected in HP-PRRSV rJXwn06 infected pigs as 
compared to VR-2332 infected pigs was consistent with the increased pathogenicity of the HP-
PRRSV in vivo. 
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Preliminary study of effect of interfering NMHCII-A on PRRSV 
induced cell apoptosis 
 
Yang Mu*, Liang-liang Li, Ji-ming Gao, En-min Zhou 
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Cell apoptosis caused by virus infection is not only an antiviral defense mechanism, but also a 
strategy for virus escaping immune response and/or developing persistent infection. In 
mitochondrial pathway and death receptor pathway of cell apoptosis, the composition of Bcl-2 
family members, especially the ratio of Bcl-2/Bax, is "molecular switch" which starts the cell 
apoptosis. Nonmuscle myosin heavy chain II-A (NMHC II-A) has been identified in our 
laboratory as a co-receptor or mediator for PRRSV infection of cells. To determine the function 
of NMHC II-A in PRRSV induced apoptosis, Marc-145 cells transfected with artificial 
microRNAs (amiNMHC II-A) to knock down NMHC II-A expression were infected with 
PRRSV strain SD16 at 0.01MOI for different time and the levels of Bcl-2, Bax and NMHC II-A 
mRNA were detected by SYBR Green I real-time PCR method. β-actin was served as an internal 
reference. The results showed that (1) Compared with the Marc-145 cells ( P5 ) transfected with 
negative control plasmid, the level of NMHC II-A was knocked down about 50% in the Marc-
145 cells ( P4 ) transfected with amiNMHC II-A expression plasmid, Bcl-2 and Bax mRNA 
expression levels were increased but Bcl-2/Bax relative ratio was no significant changes before 
the virus infection. (2) At different times after PRRSV inoculation, Bcl2/ Bax relative ratios of 
these cells decreased slightly after PRRSV absorption for 1h at 37℃, increased from 3h to 6h 
after PRRSV inoculation and then decreased again after 12h of infection. These results suggested 
that the cells were in condition of suppression of the apoptosis at the beginning of PRRSV 
infection which favors the PRRSV replication. However, cell apoptosis was increased at late 
stage of PRRSV inoculation. Transfection of interfering plasmid targeting NMHC II-A had no 
effect on PRRSV induced cell apoptosis. 
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Porcine reproductive and respiratory syndrome (PRRS) is an economically devastating disease of 
pigs worldwide. PRRS virus neutralizing (VN) antibodies are important in providing protection 
against the disease.  To evaluate PRRSV herd immunity using individual serum samples in a 
statistically valid manner requires collecting blood samples from an unacceptably high number 
of pigs.  In other viral diseases, e.g., rhinovirus, HIV, CMV, and others, VN antibodies were 
shown to be present in oral fluid samples.  Therefore, determination of PRRS VN antibody titers 
in oral fluid samples could potentially serve as an indicator of PRRS herd immunity.   The first 
step in addressing this question was the VN assay, itself.  We standardized a PRRSV VN assay 
using oral fluid samples collected over a period of three months from swine herds vaccinated 
with MLV-PRRS.  The data showed PRRSV V  antibody titer ≥1:8 in oral fluids was PRRSV-
specific.  Thereafter, for validation purposes, we used 104 pen-based oral fluid samples (25 pigs 
per pen) and serum (5 pigs per pen) from two commercial wean-to-finish barns (A and B) in the 
Midwest USA. All the 47 oral fluid samples from Barn A, a site with a history of PRRSV 
infection, were positive for virus specific antibodies by ELISA, and 34 out of 47 oral fluids were 
positive for vrial RNA by qRT-PCR. Among the 47 oral fluid samples, 8 were VN antibody 
negative (4/8 virus negative) and 39 positive (9/39 virus negative), with positive VN antibody 
titers ranging from 1:8 to 1:32. In addition, all the 235 serum samples from Barn A were positive 
for virus-specific antibodies, with the average VN antibody titer of 1:10 and 1:20 in pigs from 
pens with oral fluid VN antibody negative and positive, respectively.  In contrast, all the 57 pens 
oral fluid and 284 sera belong to Barn B, with no PRRSV infection history, were negative for 
virus, virus-specific antibody, and VN antibody titers.  In conclusion, we have standardized and 
validated an oral fluid-based PRRS VN antibody assay.  This assay has the potential to monitor 
PRRS herd immunity in infected and/or vaccinated herds. This project was supported by USDA-
NIFA PRRS CAP2 and OARDC, The Ohio State University to RJG. 
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Objective 
The polarization into M1 and M2 macrophage (MØ) is essential to understand MØ function. 
Consequently, the aim of this study was to determine the impact of IFN-γ (M1), IL-4 (M2) and 
IFN-β activation of  MØ on the susceptibility to genotype 1 and 2 PRRSV strains varying in 
virulence. 
 
Methods 
Peripheral blood mononuclear cells were isolated from SPF pig blood by Ficoll density gradient 
and CD172a+ monocytes were purified by MACS. MØ were differentiated by culture during 72h 
in DMEM+GlutaMAX cell medium with 10% porcine serum and polarization was induced for 
another 24h by addition of IFN-γ, IL-4 or INF-β. MØ were infected with genotype 1 (LVP23, 
3267, 2982 and Olot/91) and genotype 2 (American VR 2332 and JA1182, and Chinese SY0608) 
PRRSV strains at MOI 0,1 during 20 h. Nucleocapsid expression and viral titers were 
determined.  Kruskal-Wallis and Mann-Whitney-U tests were used for statistical analysis (SPSS-
15 software). 
 
Results 
Undifferentiated and M2 MØ were highly susceptible to all PRRSV isolates. In contrast, M1 and 
IFN-β activated MØ were resistant to genotype 1 PRRSV but not to genotype 2 PRRSV strains. 
Highly pathogenic PRRSV isolates showed the highest level of infection, also in undifferentiated  
and M2 MØ (p<0,05). This was seen at the level of nucleocapsid expression, viral titers and 
virus-induced cell death. 
 
Conclusions 
Using IFN-γ and IF -β stimulated MØ it is possible to discriminate between PRRSV varying in 
virulence. This indicates that highly pathogenic PRRSV strains are more efficient at escaping the 
intrinsic antiviral effects induced by type I and II IFNs. Our in vitro model will help to identify 
viral genetic elements responsible for virulence. Our results, also suggest that monocyte-derived 
MØ could be used as a PRRSV infection model instead of alveolar  MØ, avoiding the killing of 
pigs.  
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Type I interferon (alpha/beta interferon [IFN-]) stimulates the expression of interferon-
stimulated gene 15 (ISG15), which encodes a ubiquitin-like protein, ISG15. Free ISG15 and 
ISG15 conjugates function in diverse cellular pathways, particularly regulation of antiviral innate 
immune responses. In this study, we demonstrate that ISG15 over expression inhibits porcine 
reproductive and respiratory syndrome virus (PRRSV) replication in cell culture and that the 
antiviral activity of interferon is reduced by inhibition of ISG15 conjugation. PRRSV 
nonstructural protein 2 (nsp2) was previously identified as a potential antagonist of ISG15 
production and conjugation. The protein contains a papain-like protease domain (PLP2) that 
plays a crucial role in the proteolytic cleavage of the PRRSV replicase polyproteins. PLP2 was 
also proposed to belong to the ovarian tumor domain containing superfamily of deubiquitinating 
enzymes (DUBs), which is capable of inhibiting ISG15 production and counteractingISG15 
conjugation to cellular proteins. To determine whether this immune antagonist function could be 
selectively inactivated, we engineered a panel of mutants with deletions and/or mutations at the 
N-terminal border of the nsp2 PLP2-DUBdomain. A 23-amino-acid deletion (amino acids 402 to 
424 of the ORF1a-encoded protein) largely abolished the inhibitory effectof nsp2 on ISG15 
production and conjugation, but no viable recombinant virus was recovered. A 19-amino-acid 
deletion (amino acids 402 to 420), in combination with a downstream point mutation (S465A), 
partially relieved the ISG15 antagonist function and yielded a viable recombinant virus. Taken 
together, our data demonstrate that ISG15 and ISGylation play an important role in the response 
to PRRSV infection and that nsp2 is a key factor in counteracting the antiviral function of 
ISG15. 
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syndrome virus replication in MARC-145 cells 
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Ziyue Road, Shanghai, PR China 
 
 Porcine reproductive and respiratory syndrome virus (PRRSV) poses significant threat to 
the swine production worldwide. Currently, no therapeutic options are available. In this report, 
we demonstrated that the treatment of MARC-145 cells with glycogen synthase kinase 3 (GSK-
3) inhibitor X significantly reduced PRRSV replication. It indicated that the activity of GSK-3 
was essential for the virus infection and this molecule exhibited a potential target for the 
treatment of PRRSV infection.  
    In this study, MARC-145 cells pretreated with GSK-3 inhibitor X at various 
concentrations as indicated were infected with HuN4-F112 (an attenuated strain of highly 
pathogenic porcine reproductive and respiratory syndrome virus HuN4) at various multiplicity of 
infection (MOI) at 24 h postinfection (h p.i) the progeny virus was titrated with TCID50 assay. 
To select the mutant virus which was conferred the drug resistance, GSK-3 inhibitor X was used 
to suppress the virus replication in MARC-145 for 14 passages. After fourteen passages, the 
virus titer increased and restored to level of the control without pharmaceutical treatment. Then 
complete genome of the selected mutant virus which tolerated to the GSK-3 inhibitor X was 
sequenced, and several mutations were found.  
    The chemical significantly diminished the virus infectivity with a does-dependent 
manner. With a concentration of both 10 and 20μM, it could efficiently inhibit the virus 
replication when infected with less than 10 MOI. While, when infected with a higher MOI of 10, 
the inhibitor of 10 μM showed miners inhibitory effect.   
    Alignment of the complete genome sequence of the parental virus to the mutant virus 
with GSK-3 inhibitor X resistance indicated that there are fifteen nucleotides changes. Six of 
them led to non-synonymous mutation, one was found in both Nsp12 and GP3, and two in Nsp2 
GP4, respectively.  
    Here, our study indicated that GSK-3 was essential for the PRRSV infection, and it may 
serve as a potential target for the therapeutic and prophylactic reagent development. The 
complete genome sequence analysis revealed that some amino acids in Nsp2, Nsp12, GP3 and 
GP4 were essential for the interaction with GSK-3 individually or coordinately, which was 
required for the virus replication. 
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China, 3Centro Nacional de Biotecnologia, Campus Universidad Autonoma, Cantoblanco 
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Insertion of enhanced green fluorescent protein (EGFP) encoding-gene into virus genes has 
provided a valuable tool for porcine reproductive and respiratory syndrome virus (PRRSV) 
research. Several data have proven the possibility to generate viable PRRSV with EGFP gene 
fused with the different genes. This study aimed to develop a PRRSV replicon expressing EGFP 
reporter that would provide a fast in vitro system to analyze functional roles of PRRSV in viral 
replication. Here, we report rescue of a recombinant PRRSV carrying an EGFP reporter gene as 
a separate transcription unit. Two unique restriction sites (Asis I and Mlu I) and a copy of the 
transcription regulatory sequence for ORF6 (TRS6) were inserted between the N protein and 3`-
UTR, yielding a general purpose expression vector. A viable recombinant of the PRRSV, 
vPRRSV-Ch-1R-EGFP, was obtained, which contained the EGFP insert at the site specifying the 
junction between the N protein and 3`-UTR. The vPRRSV-Ch-1R-EGFP could be launched by 
transfection of cells with a DNA launch plasmid pBAC-Ch-1RFL-EGFP. So far, vPRRSV-Ch-
1R-EGFP showed growth characteristics similar to those of the wild-type virus and was found to 
maintain the insert stably for at least ten passages. Live-cell imaging was used to follow virus 
spread in real time. In conclusion, the EGFP-expressing PRRSV will be a useful tool not only to 
monitor virus spread and screen for antiviral compounds, but also to investigate the biology of 
inclusion body formation. 
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Univ. of Alberta, Edmonton, AB, Canada, 3The Roslin Institute and R(D)SVS, University of 
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Recent swine genomics results have demonstrated that specific chromosomal regions impact 
nursery pig response to experimental PRRS virus challenge.  One would expect these results to 
extend to natural outbreaks of PRRS in a production system. Gilts and sows can face many 
health challenges in commercial production systems. Understanding the impact of genomics on 
the response of gilts and sows to these challenges can provide tools to select for improved sow 
health. 
 
This project combines a novel gilt acclimation and health/productivity assessment strategy with 
genetic information to evaluate the impact of swine genetics on gilt and sow health in 
commercial herds. A target of 4,000 high-health replacement gilts in approximately 35 lower-
health commercial herds will be used.  Blood will be collected on gilts prior to entry, 30 days 
post-entry and at parities 1 and 2.  Herd records will be used to evaluate gilt health and 
productivity. Gilts will be screened for exposure to PRRS, circovirus, influenza, Mycoplasma 
hyopneumoniae and Actinobacillus pleuropneumoniae.   Genomic analyses will evaluate the 
relationships of genetic markers with health and productivity outcomes.  Possible early-life 
indicators of sow health and productivity based on relationships of gilt acclimation with sow 
productivity traits will also be evaluated.  Collected samples and data will also be a valuable 
resource for future studies. 
 
By fall 2012, approximately 2,000 gilts will be sampled, and serologic analysis begun.  
Approximately 0.5% of gilts experienced adverse health that required removal from the herd 
within 30 days of arrival. Additionally, use was made of natural PRRS outbreaks to collect sow 
performance, genomic information and PRRS status on nearly 600 sows and 75 gilts.  
 
Project funding from CSHB and PigGen Canada is used for this project and this has been highly 
leveraged through participation in swine genomics research sponsored by Genome Canada and 
Genome Alberta.   
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MicroRNAs (miRNAs) repress the expression levels of genes by binding to mRNA 
transcripts, acting as master regulators of cellular processes. Cellular miRNAs also play critical 
roles in virus-host interactions, such as influenza A virus, hepatitis C virus, and retrovirus 
families. In contrast, no biological and molecular information has been reported on the potential 
role of cellular miRNAs in the lifecycle of PRRSV.  
In this report, we hypothesize that elucidating the miRNA expression signatures induced by 
H-PRRSV and N-PRRSV infections could reveal strain specific miRNA fingerprints, shedding 
important insights into the potential role of cellular miRNAs in host-PRRSV interactions. 
PRRSV preferentially infects and replicates in pulmonary alveolar macrophages (PAMs), using 
an Illumina deep sequencing platform, we profiled cellular miRNA expression in PAM infected 
with H- and N-PRRSV at multiple time-points during the viral lifecycle, including global mRNA 
gene expression profiling.  
By integrating the deregulated miRNAs and deregulated mRNAs (inversely correlated 
miRNA targets), miRNA-mRNA interactome networks were constructed. The functional 
relationship between miR10a and its potential target identified by the miRNA-mRNA inverse 
correlation interactome network was validated.  
Using gene ontology (GO) and pathway enrichment analyses, we identified the key GO and 
cellular pathways associated with the differentially expressed miRNAs and predicted inversely 
correlated miRNA targets during PRRSV infection, including immune response, phagosome, 
autophagy, Lysosome, autolysis, apoptosis, cell cycle. Our results also identify novel potential 
exosomal miRNA biomarkers associated with H-PRRSV and N-PRRSV-host infection. 
We used Illumina deep sequencing analysis to identify miR10a and miR10b as significantly 
deregulated upon PRRSV infection. Inhibition of miR10a and miR10b in PAM cells 
significantly increased transcription level of PRRSV N gene, while over-expression of miR10a 
and miR10b decreased virus N protein expression and decreased virus titer. Simultaneously, 
over-expression of miR10a and miR10b increased production of IL-1β. Further study showed 
that over-expression of miR10a inhibited expression of SRP14 and reduced the luciferase 
activity of SRP14 3’UTR. These results implicate miR10a and miR10b may inhibit PRRSV 
replication. 
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Non-structural protein (nsp) 11 of PRRS virus is a vial endoribonuclease that is essential for 
infectivity with an unknown mechanism. To examine the cellular gene expression profiles 
regulated by nsp11, MARC-nsp11 cells were constructed by retrovirus-mediated gene transfer to 
express the nsp11 gene of PRRSV, and an RNA microarray was conducted in these cells. In 
MARC-nsp11 cells, the IFN-beta, IRF3 (interferon regulatory factor 3), and nuclear factor (NF)-
kappaB luciferase reporter activities were suppressed compared to those of parental MARC-145 
cells, suggesting that nsp11 may be an IFN antagonist and MARC-nsp11 cells retained the 
biological function of nsp11. Differential cellular transcription profiles regulated by nsp11 were 
then examined using Affymatrix exon chips representing 28,536 human gene transcripts since 
MARC-145 cells are non-human primate origin. After statistical analyses, 66 cellular genes were 
shown to be up-regulated and 104 genes were down-regulated. These genes were further 
examined and grouped into five major cellular pathways according to their functional relations. 
The flow cytometry analysis of MARC-nsp11 cells showed that the nsp11 expression caused the 
delay of cell cycle progression, and the BrdU staining for cellular DNA in replicating cells 
indicated slower cell cycle through the S phase. Our study shows that the PRRSV nsp11 protein 
plays a role to modulate the host cell cycle progression and provides insights into specific 
cellular responses to nsp11 during infection. 
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Non-structural protein (nsp) 1 of PRRS virus has been shown to be a viral antagonist for type I 
interferon (IFN) production, and in cells expressing nsp1, CREB-binding protein (CBP) is 
degraded. Nsp1 is autoprocessed into nsp1-alpha and nsp1-beta subunits, and in the present study 
we show that the nsp1-alpha subunit was responsible for CBP degradation. The nsp1-alpha 
subunit contains three distinct functional motifs; a papain-like cysteine protease (PCP) motif, an 
N-terminal zinc finger motif (ZF1), and a C-terminal zinc finger motif (ZF2). To study the 
structure function relationship of nsp1-alpha and IFN antagonism, theses motifs were 
individually mutated and examined for their ability for IFN suppression. The mutations that 
destroyed the cysteine protease activities (C76S, H146Y, and C76S/H146Y) maintained the IFN 
suppressive activity, indicating that the cysteine protease activity did not participate in the IFN 
suppression. The mutations of C70, C76, H146, and/or M180, which coordinate the ZF2 motif, 
also did not change the IFN suppression, showing that ZF2 was not involved in the IFN down-
regulation. The mutations of C8, C10, C25, and/or C28 for the ZF1 motif appeared to impair the 
IFN suppression, indicating that ZF1 at the N-terminal region was the essential element for IFN 
suppression by nsp1-alpha. The wild-type nsp1-alpha subunit was normally localized in the both 
nucleus and cytoplasm, but the ZF1 mutants that lost the IFN suppressive activity were found to 
remain in the cytoplasm. Consistent with their cytoplasmic localization of the ZF1 mutants, CBP 
was not degraded by these mutants. Our results indicate that the ZF1 motif of Nsp1-alpha plays 
an important role for IFN regulation during PRRSV infection, and further demonstrate that the 
CBP degradation is likely the key mechanism for IFN suppression mediated by nsp1-alpha 
subunit of PRRS virus. 
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Porcine reproductive and respiratory syndrome virus (PRRSV) belongs to the 
Arteriviridae family and encompasses a single-stranded positive-sense RNA genome. As an 
obligate intracellular parasite, PRRSV depends on the host’s translation machinery for its protein 
synthesis. A key regulator of the translation process is the alpha subunit of eukaryotic translation 
initiation factor 2 (eIF2α). When phosphorylated, eIF2α inhibits the initiation of translation by 
preventing eIF2 from delivering the initiator Met-tRNA to the 40S ribosomal subunit. During 
viral infections, double-stranded RNA-dependent protein kinase R (PKR) is known to 
phosphorylate eIF2α following activation by double-stranded RNA. The status of PKR activation 
with regards to phosphorylation of eIF2α has yet to be determined in PRRSV-infected cells. We 
sought to reveal the roles of PKR and its substrate, eIF2α, in relation to PRRSV replication. 
Results showed that PRRSV induced the phosphorylation of PKR early in infection. Similarly, 
the transcription of GADD34, a regulatory subunit of the protein phosphatase 1 complex (PP1c), 
was also upregulated early in infection. PRRSV induced the phosphorylation of eIF2α during 
late infection in a time-dependent manner. It is likely that GADD34 is responsible for the 
dephosphorylation of eIF2α mediated by activated PKR to facilitate viral protein synthesis 
during early infection. We have indeed observed that phosphorylation of eIF2α correlated with a 
reduced rate of viral protein synthesis, indicating viral protein synthesis depends on eIF2α. The 
appearance of cytopathic effects was strongly correlated with eIF2α phosphorylation, suggesting 
a possible role of eIF2α phosphorylation in PRRSV-induced apoptosis. Furthermore, inhibiting 
the phosphorylation of PKR with the PKR-specific inhibitor, 2-aminopurine (2-AP), did not 
affect the phosphorylation status of eIF2α, indicating that another eIF2α kinase is responsible for 
the phosphorylation eIF2α in PRRSV-infected MARC-145 cells. Although PRRSV protein 
synthesis was not affected by 2-AP treatment, PRRSV titers were reduced by approximately 1 
log, suggesting that PKR activation may contribute to PRRSV replication in an eIF2α-
independent manner. Overall, the results obtained in this study reveal that PRRSV activates the 
phosphorylation of PKR while limiting the phosphorylation of eIF2α during early infection to 
promote viral protein synthesis. PRRSV induced the phosphorylation of eIF2α during later 
infection by undefined kinases, which may contribute to the observed cell death and virus release 
from infected cells. The results will aid in future research regarding control of the host 
translation machinery with respect to maintaining viral replication. 
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A monoclonal anti-idiotypic antibody (designated Mab2-5G2) was generated against anti-
PRRSV antibodies and characterized as an internal image Ab2, which mimics GP antigen and 
binds Marc-145 cells and porcine alveolar macrophages. Mab2-5G2 was used to purify a 230Kda 
soluble protein from these cells using immunoprecipitation and separated by SDS-PAGE. Based 
on the amino acid sequence by MS, the 230 KDa protein was identified as nonmuscle myosin 
heavy chain II-A (NMHC II-A) with the functional region located in its carboxyl terminus. A 
930bp gene (named PRA) at carboxyl terminus of NMHC II-A was amplified and cloned into 
eukaryotic expression vector. In cells transfected with PRA, the PRRSV infection was decreased 
by 50%. The recombinant PRA protein was produced which not only bound with Marc-145 cells 
but blocked PRRSV infection of Marc-145 cells. Six truncated PRA proteins were then 
expressed to define the binding site of NMHC II-A by Mab2-5G2. Using ELISA and Western 
blotting, the binding site was identified within N1669-C1720 of NMHC II-A. One of the 
truncated protein, named PR3 (targeting N1811-C1893), bound with Marc-145 cells and blocked 
PRRSV infection. Seven peptides within PRA region were synthesized and their polyclonal 
antibodies were prepared. Three peptides and their polyclonal antibodies blocked PRRSV 
infection. By using RNA interference to knockdown NMHC II-A expression, the binding of 
PRRSV to the cells was not interfered, but the PRRSV internalization and replication were 
markedly decreased. These results indicated that NMHC II-A identified by Mab2-5G2 that 
functionally mimics GP5 is involed in PRRSV entry into cells by direct interaction with PRRSV 
or in association with other cellular receptor proteins. 
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Meetings of Interest 
 
 
 
The 2012 Conference of Research Workers in Animal Diseases (CRWAD) 
Meeting will be held December 2-4, 2012, at the Chicago Marriott, Downtown 
Magnificent Mile, Chicago, Illinois.  
For more information, go to: http://www.cvmbs.colostate.edu/mip/crwad/  
 
The 44th annual meeting of the American Association of Swine Veterinarians 
(AASV) is scheduled for March 2-5, 2013 in San Diego, California, USA.  
For more information, go to: http://www.aasv.org/annmtg/  
 
European Federation of Animal Science 64th Annual Meeting will be held 
August 26-30 in Nantes, France.  For more information, go to: www.eaap.org 
 
The 10th annual International Veterinary Immunology Symposium will be held 
in Milano, Italy on August 28-September 1, 2013.  For more information, go to: 
http://www.ivis2013.org/  
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